{"id":41067,"date":"2015-09-17T11:25:58","date_gmt":"2015-09-17T16:25:58","guid":{"rendered":"https:\/\/content.findlaw-admin.com\/ability-legal\/contracts\/uncategorized\/indenture-healthsouth-corp-and-national-city-bank.html"},"modified":"2015-09-17T11:25:58","modified_gmt":"2015-09-17T16:25:58","slug":"indenture-healthsouth-corp-and-national-city-bank","status":"publish","type":"corporate_contracts","link":"https:\/\/corporate.findlaw.com\/contracts\/finance\/indenture-healthsouth-corp-and-national-city-bank.html","title":{"rendered":"Indenture &#8211; HealthSouth Corp. and National City Bank"},"content":{"rendered":"<pre>\n================================================================================\n\n                            HEALTHSOUTH CORPORATION,\n                                   as Issuer,\n\n\n                                       and\n\n\n                               NATIONAL CITY BANK,\n                                   as Trustee\n\n\n                                    INDENTURE\n\n\n                         Dated as of September 28, 2001\n\n\n                       7 3\/8% Senior Notes due 2006, Series A\n                       7 3\/8% Senior Notes due 2006, Series B\n\n\n                       8 3\/8% Senior Notes due 2011, Series A\n                       8 3\/8% Senior Notes due 2011, Series B\n\n\n\n================================================================================\n\n\n\n                              CROSS-REFERENCE TABLE\n\n\nTIA                                                            Indenture\nSection                                                         Section\n-------                                                        --------\n310(a)(1)                                                      7.10\n(a)(2)                                                         7.10\n(a)(3)                                                         N.A.\n(a)(4)                                                         N.A\n(a)(5)                                                         7.10\n(b)                                                            7.08; 7.10; 10.02\n(c)                                                            N.A.\n311(a)                                                         7.11\n(b)                                                            7.11\n(c)                                                            N.A.\n312(a)                                                         2.05\n(b)                                                            10.03\n(c)                                                            10.03\n313(a)                                                         7.06\n(b)(1)                                                         7.06\n(b)(2)                                                         7.06\n(c)                                                            7.06; 10.02\n(d)                                                            7.06\n314(a)                                                         4.02; 4.08; 10.02\n(b)                                                            N.A.\n(c)(1)                                                         10.04; 10.05\n(c)(2)                                                         10.04; 10.05\n(c)(3)                                                         N.A.\n(d)                                                            N.A.\n(e)                                                            10.05\n(f)                                                            N.A.\n315(a)                                                         7.01; 7.02\n(b)                                                            7.05; 10.02\n(c)                                                            7.01\n(d)                                                            6.05; 7.01; 7.02\n(e)                                                            6.11\n316(a) (last sentence)                                         2.08\n(a)(1)(A)                                                      6.05\n(a)(1)(B)                                                      6.04\n(a)(2)                                                         8.02\n(b)                                                            6.07\n\n                            N.A. means Not Applicable\n\n\nTIA                                                             Indenture\nSection                                                          Section\n-------                                                         --------\n(c)                                                             8.04\n317(a)(1)                                                       6.08\n(a)(2)                                                          6.09\n(b)                                                             2.04\n318(a)                                                          10.01\n--------------------\n\nNOTE:  This Cross-Reference  Table shall not, for any purpose, be deemed to be a\n       part of this Indenture.\n\n\n\n\n\n                                TABLE OF CONTENTS\n\n<\/pre>\n<table>\n<caption>\n                                                                                                              Page<br \/>\n                                                                                                              &#8212;-<br \/>\n                                                               ARTICLE 1<\/p>\n<p><s>                                                                                                             <c><br \/>\nDEFINITIONS&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;1<br \/>\n&#8212;&#8212;&#8212;&#8211;                                                                                                        <\/p>\n<p>Section 1.01      Definitions&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;1<br \/>\n                  &#8212;&#8212;&#8212;&#8211;<br \/>\nSection 1.02      Other Definitions&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..16<br \/>\n                  &#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\nSection 1.03      Incorporation by Reference of Trust Indenture Act&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;17<br \/>\n                  &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;-<br \/>\nSection 1.04      Rules of Construction&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.17<br \/>\n                  &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<\/p>\n<p>                                                               ARTICLE 2<\/p>\n<p>THE NOTES&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..17<br \/>\n&#8212;&#8212;&#8212;                                                                                                          <\/p>\n<p>Section 2.01      Dating; Incorporation of Form in Indenture; Form of Notes&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.17<br \/>\n                  &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\nSection 2.02      Execution and Authentication; Appointment of Authenticating Agent&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..18<br \/>\n                  &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\nSection 2.03      Registrar and Paying Agent&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..19<br \/>\n                  &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\nSection 2.04      Paying Agent To Hold Money in Trust&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..19<br \/>\n                  &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\nSection 2.05      Holder Lists&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.19<br \/>\n                  &#8212;&#8212;&#8212;&#8212;<br \/>\nSection 2.06      Replacement Notes&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..20<br \/>\n                  &#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\nSection 2.07      Outstanding Notes&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..20<br \/>\n                  &#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\nSection 2.08      Treasury Notes&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..20<br \/>\n                  &#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\nSection 2.09      Temporary Notes&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.21<br \/>\n                  &#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\nSection 2.10      Cancellation&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.21<br \/>\n                  &#8212;&#8212;&#8212;&#8212;<br \/>\nSection 2.11      Defaulted Interest&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.21<br \/>\n                  &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\nSection 2.12      Deposit of Moneys; Payments&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.21<br \/>\n                  &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\nSection 2.13      &#8220;CUSIP&#8221; Number&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..22<br \/>\n                  &#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\nSection 2.14      Depositary&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;22<br \/>\n                  &#8212;&#8212;&#8212;-<br \/>\nSection 2.15      Registration of Transfers and Exchanges&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.23<br \/>\n                  &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\nSection 2.16      Restrictive Legends&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;30<br \/>\n                  &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;-<\/p>\n<p>                                                               ARTICLE 3<\/p>\n<p>REDEMPTION&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.31<br \/>\n&#8212;&#8212;&#8212;-                                                                                                         <\/p>\n<p>Section 3.01      Notices to Trustee&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.31<br \/>\n                  &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\nSection 3.02      Selection of Notes To Be Redeemed&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.31<br \/>\n                  &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\nSection 3.03      Notice of Redemption&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..32<br \/>\n                  &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\nSection 3.04      Effect of Notice of Redemption&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.33<br \/>\n                  &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\nSection 3.05      Deposit of Redemption Price&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.33<br \/>\n                  &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\nSection 3.06      Notes Redeemed in Part&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;34<br \/>\n                  &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;-<br \/>\n<\/c><\/s><\/caption>\n<\/table>\n<p>                                        i<\/p>\n<table>\n<caption>\n                                                               ARTICLE 4<br \/>\n<s>                                                                                                             <c><br \/>\nCOVENANTS&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.34<br \/>\n&#8212;&#8212;&#8212;                                                                                                          <\/p>\n<p>Section 4.01      Payment of Notes&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;34<br \/>\n                  &#8212;&#8212;&#8212;&#8212;&#8212;-<br \/>\nSection 4.02      Reports&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;34<br \/>\n                  &#8212;&#8212;-<br \/>\nSection 4.03      Waiver of Stay, Extension or Usury Laws&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.34<br \/>\n                  &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\nSection 4.04      Compliance Certificate; Notice of Default; Tax Information&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;35<br \/>\n                  &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;-<br \/>\nSection 4.05      Payment of Taxes and Other Claims&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.35<br \/>\n                  &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\nSection 4.06      Corporate Existence&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;35<br \/>\n                  &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;-<br \/>\nSection 4.07      Maintenance of Office or Agency&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;36<br \/>\n                  &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;-<br \/>\nSection 4.08      Compliance with Laws&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..36<br \/>\n                  &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\nSection 4.09      Maintenance of Properties and Insurance&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.36<br \/>\n                  &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\nSection 4.10      Limitation on Restricted Payments&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.37<br \/>\n                  &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\nSection 4.11      Limitation on Additional Indebtedness and Subsidiary Preferred Stock&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..37<br \/>\n                  &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\nSection 4.12      Limitation on Asset Sales&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;39<br \/>\n                  &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;-<br \/>\nSection 4.13      Limitation on Transactions with Affiliates&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.42<br \/>\n                  &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\nSection 4.14      Limitation on Liens Prior to the Fall-Away Event&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.42<br \/>\n                  &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\nSection 4.15      Purchase of Notes upon a Change of Control&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.43<br \/>\n                  &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\nSection 4.16      Limitation on Restrictions on Distributions from Subsidiaries&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;44<br \/>\n                  &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;-<br \/>\nSection 4.17      Limitations on Layering Indebtedness&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.45<br \/>\n                  &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\nSection 4.18      Limitations on Liens After the Fall-Away Event&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;45<br \/>\n                  &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;-<br \/>\nSection 4.19      Limitation on Sale and Leaseback Transactions&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.46<br \/>\n                  &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<\/p>\n<p>                                                               ARTICLE 5<\/p>\n<p>SURVIVING ENTITY&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;46<br \/>\n&#8212;&#8212;&#8212;&#8212;&#8212;-                                                                                                   <\/p>\n<p>Section 5.01      Limitations on Mergers and Consolidations Prior to the Fall-Away Event&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;46<br \/>\n                  &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;-<br \/>\nSection 5.02      Limitations on Mergers and Consolidations After the Fall-Away Event&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;47<br \/>\n                  &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;-<br \/>\nSection 5.03      Successor Substituted&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.47<br \/>\n                  &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<\/p>\n<p>                                                               ARTICLE 6<\/p>\n<p>DEFAULTS AND REMEDIES&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.47<br \/>\n&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;                                                                                              <\/p>\n<p>Section 6.01      Events of Default&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..47<br \/>\n                  &#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\nSection 6.02      Acceleration&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.49<br \/>\n                  &#8212;&#8212;&#8212;&#8212;<br \/>\nSection 6.03      Other Remedies&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..50<br \/>\n                  &#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\nSection 6.04      Waiver of Existing Defaults and Events of Default&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;50<br \/>\n                  &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;-<br \/>\nSection 6.05      Control by Majority&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;50<br \/>\n                  &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;-<br \/>\nSection 6.06      Limitation on Suits&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;51<br \/>\n                  &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;-<br \/>\nSection 6.07      Rights of Holders To Receive Payment&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.51<br \/>\n                  &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\nSection 6.08      Collection Suit by Trustee&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..51<br \/>\n                  &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\nSection 6.09      Trustee May File Proofs of Claim&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..52<br \/>\n                  &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\nSection 6.10      Priorities&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;52<br \/>\n                  &#8212;&#8212;&#8212;-<br \/>\n<\/c><\/s><\/caption>\n<\/table>\n<p>                                       ii<\/p>\n<table>\n<p><s>                                                                                                             <c><br \/>\nSection 6.11      Undertaking for Costs&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.52<br \/>\n                  &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<\/p>\n<p>                                                               ARTICLE 7<\/p>\n<p>TRUSTEE&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;53<br \/>\n&#8212;&#8212;-                                                                                                            <\/p>\n<p>Section 7.01      Duties of Trustee&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..53<br \/>\n                  &#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\nSection 7.02      Rights of Trustee&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..54<br \/>\n                  &#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\nSection 7.03      Individual Rights of Trustee&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;55<br \/>\n                  &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;-<br \/>\nSection 7.04      Trustee&#8217;s Disclaimer&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..55<br \/>\n                  &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\nSection 7.05      Notice of Defaults&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.55<br \/>\n                  &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\nSection 7.06      Reports by Trustee to Holders&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..56<br \/>\n                  &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\nSection 7.07      Compensation and Indemnity&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..56<br \/>\n                  &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\nSection 7.08      Replacement of Trustee&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;57<br \/>\n                  &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;-<br \/>\nSection 7.09      Successor Trustee by Consolidation, Merger or Conversion&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..58<br \/>\n                  &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\nSection 7.10      Eligibility; Disqualification&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..58<br \/>\n                  &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\nSection 7.11      Preferential Collection of Claims Against Company&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;58<br \/>\n                  &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;-<\/p>\n<p>                                                               ARTICLE 8<\/p>\n<p>MODIFICATIONS, AMENDMENTS, SUPPLEMENTS AND WAIVERS&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..58<br \/>\n&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;                                                                 <\/p>\n<p>Section 8.01      Without Consent of Holders&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..58<br \/>\n                  &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\nSection 8.02      With Consent of Holders&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..59<br \/>\n                  &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\nSection 8.03      Compliance with TIA&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;60<br \/>\n                  &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;-<br \/>\nSection 8.04      Revocation and Effect of Consents&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.60<br \/>\n                  &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\nSection 8.05      Notation on or Exchange of Notes&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..61<br \/>\n                  &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\nSection 8.06      Trustee To Sign Amendments, etc&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;61<br \/>\n                  &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;-<\/p>\n<p>                                                               ARTICLE 9<\/p>\n<p>DISCHARGE OF INDENTURE; DEFEASANCE&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;61<br \/>\n&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;-                                                                                 <\/p>\n<p>Section 9.01      Satisfaction and Discharge of Indenture&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.61<br \/>\n                  &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\nSection 9.02      Legal Defeasance&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;62<br \/>\n                  &#8212;&#8212;&#8212;&#8212;&#8212;-<br \/>\nSection 9.03      Covenant Defeasance&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;63<br \/>\n                  &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;-<br \/>\nSection 9.04      Conditions to Legal Defeasance or Covenant Defeasance&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..63<br \/>\n                  &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\nSection 9.05      Application of Trust Money&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..64<br \/>\n                  &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\nSection 9.06      Repayment to the Company&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.65<br \/>\n                  &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\nSection 9.07      Reinstatement&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;65<br \/>\n                  &#8212;&#8212;&#8212;&#8212;-<\/p>\n<p>                                                              ARTICLE 10<\/p>\n<p>MISCELLANEOUS&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.65<br \/>\n&#8212;&#8212;&#8212;&#8212;-                                                                                                      <\/p>\n<p>Section 10.01     TIA Controls&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.65<br \/>\n                  &#8212;&#8212;&#8212;&#8212;<br \/>\n<\/c><\/s><\/table>\n<p>                                       iii<\/p>\n<table>\n<caption>\n<p><s>                                                                                                             <c><br \/>\nSection 10.02     Notices&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;66<br \/>\n                  &#8212;&#8212;-<br \/>\nSection 10.03     Communications by Holders with Other Holders&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..66<br \/>\n                  &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\nSection 10.04     Certificate and Opinion as to Conditions Precedent&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..67<br \/>\n                  &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\nSection 10.05     Statements Required in Certificate and Opinion&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;67<br \/>\n                  &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;-<br \/>\nSection 10.06     Rules by Trustee and Agents&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.67<br \/>\n                  &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\nSection 10.07     Business Days; Legal Holidays&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..67<br \/>\n                  &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\nSection 10.08     Governing Law&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;67<br \/>\n                  &#8212;&#8212;&#8212;&#8212;-<br \/>\nSection 10.09     Waiver of Trial by Jury&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..68<br \/>\n                  &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\nSection 10.10     Submission to Jurisdiction&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..68<br \/>\n                  &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\nSection 10.11     No Adverse Interpretation of Other Agreements&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.68<br \/>\n                  &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\nSection 10.12     No Recourse Against Others&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..68<br \/>\n                  &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\nSection 10.13     Successors&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;68<br \/>\n                  &#8212;&#8212;&#8212;-<br \/>\nSection 10.14     Multiple Counterparts&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.68<br \/>\n                  &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\nSection 10.15     Table of Contents, Headings, etc&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..68<br \/>\n                  &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\nSection 10.16     Separability&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.68<br \/>\n                  &#8212;&#8212;&#8212;&#8212;<br \/>\nSection 10.17     Translation&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..68<br \/>\n                  &#8212;&#8212;&#8212;&#8211;<\/p>\n<p>SIGNATURES&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;S-1<\/p>\n<p>EXHIBITS<\/p>\n<p>Exhibit A         Form of Initial Notes<br \/>\nExhibit B         Form of Exchange Notes<br \/>\nExhibit C         Form of Rule 144A Transfer Certificate<br \/>\nExhibit D         Form of Regulation S Transfer Certificate<br \/>\nExhibit E         Form of Rule 144 Transfer Certificate<br \/>\nExhibit F         Form of Accredited Investor Transfer Certificate<\/p>\n<p><\/c><\/s><\/caption>\n<\/table>\n<p>                                       iv<\/p>\n<p>         INDENTURE, dated as of September 28, 2001, between HEALTHSOUTH<br \/>\nCORPORATION, a corporation incorporated in Delaware (the &#8220;Company&#8221;), as Issuer,<br \/>\nand National City Bank, a national banking association, as Trustee (the<br \/>\n&#8220;Trustee&#8221;).<\/p>\n<p>         The Company has duly authorized the creation of an issue of Series A<br \/>\n7 3\/8% Senior Notes due 2006, Series B 7 3\/8% Senior Notes due 2006, Series A<br \/>\n8 3\/8% Senior Notes due 2011 and Series B 8 3\/8% Senior Notes due 2011, and, to<br \/>\nprovide therefor, the Company has duly authorized the execution and delivery of<br \/>\nthis Indenture. All things necessary to make the Notes, when duly issued and<br \/>\nexecuted by the Company, and authenticated and delivered hereunder, the valid<br \/>\nobligations of the Company, and to make this Indenture a valid and binding<br \/>\nagreement of the Company, have been done.<\/p>\n<p>         Each party agrees as follows for the benefit of the other parties and<br \/>\nfor the equal and ratable benefit of the Holders:<\/p>\n<p>                                    ARTICLE 1<\/p>\n<p>                                  DEFINITIONS<br \/>\n                                  &#8212;&#8212;&#8212;&#8211; <\/p>\n<p>         Section 1.01        Definitions.<br \/>\n                             &#8212;&#8212;&#8212;&#8211; <\/p>\n<p>         &#8220;Acquired Indebtedness&#8221; means (i) with respect to any Person that<br \/>\nbecomes a Subsidiary of the Company after the Issue Date, Indebtedness of such<br \/>\nPerson and its Subsidiaries existing at the time such Person becomes a<br \/>\nSubsidiary of the Company and (ii) with respect to the Company or any of its<br \/>\nSubsidiaries, any Indebtedness assumed by the Company or any of its Subsidiaries<br \/>\nin connection with the acquisition of an asset from another Person.<\/p>\n<p>         &#8220;Additional Interest&#8221; has the meaning provided to such term in the<br \/>\nRegistration Rights Agreement.<\/p>\n<p>         &#8220;Affiliate&#8221; of any specified Person means any other Person directly or<br \/>\nindirectly controlling, controlled by or under direct or indirect common control<br \/>\nwith such specified Person. For the purposes of this definition, &#8220;control&#8221; when<br \/>\nused with respect to any specified Person means the power to direct the<br \/>\nmanagement and policies of such Person, directly or indirectly, whether through<br \/>\nthe ownership of voting securities, by contract or otherwise, and the terms<br \/>\n&#8220;controlling&#8221; and &#8220;controlled&#8221; have meanings correlative to the foregoing.<\/p>\n<p>         &#8220;Agent&#8221; means any Registrar, Paying Agent, co-Registrar, authenticating<br \/>\nagent or agent for service of notices and demands.<\/p>\n<p>         &#8220;Asset Sale&#8221; for any Person means the sale, lease, conveyance or other<br \/>\ndisposition (including, without limitation, by merger or consolidation, and<br \/>\nwhether by operation of law or otherwise) of any of that Person&#8217;s assets<br \/>\n(including, without limitation, the sale or other disposition of Capital Stock<br \/>\nof any Subsidiary of such Person, whether by such Person or by such Subsidiary),<br \/>\nwhether owned on the Issue Date or subsequently acquired, in one transaction<\/p>\n<p>or a series of related transactions, in which such Person and\/or its<br \/>\nSubsidiaries sell, lease, convey or otherwise dispose of: (i) all or<br \/>\nsubstantially all of the Capital Stock of any of such Person&#8217;s Subsidiaries;<br \/>\n(ii) assets which constitute all or substantially all of any division or line of<br \/>\nbusiness of such Person or any of its Subsidiaries; or (iii) any other assets of<br \/>\nsuch Person or any of its Subsidiaries, other than in the ordinary course of<br \/>\nbusiness, provided, that the Fair Market Value thereof shall be at least 1% of<br \/>\nConsolidated Tangible Assets at such time; provided, however, that the following<br \/>\nshall not constitute Asset Sales: (a) transactions between the Company and any<br \/>\nof its Wholly Owned Subsidiaries or among such Wholly Owned Subsidiaries; (b)<br \/>\nany transaction not prohibited by SECTION 4.10 hereof or that constitutes a<br \/>\nPermitted Investment; (c) any transfer of assets (including Capital Stock) that<br \/>\nis governed by and in accordance with Article 5 hereof or the creation of any<br \/>\nLien not prohibited by SECTION 4.14 hereof; or (d) sales of damaged, worn-out or<br \/>\nobsolete equipment or assets that, in the Company&#8217;s reasonable judgment, are no<br \/>\nlonger either used or useful in the business of the Company or its Subsidiaries.<\/p>\n<p>         &#8220;Attributable Indebtedness&#8221; when used with respect to any Sale and<br \/>\nLeaseback Transaction means, as at the time of determination, the present value<br \/>\n(discounted at a rate equivalent to the interest rate implicit in the lease,<br \/>\ncompounded on a semiannual basis) of the total obligations of the lessee for<br \/>\nrental payments, after excluding all amounts required to be paid on account of<br \/>\nmaintenance and repairs, insurance, taxes, utilities and other similar expenses<br \/>\npayable by the lessee pursuant to the terms of the lease, during the remaining<br \/>\nterm of the lease included in any such Sale and Leaseback Transaction or until<br \/>\nthe earliest date on which the lessee may terminate such lease without penalty<br \/>\nor upon payment of a penalty (in which case the rental payments shall include<br \/>\nsuch penalty); provided, that the Attributable Indebtedness with respect to a<br \/>\nSale and Leaseback Transaction shall be no less than the fair market value of<br \/>\nthe property subject to such Sale and Leaseback Transaction.<\/p>\n<p>         &#8220;Bank Debt&#8221; means all obligations of the Company and its Subsidiaries,<br \/>\nnow or hereafter existing under (i) the Credit Agreements, whether for<br \/>\nprincipal, interest, reimbursement of amounts drawn under letters of credit<br \/>\nissued pursuant thereto, guarantees in respect thereof, fees, expenses,<br \/>\npremiums, indemnities or otherwise, and (ii) any Indebtedness incurred by the<br \/>\nCompany to extend, refund, supplement, refinance or replace, in whole or in<br \/>\npart, such Bank Debt, including any interest and premium on any such<br \/>\nIndebtedness.<\/p>\n<p>         &#8220;Board of Directors&#8221; means, with respect to any Person, the board of<br \/>\ndirectors or similar governing body of such Person or any duly authorized<br \/>\ncommittee thereof.<\/p>\n<p>         &#8220;Board Resolution&#8221; means, with respect to any Person, a copy of a<br \/>\nresolution certified by the Secretary or an Assistant Secretary of such Person<br \/>\nto have been duly adopted by the Board of Directors of such Person and to be in<br \/>\nfull force and effect on the date of such certification and delivered to the<br \/>\nTrustee.<\/p>\n<p>         &#8220;Capital Stock&#8221; of any Person means any and all shares, rights to<br \/>\npurchase, warrants or options (whether or not currently exercisable),<br \/>\nparticipation or other equivalents of or interest in (however designated) the<br \/>\nequity (including without limitation common stock, preferred stock and<br \/>\npartnership, joint venture and limited liability company interests) of such<br \/>\nPerson (excluding any debt securities that are convertible into, or exchangeable<br \/>\nfor, such equity).<\/p>\n<p>                                       2<\/p>\n<p>         &#8220;Capitalized Lease Obligations&#8221; of any Person means the obligation of<br \/>\nsuch Person to pay rent or other amounts under a lease that is required to be<br \/>\ncapitalized for financial reporting purposes in accordance with GAAP, and the<br \/>\namount of such obligation shall be the capitalized amount thereof determined in<br \/>\naccordance with GAAP.<\/p>\n<p>         &#8220;Certificated Note&#8221; means a Note issued in certificated form to a<br \/>\nPerson other than the Depositary.<\/p>\n<p>         &#8220;Change of Control&#8221; means the occurrence at any time prior to the<br \/>\noccurrence of the Fall-Away Event of any of the following: (i) all or<br \/>\nsubstantially all of the Company&#8217;s assets are sold as an entirety to any Person<br \/>\nor related group of Persons; (ii) there shall be consummated any consolidation<br \/>\nor merger of the Company (A) in which the Company is not the continuing or<br \/>\nsurviving corporation (other than a consolidation or merger with a Wholly Owned<br \/>\nSubsidiary of the Company in which all shares of the Company&#8217;s Common Equity<br \/>\noutstanding immediately prior to the effectiveness thereof are changed into or<br \/>\nexchanged for the same consideration) or (B) pursuant to which the Company&#8217;s<br \/>\nCommon Equity would be converted into cash, securities or other property, in<br \/>\neach case other than a consolidation or merger of the Company in which the<br \/>\nholders of the Company&#8217;s Common Equity immediately prior to the consolidation or<br \/>\nmerger have, directly or indirectly, at least a majority of the total voting<br \/>\npower of all classes of Capital Stock entitled to vote generally in the election<br \/>\nof directors of the continuing or surviving corporation immediately after such<br \/>\nconsolidation or merger in substantially the same proportion as their ownership<br \/>\nof the Company&#8217;s Common Equity immediately before such transaction; (iii) any<br \/>\nPerson, or any Persons acting together which would constitute a &#8220;group&#8221; for<br \/>\npurposes of Section 13(d) of the Exchange Act, together with any affiliates<br \/>\nthereof, shall beneficially own (as defined in Rule 13d-3 under the Exchange<br \/>\nAct) at least 50% of the total voting power of all classes of Capital Stock of<br \/>\nthe Company entitled to vote generally in the election of directors of the<br \/>\nCompany; (iv) at any time during any consecutive two-year period, individuals<br \/>\nwho at the beginning of such period constituted the Board of Directors of the<br \/>\nCompany (together with any new directors whose election by such Board of<br \/>\nDirectors or whose nomination for election by the stockholders of the Company<br \/>\nwas approved by a vote of 66-2\/3% of the directors then still in office who were<br \/>\neither directors at the beginning of such period or whose election or nomination<br \/>\nfor election was previously so approved) cease for any reason to constitute a<br \/>\nmajority of the Board of Directors of the Company then in office; or (v) the<br \/>\nCompany is liquidated or dissolved or adopts a plan of liquidation or<br \/>\ndissolution.<\/p>\n<p>         &#8220;Commission&#8221; means the Securities and Exchange Commission, as from time<br \/>\nto time constituted, created under the Exchange Act, or if at any time after the<br \/>\nexecution of this Indenture such Commission is not existing and performing the<br \/>\nduties now assigned to it under the Trust Indenture Act, the body performing<br \/>\nsuch duties at the time.<\/p>\n<p>         &#8220;Common Equity&#8221; of any Person means all Capital Stock of such Person<br \/>\nthat is generally entitled to (i) vote in the election of directors of such<br \/>\nPerson or (ii) if such Person is not a corporation, vote or otherwise<br \/>\nparticipate in the selection of the governing body, partners, managers or others<br \/>\nthat will control the management and policies of such Person.<\/p>\n<p>         &#8220;Company&#8221; means the party named as such in the first paragraph of this<br \/>\nIndenture until a successor replaces such party pursuant to Article 5 hereof and<br \/>\nthereafter means such successor.<\/p>\n<p>                                       3<\/p>\n<p>         &#8220;Consolidated Amortization Expense&#8221; of any Person for any period means<br \/>\nthe amortization expense of such Person and its Subsidiaries for such period (to<br \/>\nthe extent included in the computation of Consolidated Net Income of such<br \/>\nPerson), determined on a consolidated basis in accordance with GAAP.<\/p>\n<p>         &#8220;Consolidated Depreciation Expense&#8221; of any Person means the<br \/>\ndepreciation expense of such Person and its Subsidiaries for such period (to the<br \/>\nextent included in the computation of Consolidated Net Income of such Person),<br \/>\ndetermined on a consolidated basis in accordance with GAAP.<\/p>\n<p>         &#8220;Consolidated EBITDA&#8221; of any Person means, with respect to any<br \/>\ndetermination date, Consolidated Net Income, plus (i) Consolidated Income Tax<br \/>\nExpense, plus (ii) Consolidated Depreciation Expense, plus (iii) Consolidated<br \/>\nAmortization Expense, plus (iv) Consolidated Interest Expense, plus (v) all<br \/>\nother unusual non-cash items or non-recurring non-cash items reducing<br \/>\nConsolidated Net Income of such Person and its Subsidiaries, determined on a<br \/>\nconsolidated basis in accordance with GAAP, and less all non-cash items<br \/>\nincreasing Consolidated Net Income of such Person and its Subsidiaries,<br \/>\ndetermined on a consolidated basis in accordance with GAAP, in each case, for<br \/>\nsuch Person&#8217;s prior four full fiscal quarters for which financial results have<br \/>\nbeen reported immediately preceding the determination date.<\/p>\n<p>         &#8220;Consolidated Income Tax Expense&#8221; means, for any Person for any period,<br \/>\nthe provision for taxes based on income and profits of such Person and its<br \/>\nSubsidiaries to the extent such provision for income taxes was deducted in<br \/>\ncomputing Consolidated Net Income of such Person for such period, determined on<br \/>\na consolidated basis in accordance with GAAP.<\/p>\n<p>         &#8220;Consolidated Interest Expense&#8221; of any Person for any period means,<br \/>\nwithout duplication, (i) the Interest Expense of such Person and its<br \/>\nSubsidiaries for such period, determined on a consolidated basis in accordance<br \/>\nwith GAAP, plus (ii) (to the extent not otherwise included within the definition<br \/>\nof Interest Expense as imputed interest) one-third of the rental expense on<br \/>\nAttributable Indebtedness of such Person for such period determined on a<br \/>\nconsolidated basis, plus (iii) the dividend requirements of such Person and its<br \/>\nSubsidiaries with respect to Disqualified Stock and with respect to all other<br \/>\nPreferred Stock of Subsidiaries of such Person (in each case whether in cash or<br \/>\notherwise (except dividends payable solely in shares of Capital Stock (other<br \/>\nthan Disqualified Stock) of such Person or such Subsidiary)) paid, accrued or<br \/>\naccumulated during such period times a fraction the numerator of which is one<br \/>\nand the denominator of which is one minus the then effective consolidated<br \/>\nFederal, state and local tax rate of such Person, expressed as a decimal.<\/p>\n<p>         &#8220;Consolidated Net Income&#8221; of any Person for any period means the net<br \/>\nincome (or loss) of such Person and its Subsidiaries for such period determined<br \/>\non a consolidated basis in accordance with GAAP; provided that there shall be<br \/>\nexcluded from such net income (to the extent otherwise included therein),<br \/>\nwithout duplication:<\/p>\n<p>                        (i) the net income (or loss) of any Person (other than a<br \/>\n         Subsidiary of the referent Person) in which any Person other than the<br \/>\n         referent Person has an ownership interest, except to the extent that<br \/>\n         any such income has actually been received by the<\/p>\n<p>                                       4<\/p>\n<p>         referent Person or any of its Wholly Owned Subsidiaries in the form of<br \/>\n         dividends or similar distributions during such period;<\/p>\n<p>                       (ii) except to the extent includable in the consolidated<br \/>\n         net income of the referent Person pursuant to the foregoing clause (i),<br \/>\n         the net income (or loss) of any Person that accrues prior to the date<br \/>\n         that (a) such Person becomes a Subsidiary of the referent Person or is<br \/>\n         merged into or consolidated with the referent Person or any of its<br \/>\n         Subsidiaries or (b) the assets of such Person are acquired by the<br \/>\n         referent Person or any of its Subsidiaries;<\/p>\n<p>                      (iii) the net income of any Subsidiary of the referent<br \/>\n         Person (other than a Wholly Owned Subsidiary) to the extent that the<br \/>\n         declaration or payment of dividends or similar distributions by such<br \/>\n         Subsidiary of that income is not permitted by operation of the terms of<br \/>\n         its charter or any agreement, instrument, judgment, decree, order,<br \/>\n         statute, rule or governmental regulation applicable to that Subsidiary<br \/>\n         during such period;<\/p>\n<p>                       (iv) any gain (or loss), together with any related<br \/>\n         provisions for taxes on any such gain, realized during such period by<br \/>\n         the referent Person or any of its Subsidiaries upon (a) the acquisition<br \/>\n         of any securities, or the extinguishment of any Indebtedness, of the<br \/>\n         referent Person or any of its Subsidiaries or (b) any Asset Sale by the<br \/>\n         referent Person or any of its Subsidiaries;<\/p>\n<p>                        (v) any extraordinary gain or extraordinary loss,<br \/>\n         together with any related provision for taxes or tax benefit resulting<br \/>\n         from any such extraordinary gain or extraordinary loss, realized by the<br \/>\n         referent Person or any of its Subsidiaries during such period; and<\/p>\n<p>                       (vi) in the case of a successor to such Person by<br \/>\n         consolidation, merger or transfer of its assets, any earnings of the<br \/>\n         successor prior to such merger, consolidation or transfer of assets.<\/p>\n<p>         &#8220;Consolidated Net Worth&#8221; of any Person as of any date means the<br \/>\nstockholders&#8217; equity (including any preferred stock that is classified as equity<br \/>\nunder GAAP, other than Disqualified Stock) of such Person and its Subsidiaries<br \/>\n(excluding any equity adjustment for foreign currency translation for any period<br \/>\nsubsequent to the Issue Date) on a consolidated basis at such date, as<br \/>\ndetermined in accordance with GAAP, less all write-ups subsequent to the Issue<br \/>\nDate in the book value of any asset owned by such Person or any of its<br \/>\nSubsidiaries.<\/p>\n<p>         &#8220;Consolidated Tangible Assets&#8221; of any Person as of any date means the<br \/>\ntotal assets of such Person and its Subsidiaries (excluding any assets that<br \/>\nwould be classified as &#8220;intangible assets&#8221; under GAAP) on a consolidated basis<br \/>\nat such date, as determined in accordance with GAAP, less all write-ups<br \/>\nsubsequent to the Issue Date in the book value of any asset owned by such Person<br \/>\nor any of its Subsidiaries.<\/p>\n<p>         &#8220;Corporate Trust Office&#8221; means the office of the Trustee at which at<br \/>\nany particular time its corporate trust business shall be principally<br \/>\nadministered, which office at the date of execution of this Indenture is located<br \/>\nat National City Bank, c\/o Mellon Securities Trust Company, 120 Broadway, 13th<br \/>\nFloor, New York, New York 10271, or such other address as the <\/p>\n<p>                                       5<\/p>\n<p>Trustee may designate from time to time by notice to the Holders and the<br \/>\nCompany, or the principal corporate trust office of any successor Trustee (or<br \/>\nsuch other address as a successor Trustee may designate from time to time by<br \/>\nnotice to the Holders and the Company).<\/p>\n<p>         &#8220;Credit Agreements&#8221; mean (i) the Credit Agreement dated as of June 23,<br \/>\n1998 by and among the Company, as borrower, Bank of America, N.A. (as successor<br \/>\nto Nationsbank, National Association), as Administrative Agent and Arranger,<br \/>\nJ.P. Morgan Securities Inc., Deutsche Bank AG and Scotiabanc, Inc., as<br \/>\nSyndication Agents and Co-Arrangers, and the other lenders party thereto from<br \/>\ntime to time, together with the related documents thereto, including, without<br \/>\nlimitation, any security documents, if any, and all exhibits and schedules<br \/>\nthereto, and (ii) any other credit agreement entered into by the Company or any<br \/>\nof its Subsidiaries for money borrowed from or guaranteed to persons, firms or<br \/>\ncorporations which engage in the business of lending money, in order to provide<br \/>\nfunding for the acquisition and development of healthcare facilities or to<br \/>\nprovide for working capital needs and other corporate purposes, including, in<br \/>\nthe case of clause (i) or (ii) above, any agreement or agreements relating to<br \/>\nany extension, refunding, refinancing, successor or replacement facility,<br \/>\nwhether or not with the same lender, and whether or not the principal amount or<br \/>\namount of letters of credit outstanding thereunder or the interest rate payable<br \/>\nin respect thereof shall be thereby increased, in each case as amended and in<br \/>\neffect from time to time.<\/p>\n<p>         &#8220;Default&#8221; means any event, act or condition that is, or after notice or<br \/>\nthe passage of time or both would be, an Event of Default.<\/p>\n<p>         &#8220;Disqualified Stock&#8221; means any Capital Stock that, by its terms (or by<br \/>\nthe terms of any security into which it is convertible or for which it is<br \/>\nexchangeable), or upon the happening of any event, matures or is mandatorily<br \/>\nredeemable, pursuant to a sinking fund obligation or otherwise, or is redeemable<br \/>\nat the option of the holder thereof, in whole or in part, on or prior to the<br \/>\nStated Maturity date of the Notes.<\/p>\n<p>         &#8220;DTC&#8221; means The Depository Trust Company, a New York corporation.<\/p>\n<p>         &#8220;DTC Letter of Representations&#8221; shall mean the Letter of<br \/>\nRepresentations, dated the Issue Date, among the Company, DTC and the Trustee.<\/p>\n<p>         &#8220;EBITDA Coverage Ratio&#8221; with respect to any period means the ratio of<br \/>\n(i) Consolidated EBITDA of the Company to (ii) the aggregate amount of<br \/>\nConsolidated Interest Expense of the Company for such period; provided, however,<br \/>\nthat if any calculation of the Company&#8217;s EBITDA Coverage Ratio requires the use<br \/>\nof any quarter prior to the Issue Date, such calculation shall be made on a pro<br \/>\nforma basis, giving effect to the issuance of the Notes and the use of the net<br \/>\nproceeds therefrom as if the same had occurred at the beginning of the<br \/>\nfour-quarter period used to make such calculation; and provided further that if<br \/>\nany such calculation requires the use of any quarter prior to the date that any<br \/>\nAsset Sale was consummated, or that any Indebtedness was incurred, or that any<br \/>\nacquisition of a hospital or other healthcare facility or any assets purchased<br \/>\noutside the ordinary course of business was effected, by the Company or any of<br \/>\nits Subsidiaries, such calculation shall be made on a pro forma basis, giving<br \/>\neffect to each such Asset Sale, incurrence of Indebtedness or acquisition, as<br \/>\nthe case may be, and the use of any proceeds<\/p>\n<p>                                       6<\/p>\n<p>therefrom, as if the same had occurred at the beginning of the four-quarter<br \/>\nperiod used to make such calculation.<\/p>\n<p>         &#8220;Eligible Investments&#8221; of any Person means Investments of such Person<br \/>\nin:<\/p>\n<p>                        (i) direct obligations of, or obligations the payment of<br \/>\n         which is guaranteed by, the United States of America or an interest in<br \/>\n         any trust or fund that invests solely in such obligations or repurchase<br \/>\n         agreements, properly secured, with respect to such obligations;<\/p>\n<p>                       (ii) direct obligations of agencies or instrumentalities<br \/>\n         of the United States of America having a rating of A or higher by S&amp;P<br \/>\n         or A2 or higher by Moody&#8217;s;<\/p>\n<p>                      (iii) a certificate of deposit issued by, or other<br \/>\n         interest-bearing deposits with, a bank having its principal place of<br \/>\n         business in the United States of America and having equity capital of<br \/>\n         not less than $250,000,000;<\/p>\n<p>                       (iv) a certificate of deposit issued by, or other<br \/>\n         interest-bearing deposits with, any other bank organized under the laws<br \/>\n         of the United States of America or any state thereof, provided that<br \/>\n         such deposit is either (a) insured by the Federal Deposit Insurance<br \/>\n         Corporation or (b) properly secured by such bank by pledging direct<br \/>\n         obligations of the United States of America having a market value of<br \/>\n         not less than the face amount of such deposits;<\/p>\n<p>                        (v) prime commercial paper maturing within 270 days of<br \/>\n         the acquisition thereof and, at the time of acquisition, having a<br \/>\n         rating of A-1 or higher by S&amp;P, or P-1 or higher by Moody&#8217;s; or<\/p>\n<p>                       (vi) eligible banker&#8217;s acceptances, repurchase agreements<br \/>\n         and tax-exempt municipal bonds having a maturity of less than one year,<br \/>\n         in each case having a rating of, or evidencing the full recourse<br \/>\n         obligation of a person whose senior debt is rated, A or higher by S&amp;P<br \/>\n         or A2 or higher by Moody&#8217;s.<\/p>\n<p>         &#8220;Exchange Act&#8221; means the Securities Exchange Act of 1934, as amended.<\/p>\n<p>         &#8220;Exchange Notes&#8221; means the Series B 7 3\/8% Senior Notes due 2006 (the<br \/>\n&#8220;Exchange 2006 Notes&#8221;) and the Series B 8 3\/8% Senior Notes due 2011 (the<br \/>\n&#8220;Exchange 2011 Notes&#8221;) (the terms of which are identical to the Initial Notes<br \/>\nexcept that, unless any Exchange Notes shall be issued as Private Exchange Notes<br \/>\n(as defined in the Registration Rights Agreement), the Exchange Notes shall be<br \/>\nregistered under the Securities Act, and shall not contain the restrictive<br \/>\nlegend on the face of the form of the Initial Notes), to be issued in exchange<br \/>\nfor the Initial Notes pursuant to the registered Exchange Offer or a Private<br \/>\nExchange (as defined in the Registration Rights Agreement).<\/p>\n<p>         &#8220;Exchange Offer&#8221; means the registration by the Company under the<br \/>\nSecurities Act pursuant to a registration statement of the offer by the Company<br \/>\nto each Holder of the Initial Notes to exchange all the Initial Notes held by<br \/>\nsuch Holder for the Exchange Notes in an aggregate principal amount equal to the<br \/>\naggregate principal amount of the Initial Notes held by<\/p>\n<p>                                       7<\/p>\n<p>such Holder, all in accordance with the terms and conditions of the Registration<br \/>\nRights Agreement.<\/p>\n<p>         &#8220;Exempted Debt&#8221; means the sum of the following as of any date of<br \/>\ndetermination: (i) Indebtedness of the Company and its Subsidiaries incurred<br \/>\nafter the Issue Date and secured by Liens not otherwise permitted by SECTION<br \/>\n4.14 hereof or SECTION 4.18 hereof, as the case may be, and (ii) Attributable<br \/>\nIndebtedness of the Company and its Subsidiaries in respect of every Sale and<br \/>\nLeaseback Transaction entered into after the Issue Date.<\/p>\n<p>         &#8220;Existing Indebtedness&#8221; means all of the Indebtedness of the Company<br \/>\nand its Subsidiaries that is outstanding on the Issue Date.<\/p>\n<p>         &#8220;Fair Market Value&#8221; of any asset or items means the fair market value<br \/>\nof such asset or items as determined in good faith by the Board of Directors and<br \/>\nevidenced by a resolution of the Board of Directors.<\/p>\n<p>         &#8220;Fall-Away Event&#8221; means the Notes shall have been rated Investment<br \/>\nGrade and, if no Event of Default or Default shall have occurred and be<br \/>\ncontinuing at such time, the Company shall have delivered to the Trustee an<br \/>\nOfficers&#8217; Certificate certifying as to the foregoing.<\/p>\n<p>         &#8220;GAAP&#8221; means generally accepted accounting principles set forth in the<br \/>\nopinions and pronouncements of the Accounting Principles Board of the American<br \/>\nInstitute of Certified Public Accountants and statements and pronouncements of<br \/>\nthe Financial Accounting Standards Board or in such other statements by such<br \/>\nother entity as may be approved by a significant segment of the accounting<br \/>\nprofession of the United States of America, as from time to time in effect.<\/p>\n<p>         &#8220;guarantee&#8221; means, as applied to any obligation, (a) a guarantee (other<br \/>\nthan by endorsement of negotiable instruments for collection in the ordinary<br \/>\ncourse of business), direct or indirect, in any manner, of any part or all of<br \/>\nsuch obligation and (b) an agreement, direct or indirect, contingent or<br \/>\notherwise, the practical effect of which is to assure in any way the payment or<br \/>\nperformance (or payment of damages in the event of non-performance) of all or<br \/>\nany part of such obligation, including, without limiting the foregoing, the<br \/>\npayment of amounts drawn down under letters of credit.<\/p>\n<p>         &#8220;Hedging Obligations&#8221; of any Person means the obligations of such<br \/>\nPerson pursuant to any interest rate swap agreement, foreign currency exchange<br \/>\nagreement, interest rate collar agreement, option or futures contract or other<br \/>\nsimilar agreement or arrangement relating to interest rates or foreign exchange<br \/>\nrates.<\/p>\n<p>         &#8220;Holder&#8221; means a Person in whose name a Note is registered on the<br \/>\nRegistrar&#8217;s books or records.<\/p>\n<p>         &#8220;Indebtedness&#8221; of any Person at any date means, without duplication:<br \/>\n(i) all indebtedness of such Person for borrowed money (whether or not the<br \/>\nrecourse of the lender is to the whole of the assets of such Person or only to a<br \/>\nportion thereof); (ii) all obligations of such Person evidenced by bonds,<br \/>\ndebentures, notes or other similar instruments; (iii) all obligations of such<br \/>\nPerson in respect of letters of credit or other similar instruments (or<br \/>\nreimbursement obligations with respect thereto); (iv) all obligations of such<br \/>\nPerson with respect to Hedging Obligations<\/p>\n<p>                                       8<\/p>\n<p>(other than those that fix the interest rate on variable rate indebtedness<br \/>\notherwise permitted by this Indenture or that protect the Company and\/or its<br \/>\nSubsidiaries against changes in foreign exchange rates); (v) all obligations of<br \/>\nsuch Person to pay the deferred and unpaid purchase price of property or<br \/>\nservices, except trade payables and accrued expenses incurred in the ordinary<br \/>\ncourse of business; (vi) all Capitalized Lease Obligations of such Person; (vii)<br \/>\nall Indebtedness of others secured by a Lien on any asset of such Person,<br \/>\nwhether or not such Indebtedness is assumed by such Person; (viii) all<br \/>\nIndebtedness of others guaranteed by such Person to the extent of such<br \/>\nguarantee; (ix) all Attributable Indebtedness; and (x) all Disqualified Stock of<br \/>\nsuch Person and its Subsidiaries and all other Preferred Stock of Subsidiaries<br \/>\nof such Person valued at the greater of (a) the voluntary or involuntary<br \/>\nliquidation preference of such Disqualified Stock or such Preferred Stock, as<br \/>\nthe case may be, and (b) the aggregate amount payable upon purchase, redemption,<br \/>\ndefeasance or payment of such Disqualified Stock or such Preferred Stock, as the<br \/>\ncase may be. The amount of Indebtedness of any Person at any date shall be the<br \/>\noutstanding balance at such date of all unconditional obligations plus past due<br \/>\ninterest as described above, the maximum liability of such Person for any such<br \/>\ncontingent obligations at such date and, in the case of clause (vii), the amount<br \/>\nof the Indebtedness secured.<\/p>\n<p>         &#8220;Indenture&#8221; means this Indenture as amended, restated or supplemented<br \/>\nfrom time to time.<\/p>\n<p>         &#8220;Initial Notes&#8221; means the Series A 7 3\/8% Senior Notes due 2006 (the<br \/>\n&#8220;Initial 2006 Notes&#8221;) and the Series A 8 3\/8% Senior Notes due 2011 (the<br \/>\n&#8220;Initial 2011 Notes&#8221;) of the Company issued on the Issue Date and authenticated<br \/>\nand delivered under this Indenture pursuant to SECTION 2.02 of this Indenture<br \/>\nand any other notes (other than Exchange Notes) issued after the Issue Date in<br \/>\naccordance with clause (iv) of the fourth paragraph of SECTION 2.02.<\/p>\n<p>         &#8220;Initial Purchasers&#8221; refers to UBS Warburg LLC, Deutsche Banc Alex.<br \/>\nBrown Inc., First Union Securities, Inc., J.P. Morgan Securities, Inc., Lehman<br \/>\nBrothers Inc., Scotia Capital (USA) Inc., Jefferies &amp; Company, Inc., BNY Capital<br \/>\nMarkets, Inc., Fleet Securities, Inc. and NatCity Investments, Inc.<\/p>\n<p>         &#8220;Interest Expense&#8221; of any Person for any period means the aggregate<br \/>\namount of interest which, in accordance with GAAP, would be set opposite the<br \/>\ncaption &#8220;interest expense&#8221; or any like caption on an income statement for such<br \/>\nPerson (including, without limitation or duplication, imputed interest included<br \/>\nin Capitalized Lease Obligations, all commissions, discounts and other fees and<br \/>\ncharges owed with respect to letters of credit and bankers&#8217; acceptance<br \/>\nfinancing, the net costs associated with Hedging Obligations, amortization of<br \/>\nfinancing fees and expenses, the interest portion of any deferred payment<br \/>\nobligation, amortization of discount and all other non-cash interest expense<br \/>\nother than interest amortized to cost of sales) plus the aggregate amount, if<br \/>\nany, by which such interest expense was reduced as a result of the amortization<br \/>\nof deferred debt restructuring credits for such period.<\/p>\n<p>         &#8220;Interest Payment Date&#8221; means the Stated Maturity of an installment of<br \/>\ninterest on the Notes as specified in the forms of Note attached hereto as<br \/>\nExhibits A and B.<\/p>\n<p>         &#8220;Investment Grade&#8221; means (i) a rating of BBB- or above, in the case of<br \/>\nS&amp;P (or its equivalent under any successor Rating Categories of S&amp;P), and Baa3<br \/>\nor above, in the case of<\/p>\n<p>                                       9<\/p>\n<p>Moody&#8217;s (or its equivalent under any successor Rating Categories of Moody&#8217;s), or<br \/>\n(ii) the equivalent in respect of the Rating Categories of any other Rating<br \/>\nAgencies; provided, however, that if such rating is BBB- in the case of S&amp;P, or<br \/>\nBaa3 in the case of Moody&#8217;s (or the equivalent in respect of the Rating<br \/>\nCategories of any other Rating Agencies), then such rating also shall not be<br \/>\naccompanied by a negative outlook, negative credit watch or review for possible<br \/>\ndowngrade (or the equivalent thereof), as the case may be.<\/p>\n<p>         &#8220;Investments&#8221; of any Person means: (i) all investments by such Person<br \/>\nin any other Person in the form of loans, advances or capital contributions<br \/>\n(excluding commission, travel and similar advances to officers and employees<br \/>\nmade in the ordinary course of business); (ii) all guarantees of Indebtedness or<br \/>\nother obligations of any other Person by such Person; (iii) all purchases (or<br \/>\nother acquisitions for consideration) by such Person of Indebtedness, Capital<br \/>\nStock or other securities of any other Person; and (iv) all other items that<br \/>\nwould be classified as investments (including, without limitation, purchases of<br \/>\nassets outside the ordinary course of business) on a balance sheet of such<br \/>\nPerson prepared in accordance with GAAP.<\/p>\n<p>         &#8220;Issue Date&#8221; means September 28, 2001, the date the Initial Notes are<br \/>\ninitially issued.<\/p>\n<p>         &#8220;Joint Venture&#8221; means any Person at least a majority of whose revenues<br \/>\nresult from healthcare related businesses or facilities.<\/p>\n<p>         &#8220;Lien&#8221; means, with respect to any asset, any mortgage, lien, pledge,<br \/>\ncharge, security interest or other similar encumbrance of any kind in respect of<br \/>\nsuch asset, whether or not filed, recorded or otherwise perfected under<br \/>\napplicable law (including, without limitation, any conditional sale or other<br \/>\ntitle retention agreement, and any financing lease in the nature thereof, any<br \/>\nagreement to sell, and any filing of, or agreement to give, any financing<br \/>\nstatement (other than notice filings not perfecting a security interest) under<br \/>\nthe Uniform Commercial Code (or equivalent statutes) of any jurisdiction).<\/p>\n<p>         &#8220;Moody&#8217;s&#8221; means Moody&#8217;s Investors Service, Inc. and its successors.<\/p>\n<p>         &#8220;Net Proceeds&#8221; with respect to any Asset Sale means (i) cash (in U.S.<br \/>\ndollars or freely convertible into U.S. dollars) received by the Company or any<br \/>\nof its Subsidiaries from such Asset Sale (including, without limitation, cash<br \/>\nreceived as consideration for the assumption or incurrence of liabilities<br \/>\nincurred in connection with or in anticipation of such Asset Sale), after (a)<br \/>\nprovision for all income or other taxes measured by or resulting from such Asset<br \/>\nSale or the transfer of the proceeds of such Asset Sale to the Company or any of<br \/>\nits Subsidiaries, (b) payment of all commissions and other fees and expenses<br \/>\nrelated to such Asset Sale and (c) deduction of an appropriate amount to be<br \/>\nprovided by the Company or any of its Subsidiaries as a reserve, in accordance<br \/>\nwith GAAP, against any liabilities associated with the assets sold or otherwise<br \/>\ndisposed of in such Asset Sale and retained by the Company or any of its<br \/>\nSubsidiaries after such Asset Sale (including, without limitation, pension and<br \/>\nother post-employment benefit liabilities and liabilities related to<br \/>\nenvironmental matters) or against any indemnification obligations associated<br \/>\nwith the sale or other disposition of the assets sold or otherwise disposed of<br \/>\nin such Asset Sale and (ii) all non-cash consideration received by the Company<br \/>\nor any of its Subsidiaries from such Asset Sales upon the liquidation or<br \/>\nconversion of such consideration into cash.<\/p>\n<p>                                       10<\/p>\n<p>         &#8220;Notes&#8221; means the Initial 2006 Notes and the Exchange 2006 Notes,<br \/>\ntreated as a single class of securities, and the Initial 2011 Notes and the<br \/>\nExchange 2011 Notes, treated as a single class of securities, in each case as<br \/>\namended or supplemented from time to time in accordance with the terms hereof,<br \/>\nthat are issued pursuant to this Indenture.<\/p>\n<p>         &#8220;Officer&#8221; means, with respect to any Person, the Chairman of the Board,<br \/>\nthe Chief Executive Officer, the Chief Financial Officer, Chief Accounting<br \/>\nOfficer, Treasurer, President, any Vice President, secretary, assistant<br \/>\nsecretary, director or other authorized signatory of such Person.<\/p>\n<p>         &#8220;Officers&#8217; Certificate&#8221; means a certificate signed by the Chairman of<br \/>\nthe Board, any Vice Chairman of the Board, the Chief Executive Officer, the<br \/>\nPresident or any Vice President and by the Treasurer, any Assistant Treasurer,<br \/>\nthe Secretary or any Assistant Secretary of the Company in their official (and<br \/>\nnot individual) capacities; provided, however, that every Officers&#8217; Certificate<br \/>\nwith respect to the compliance with a condition precedent to the taking of any<br \/>\naction under this Indenture shall include (i) a statement that the officers<br \/>\nmaking or giving such Officers&#8217; Certificate have read such condition and any<br \/>\ndefinitions or other provisions contained in this Indenture relating thereto and<br \/>\n(ii) a statement as to whether, in the opinion of the signers, such condition<br \/>\nhas been complied with.<\/p>\n<p>         &#8220;Opinion of Counsel&#8221; means a written opinion from legal counsel (such<br \/>\ncounsel may be an employee of or counsel to the Company or the Trustee) that<br \/>\ncomplies with the requirements of this Indenture.<\/p>\n<p>         &#8220;Permitted Investments&#8221; means: (i) capital contributions, advances or<br \/>\nloans to the Company by any Subsidiary or by the Company or any of its<br \/>\nSubsidiaries to a Subsidiary of the Company; (ii) the acquisition and holding by<br \/>\nthe Company and each of its Subsidiaries of receivables owing to the Company and<br \/>\nsuch Subsidiary, if created or acquired in the ordinary course of business and<br \/>\npayable or dischargeable in accordance with customary trade terms; (iii) the<br \/>\nacquisition and holding by the Company and its Subsidiaries of cash and Eligible<br \/>\nInvestments; (iv) Investments in any Person as a result of which such other<br \/>\nPerson becomes a Subsidiary of the Company or is merged into or consolidated<br \/>\nwith or transfers all or substantially all of its assets to the Company or any<br \/>\nof its Subsidiaries; and (v) the making of an Investment by the Company,<br \/>\ndirectly or through a Wholly Owned Subsidiary, in a Wholly Owned Subsidiary<br \/>\nformed solely for the purpose of insuring the healthcare business and facilities<br \/>\nowned or operated by the Company or a Subsidiary and any physician employed by<br \/>\nor on the staff of any such business or facility (the &#8220;Insurance Subsidiary&#8221;),<br \/>\nprovided that the amount invested in such Insurance Subsidiary does not exceed<br \/>\n$15,000,000.<\/p>\n<p>         &#8220;Permitted Liens&#8221; means: (i) Liens for taxes, assessments or<br \/>\ngovernmental charges or claims that either (a) are not yet delinquent or (b) are<br \/>\nbeing contested in good faith by appropriate proceedings; (ii) statutory Liens<br \/>\nof landlords and carriers&#8217;, warehousemen&#8217;s, mechanics&#8217;, suppliers&#8217;,<br \/>\nmaterialmen&#8217;s, repairmen&#8217;s or other like Liens arising in the ordinary course of<br \/>\nbusiness and with respect to amounts that either (a) are not yet delinquent or<br \/>\n(b) are being contested in good faith by appropriate proceedings and as to which<br \/>\nappropriate reserves or other provisions have been made in accordance with GAAP;<br \/>\n(iii) Liens (other than any Lien imposed by the Employee Retirement Income<br \/>\nSecurity Act of 1974, as amended) incurred or <\/p>\n<p>                                       11<\/p>\n<p>deposits due in the ordinary course of business in connection with workers&#8217;<br \/>\ncompensation, unemployment insurance and other types of social security; (iv)<br \/>\nLiens incurred or deposits made to secure the performance of tenders, bids,<br \/>\nleases, statutory obligations, surety and appeal bonds, progress payments,<br \/>\ngovernment contracts and other obligations of like nature (exclusive of<br \/>\nobligations for the payment of borrowed money), in each case, incurred in the<br \/>\nordinary course of business; (v) attachment or judgment Liens not giving rise to<br \/>\na Default or an Event of Default; (vi) easements, rights-of-way, restrictions<br \/>\nand other similar charges or encumbrances not interfering with the ordinary<br \/>\nconduct of the business of the Company or any of its Subsidiaries; (vii) leases<br \/>\nor subleases granted to others not interfering with the ordinary conduct of the<br \/>\nbusiness of the Company or any of its Subsidiaries; (viii) Liens with respect to<br \/>\nany Acquired Indebtedness; provided that such Liens only extend to assets that<br \/>\nwere subject to such Liens prior to the acquisition of such assets by the<br \/>\nCompany or its Subsidiaries and, with respect to Indebtedness other than<br \/>\nIndebtedness ranking pari passu with the Notes, not incurred in anticipation or<br \/>\ncontemplation of such acquisition; (ix) Liens securing Bank Debt or Refinancing<br \/>\nIndebtedness; provided, in the case of Refinancing Indebtedness, that such Liens<br \/>\nonly extend to the assets securing the Indebtedness being refinanced and such<br \/>\nrefinanced Indebtedness was previously secured by such assets; (x) purchase<br \/>\nmoney mortgages (including Capitalized Lease Obligations); (xi) Liens existing<br \/>\non the Issue Date; (xii) Liens on assets of any Subsidiary of the Company<br \/>\nsecuring Indebtedness of such Subsidiary; provided that such Indebtedness is<br \/>\npermitted to be incurred by the terms of this Indenture; (xiii) bankers&#8217; liens<br \/>\nwith respect to the right of set-off arising in the ordinary course of business<br \/>\nagainst amounts maintained in bank accounts or certificates of deposit in the<br \/>\nname of the Company or any Subsidiary; (xiv) the interest of any issuer of a<br \/>\nletter of credit in any cash or Eligible Investment deposited with or for the<br \/>\nbenefit of such issuer as collateral for such letter of credit; provided that<br \/>\nthe Indebtedness so collateralized is permitted to be incurred by the terms of<br \/>\nthis Indenture; (xv) any Lien consisting of a right of first refusal or option<br \/>\nto purchase the Company&#8217;s ownership interest in any Subsidiary or to purchase<br \/>\nassets of the Company or any Subsidiary of the Company, which right of first<br \/>\nrefusal or option is entered into in the ordinary course of business; and (xvi)<br \/>\nthe Lien granted to the Trustee pursuant to the trust created pursuant to<br \/>\nARTICLE 9 hereof and any substantially equivalent Lien granted to the respective<br \/>\ntrustees under the indentures for other debt securities of the Company.<\/p>\n<p>         &#8220;Person&#8221; means any individual, corporation, partnership, joint venture,<br \/>\nincorporated or unincorporated association, joint-stock company, trust,<br \/>\nunincorporated organization or government or other agency or political<br \/>\nsubdivision thereof or other entity of any kind.<\/p>\n<p>         &#8220;Preferred Stock&#8221; means with respect to any Person all Capital Stock of<br \/>\nsuch Person which has a preference in liquidation or a preference with respect<br \/>\nto the payment of dividends or distributions of operating profit or cash.<\/p>\n<p>         &#8220;Qualified Institutional Buyer&#8221; or &#8220;QIB&#8221; shall have the meaning<br \/>\nspecified in Rule 144A.<\/p>\n<p>         &#8220;Rating Agencies&#8221; means (i) S&amp;P and Moody&#8217;s or (ii) if S&amp;P or Moody&#8217;s<br \/>\nor both of them are not making ratings of the Notes publicly available, a<br \/>\nnationally recognized U.S. rating agency or agencies, as the case may be,<br \/>\nselected by the Company, which will be substituted for S&amp;P or Moody&#8217;s or both,<br \/>\nas the case may be.<\/p>\n<p>                                       12<\/p>\n<p>         &#8220;Rating Category&#8221; means (i) with respect to S&amp;P, any of the following<br \/>\ncategories (any of which may include a &#8220;+&#8221; or &#8220;-&#8220;): AAA, AA, A, BBB, BB, B, CCC,<br \/>\nCC, C and D (or equivalent successor categories); (ii) with respect to Moody&#8217;s,<br \/>\nany of the following categories (any of which may include a &#8220;1&#8221;, &#8220;2&#8221; or &#8220;3&#8221;):<br \/>\nAaa, Aa, A, Baa, Ba, B, Caa, Ca, C and D (or equivalent successor categories);<br \/>\nand (iii) the equivalent of any such categories of S&amp;P or Moody&#8217;s used by<br \/>\nanother Rating Agency, if applicable.<\/p>\n<p>         &#8220;Record Date&#8221; for interest payable on any Interest Payment Date (except<br \/>\na date for payment of default interest) means the March 15 or September 15<br \/>\n(whether or not a Business Day), as the case may be, immediately preceding such<br \/>\nInterest Payment Date.<\/p>\n<p>         &#8220;Redemption Date&#8221; when used with respect to any Note to be redeemed<br \/>\nmeans the date fixed for such redemption pursuant to this Indenture.<\/p>\n<p>         &#8220;Redemption Price&#8221; when used with respect to any Note to be redeemed<br \/>\nmeans the price fixed for such redemption pursuant to this Indenture or such<br \/>\nNote.<\/p>\n<p>         &#8220;Refinancing Indebtedness&#8221; means Indebtedness incurred in exchange for,<br \/>\nor the net proceeds of which are applied to refund, refinance or extend, any<br \/>\nIndebtedness; provided that: (i) the Refinancing Indebtedness is the obligation<br \/>\nof the same Person (or if the Indebtedness being refinanced is an obligation of<br \/>\none or more Subsidiaries of the Company, such Refinancing Indebtedness may be<br \/>\nincurred by the Company or one or more Subsidiaries of the Company) and is<br \/>\nsubordinated to the Notes, if at all, to the same extent as the Indebtedness<br \/>\nbeing refunded, refinanced or extended; (ii) the Refinancing Indebtedness is<br \/>\nscheduled to mature no earlier than the Indebtedness being refunded, refinanced<br \/>\nor extended; (iii) the Refinancing Indebtedness has a Weighted Average Life to<br \/>\nMaturity at the time such Refinancing Indebtedness is incurred that is equal to<br \/>\nor greater than the Weighted Average Life to Maturity of the portion of the<br \/>\nIndebtedness being refunded, refinanced or extended; (iv) the Refinancing<br \/>\nIndebtedness is secured only to the extent, if at all, and by the assets that<br \/>\nthe Indebtedness being refunded, refinanced or extended is secured; and (v) such<br \/>\nRefinancing Indebtedness is in an aggregate principal amount that is equal to or<br \/>\nless than the aggregate principal amount then outstanding under the Indebtedness<br \/>\nbeing refunded, refinanced or extended (except for issuance costs and increases<br \/>\nin Attributable Indebtedness due solely to increases in the present value<br \/>\ncalculations resulting from renewals or extensions of the terms of the<br \/>\nunderlying leases in effect on the Issue Date).<\/p>\n<p>         &#8220;Registration Rights Agreement&#8221; means the Registration Rights Agreement<br \/>\ndated as of September 28, 2001 among the Company and the Initial Purchasers.<\/p>\n<p>         &#8220;Regulation S&#8221; means Regulation S promulgated under the Securities Act.<\/p>\n<p>         &#8220;Regulation S Distribution Compliance Period&#8221; means, with respect to<br \/>\nany Note, the period of forty (40) consecutive days beginning on and including<br \/>\nthe first day after the later of (i) the day on which such Note is first offered<br \/>\nto Persons other than distributors (as defined in Regulation S) in reliance on<br \/>\nRegulation S and (ii) the closing date of the offering of such Note.<\/p>\n<p>         &#8220;Restricted Payment&#8221; means with respect to any Person: (i) the<br \/>\ndeclaration of any dividend or the making of any other payment or distribution<br \/>\nof cash, securities or other property<\/p>\n<p>                                       13<\/p>\n<p>or assets in respect of such Person&#8217;s Capital Stock (except that a dividend<br \/>\npayable solely in Capital Stock (other than Disqualified Stock) of such Person<br \/>\nshall not constitute a Restricted Payment); (ii) any payment on account of the<br \/>\npurchase, redemption, retirement or other acquisition for value of such Person&#8217;s<br \/>\nor such Person&#8217;s Subsidiaries&#8217; Capital Stock or any other payment or<br \/>\ndistribution made in respect thereof, either directly or indirectly; (iii) any<br \/>\npayment on account of the purchase, redemption, retirement, defeasance or other<br \/>\nacquisition for value, prior to any scheduled principal payment, sinking fund<br \/>\npayment or Stated Maturity, of Subordinated Indebtedness of the Company or its<br \/>\nSubsidiaries; (iv) the incurrence, creation or assumption of any guarantee of<br \/>\nIndebtedness of any Affiliate (other than a Subsidiary of the Company); or (v)<br \/>\nthe making of any Investment in any Person (other than Permitted Investments);<br \/>\nprovided, however, that with respect to the Company and its Subsidiaries,<br \/>\nRestricted Payments shall not include any payment described in clause (i), (ii)<br \/>\nor (iii) above made (1) to the Company or any of its Wholly Owned Subsidiaries<br \/>\nby any of the Company&#8217;s Subsidiaries or (2) by the Company to any of its Wholly<br \/>\nOwned Subsidiaries or (3) by any Subsidiary, provided that the Company or<br \/>\nanother Subsidiary receives its proportionate share thereof.<\/p>\n<p>         &#8220;Restricted Security&#8221; means any Note (or beneficial interest therein)<br \/>\nother than an Exchange Note (or beneficial interest therein), until such time<br \/>\nas: (i) such Note (or beneficial interest therein) has been transferred pursuant<br \/>\nto an effective registration statement under the Securities Act; (ii) such Note<br \/>\nis a 144A Global Note and two years have passed since the Issue Date; (iii) such<br \/>\nNote is a Regulation S Global Note and the Regulation S Distribution Compliance<br \/>\nPeriod has expired; or (iv) the Private Placement Legend therefor has otherwise<br \/>\nbeen removed pursuant to SECTION 2.15(C) hereof or, in the case of a beneficial<br \/>\ninterest in a Global Note, such beneficial interest has been exchanged for an<br \/>\ninterest in a Global Note not bearing a Private Placement Legend.<\/p>\n<p>         &#8220;Rule 144A&#8221; means Rule 144A promulgated under the Securities Act.<\/p>\n<p>         &#8220;S&amp;P&#8221; means Standard &amp; Poor&#8217;s Rating Services, a division of<br \/>\nMcGraw-Hill Companies, Inc., and its successors.<\/p>\n<p>         &#8220;Sale and Leaseback Transaction&#8221; means, with respect to any Person, an<br \/>\narrangement with any bank, insurance company or other lender or investor or to<br \/>\nwhich such lender or investor is a party, providing for the leasing by such<br \/>\nPerson or any of its Subsidiaries of any property or asset of such Person or any<br \/>\nof its Subsidiaries which has been or is being sold or transferred by such<br \/>\nPerson or such Subsidiary to such lender or investor or to any Person to whom<br \/>\nfunds have been or are to be advanced by such lender or investor on the security<br \/>\nof such property or asset.<\/p>\n<p>         &#8220;Secretary&#8217;s Certificate&#8221; means a certificate signed by the Secretary<br \/>\nor any Assistant Secretary of the Company in his or her official (and not<br \/>\nindividual) capacity.<\/p>\n<p>         &#8220;Securities Act&#8221; means the Securities Act of 1933, as amended.<\/p>\n<p>         &#8220;Significant Subsidiary&#8221; means a Subsidiary of the Company which at the<br \/>\ntime of determination either (i) had tangible assets which, as of the Company&#8217;s<br \/>\nmost<\/p>\n<p>                                       14<\/p>\n<p>recent quarterly consolidated balance sheet, constituted at least 5% of<br \/>\nConsolidated Tangible Assets as of such date, or (ii) had revenues for the<br \/>\n12-month period ending on the date of the Company&#8217;s most recent quarterly<br \/>\nconsolidated statement of income which constituted at least 5% of the Company&#8217;s<br \/>\ntotal consolidated revenues for such period.<\/p>\n<p>         &#8220;Stated Maturity&#8221; when used with respect to any security or any<br \/>\ninstallment of interest thereon, means that date specified in such security as<br \/>\nthe fixed date on which the principal of such security or such installment of<br \/>\ninterest is due and payable.<\/p>\n<p>         &#8220;Subordinated Indebtedness&#8221; of any Person means any Indebtedness of<br \/>\nsuch Person that is subordinated in right of payment to the Notes.<\/p>\n<p>         &#8220;Subsidiary&#8221; of any Person means (i) any corporation of which Common<br \/>\nEquity having ordinary voting power to elect a majority of the directors of such<br \/>\ncorporation is owned by such Person directly or through one or more other<br \/>\nSubsidiaries of such Person and (ii) any entity other than a corporation in<br \/>\nwhich such Person, directly or indirectly, owns at least 50% of the Common<br \/>\nEquity of such entity and has the authority to manage such entity on a<br \/>\nday-to-day basis.<\/p>\n<p>         &#8220;Trust Indenture Act&#8221; or &#8220;TIA&#8221; means the Trust Indenture Act of 1939<br \/>\n(15 U.S. Code Sections 77aaa-77bbbb) as in effect on the date of this Indenture<br \/>\n(except as provided in SECTION 8.03 hereof).<\/p>\n<p>         &#8220;Trust Officer&#8221; shall mean, when used with respect to the Trustee, any<br \/>\nofficer within the corporate trust department of the Trustee, including any vice<br \/>\npresident, assistant vice president, assistant treasurer, trust officer or any<br \/>\nother officer of the Trustee who customarily performs functions similar to those<br \/>\nperformed by the Persons who at the time shall be such officers, respectively,<br \/>\nor to whom any corporate trust matter is referred because of such Person&#8217;s<br \/>\nknowledge of and familiarity with the particular subject and who shall have<br \/>\ndirect responsibility for the administration of this Indenture.<\/p>\n<p>         &#8220;Trustee&#8221; means the party named as such in this Indenture until a<br \/>\nsuccessor replaces it pursuant to this Indenture and thereafter means the<br \/>\nsuccessor.<\/p>\n<p>         &#8220;U.S. Government Obligations&#8221; means (a) securities that are direct<br \/>\nobligations of the United States of America for the payment of which its full<br \/>\nfaith and credit are pledged or (b) obligations of a Person controlled or<br \/>\nsupervised by and acting as an agency or instrumentality of the United States of<br \/>\nAmerica, the payment of which is unconditionally guaranteed as a full faith and<br \/>\ncredit obligation by the United States of America, which, in either case, are<br \/>\nnot callable or redeemable at the option of the issuer thereof, and shall also<br \/>\ninclude a depository receipt issued by a bank (as defined in Section 3(a)(2) of<br \/>\nthe Securities Act) as custodian with respect to any such U.S. Government<br \/>\nObligation or a specific payment of principal of or interest on any such U.S.<br \/>\nGovernment Obligation held by such custodian for the account of the holder of<br \/>\nsuch depository receipt; provided that (except as required by law) such<br \/>\ncustodian is not authorized to make any deduction from the amount payable to the<br \/>\nholder of such depository receipt from any amount received by the custodian in<br \/>\nrespect of the U.S. Government Obligation or a specific payment of principal or<br \/>\ninterest on any such U.S. Government Obligation held by such custodian for the<br \/>\naccount of the holder of such depository receipt.<\/p>\n<p>         &#8220;Weighted Average Life to Maturity&#8221; means, when applied to any<br \/>\nIndebtedness or portion thereof at any date, the number of years obtained by<br \/>\ndividing (i) the then outstanding <\/p>\n<p>                                       15<\/p>\n<p>principal amount of such Indebtedness or portion thereof (if applicable) into<br \/>\n(ii) the sum of the products obtained by multiplying (a) the amount of each then<br \/>\nremaining installment, sinking fund, serial maturity or other required payment<br \/>\nof principal, including payment at final maturity, in respect thereof, by (b)<br \/>\nthe number of years (calculated to the nearest one-twelfth) that will elapse<br \/>\nbetween such date and the making of such payment.<\/p>\n<p>         &#8220;Wholly Owned Subsidiary&#8221; of any Person means (i) a Subsidiary of which<br \/>\n100% of the Common Equity (except for director&#8217;s qualifying shares or certain<br \/>\nminority interests owned by other Persons solely due to local law requirements<br \/>\nthat there be more than one stockholder, but which interest is not in excess of<br \/>\nwhat is required for such purpose) is owned directly by such Person or through<br \/>\none or more other Wholly Owned Subsidiaries of such Person and (ii) any entity<br \/>\nother than a corporation in which such Person, directly or indirectly, owns all<br \/>\nof the Common Equity of such entity.<\/p>\n<p>         Section 1.02 Other Definitions. The definitions of the following terms<br \/>\nmay be found in the sections indicated as follows:<\/p>\n<table>\n<caption>\n<p>                                   Term                                             Defined in Section<br \/>\n                                   &#8212;-                                             &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\n<s>                                                                                        <c><br \/>\n&#8220;Accredited Investors&#8221;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;                  2.01<br \/>\n &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\n&#8220;Affiliate Transaction&#8221;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..                  4.13<br \/>\n &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\n&#8220;Agent Members&#8221;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.                  2.14<br \/>\n &#8212;&#8212;&#8212;&#8212;-<br \/>\n&#8220;Applicable Procedures&#8221;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..                  2.15<br \/>\n &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\n&#8220;Asset Sale Offer&#8221;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.                  4.12<br \/>\n &#8212;&#8212;&#8212;&#8212;&#8212;-<br \/>\n&#8220;Asset Sale Payment Amount&#8221;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.                  4.12<br \/>\n &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;-<br \/>\n&#8220;Asset Sale Purchase Price&#8221;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.                  4.12<br \/>\n &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;-<br \/>\n&#8220;Bankruptcy Law&#8221;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;                  6.01<br \/>\n &#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\n&#8220;Business Day&#8221;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..                  10.07<br \/>\n &#8212;&#8212;&#8212;&#8212;<br \/>\n&#8220;Change of Control Offer&#8221;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;                  4.15<br \/>\n &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\n&#8220;Change of Control Payment Date&#8221;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..                  4.15<br \/>\n &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\n&#8220;Change of Control Purchase Price&#8221;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;                  4.15<br \/>\n &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\n&#8220;Clearstream&#8221;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;                  2.01<br \/>\n &#8212;&#8212;&#8212;&#8211;<br \/>\n&#8220;Covenant Defeasance&#8221;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.                  9.03<br \/>\n &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;-<br \/>\n&#8220;Depositary&#8221;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.                  2.14<br \/>\n &#8212;&#8212;&#8212;-<br \/>\n&#8220;Euroclear&#8221;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..                  2.01<br \/>\n &#8212;&#8212;&#8212;<br \/>\n&#8220;Event of Default&#8221;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.                  6.01<br \/>\n &#8212;&#8212;&#8212;&#8212;&#8212;-<br \/>\n&#8220;Excess Proceeds&#8221;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..                  4.12<br \/>\n &#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\n&#8220;Excess Proceeds Payment Date&#8221;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.                  4.12<br \/>\n &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;-<br \/>\n&#8220;Global Notes&#8221;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..                  2.01<br \/>\n &#8212;&#8212;&#8212;&#8212;<br \/>\n&#8220;Legal Defeasance&#8221;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.                  9.02<br \/>\n &#8212;&#8212;&#8212;&#8212;&#8212;-<br \/>\n&#8220;Legal Holiday&#8221;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.                  10.07<br \/>\n &#8212;&#8212;&#8212;&#8212;-<br \/>\n&#8220;Make-Whole Premium&#8221;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..           Exhibit A\/Exhibit B<br \/>\n &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\n&#8220;Net Proceeds Deficiency&#8221;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;                  4.12<br \/>\n &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\n&#8220;Other Debt&#8221;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.                  4.12<br \/>\n &#8212;&#8212;&#8212;-<br \/>\n&#8220;Paying Agent&#8221;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..                  2.03<br \/>\n &#8212;&#8212;&#8212;&#8212;<br \/>\n&#8220;Private Placement Legend&#8221;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..                  2.16<br \/>\n &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\n&#8220;Registrar&#8221;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..                  2.03<br \/>\n &#8212;&#8212;&#8212;<br \/>\n<\/c><\/s><\/caption>\n<\/table>\n<p>                                       16<\/p>\n<table>\n<caption>\n<p>                                   Term                                             Defined in Section<br \/>\n                                   &#8212;-                                             &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<\/p>\n<p><s>                                                                                        <c><br \/>\n&#8220;Regulation S Global Note&#8221;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..                  2.01<br \/>\n &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\n&#8220;Restricted Global Note&#8221;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.                  2.01<br \/>\n &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;-<br \/>\n&#8220;Successor&#8221;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..                  5.01<br \/>\n &#8212;&#8212;&#8212;<br \/>\n<\/c><\/s><\/caption>\n<\/table>\n<p>         Section 1.03 Incorporation by Reference of Trust Indenture Act.<br \/>\nWhenever this Indenture refers to a provision of the TIA, the portion of such<br \/>\nprovision required to be incorporated herein in order for this Indenture to be<br \/>\nqualified under the TIA is incorporated by reference in and made a part of this<br \/>\nIndenture. Unless otherwise specified, terms used in this Indenture that are<br \/>\ndefined by the TIA, defined in the TIA by reference to another statute or<br \/>\ndefined by Commission rule have the meanings therein assigned to them.<\/p>\n<p>         Section 1.04 Rules of Construction. Unless the context otherwise<br \/>\nrequires:<\/p>\n<p>                 (1) a term has the meaning assigned to it herein, whether<br \/>\n         defined expressly or by reference;<\/p>\n<p>                 (2) an accounting term not otherwise defined has the meaning<br \/>\n         assigned to it in accordance with GAAP;<\/p>\n<p>                 (3) &#8220;or&#8221; is not exclusive;<\/p>\n<p>                 (4) words in the singular include the plural, and in the plural<br \/>\n         include the singular; and<\/p>\n<p>                 (5) words used herein implying any gender shall apply to every<br \/>\n         gender.<\/p>\n<p>                                    ARTICLE 2<\/p>\n<p>                                   THE NOTES<br \/>\n                                   &#8212;&#8212;&#8212; <\/p>\n<p>         Section 2.01 Dating; Incorporation of Form in Indenture; Form of Notes.<br \/>\n(a) Generally. The Initial Notes and the Trustee&#8217;s certificate of authentication<br \/>\nshall be substantially in the form of Exhibit A, and the Exchange Notes and the<br \/>\nTrustee&#8217;s certificate of authentication shall be substantially in the form of<br \/>\nExhibit B, each of which is incorporated in and made part of this Indenture with<br \/>\nsuch appropriate insertions, substitutions and other variations as are required<br \/>\nor permitted by this Indenture. The Notes may have notations, legends or<br \/>\nendorsements required by law, stock exchange rule or usage all in a form<br \/>\napproved by the Company. Each Note shall be dated the date of its<br \/>\nauthentication.<\/p>\n<p>                  (b) Notes Sold Pursuant to Rule 144A. The Notes offered and<br \/>\nsold in their initial distribution in reliance on Rule 144A to Qualified<br \/>\nInstitutional Buyers shall be issued in the form of a permanent global note (the<br \/>\n&#8220;Restricted Global Note&#8221;) (which may be represented by more than one<br \/>\ncertificate, if so required by the Depositary&#8217;s rules regarding the maximum<br \/>\nprincipal amount to be represented by a single certificate), duly executed by<br \/>\nthe Company and authenticated by the Trustee as hereinafter provided. Each<br \/>\nRestricted Global Note shall be <\/p>\n<p>                                       17<\/p>\n<p>registered in the name of the Depositary or its nominee and deposited with the<br \/>\nTrustee, at its Corporate Trust Office, as custodian for the Depositary on<br \/>\nbehalf of the purchasers of the Notes represented thereby.<\/p>\n<p>                  (c) Notes Sold Pursuant to Regulation S. The Notes offered and<br \/>\nsold in their initial distribution in reliance on Regulation S shall be issued<br \/>\nin the form of a permanent global note (the &#8220;Regulation S Global Note&#8221; and,<br \/>\ntogether with the Restricted Global Note, the &#8220;Global Notes&#8221;) (which may be<br \/>\nrepresented by more than one certificate, if so required by the Depositary&#8217;s<br \/>\nrules regarding the maximum principal amount to be represented by a single<br \/>\ncertificate), duly executed by the Company and authenticated by the Trustee as<br \/>\nhereinafter provided. Each Regulation S Global Note shall be registered in the<br \/>\nname of the Depositary or its nominee and deposited with the Trustee, at its<br \/>\nCorporate Trust Office, as custodian for the Depositary for credit to the<br \/>\nrespective accounts of The Euroclear System (&#8220;Euroclear&#8221;) and Clearstream<br \/>\nBanking, societe anonyme (&#8220;Clearstream&#8221;). Prior to the termination of the<br \/>\nRegulation S Distribution Compliance Period, beneficial interests in a<br \/>\nRegulation S Global Note may be held only through Euroclear and Clearstream.<\/p>\n<p>                  (d) Notes Sold to Institutional Accredited Investors. The<br \/>\nNotes offered and sold in their initial distribution in reliance on an exemption<br \/>\nfrom registration under the Securities Act (other than Rule 144A or Regulation<br \/>\nS) to institutional &#8220;accredited investors&#8221; (as defined in Rule 501(a)(1), (2),<br \/>\n(3) or (7) under the Securities Act (&#8220;Accredited Investors&#8221;)) shall be issued in<br \/>\ncertificated, fully registered form without coupons and only in denominations of<br \/>\n$250,000 and integral multiples of $1,000 in excess thereof, duly executed by<br \/>\nthe Company and authenticated by the Trustee as hereinafter provided.<\/p>\n<p>         Section 2.02 Execution and Authentication; Appointment of<br \/>\nAuthenticating Agent. The Notes shall be executed on behalf of the Company by<br \/>\none or more Officers of the Company. Such signature may be either manual or<br \/>\nfacsimile.<\/p>\n<p>         If an Officer whose signature is on a Note no longer holds that office<br \/>\nat the time the Trustee authenticates the Note, the Note shall be valid<br \/>\nnevertheless.<\/p>\n<p>         A Note shall not be valid until the Trustee manually signs the<br \/>\ncertificate of authentication on the Note. Such signature shall be conclusive<br \/>\nevidence that the Note has been authenticated under this Indenture.<\/p>\n<p>         The Trustee shall authenticate (i) Initial 2006 Notes for original<br \/>\nissue on the Issue Date in the aggregate principal amount not to exceed<br \/>\n$200,000,000, (ii) Initial 2011 Notes for original issue on the Issue Date in<br \/>\nthe aggregate principal amount not to exceed $400,000,000, (iii) pursuant to the<br \/>\nExchange Offer, Exchange Notes from time to time for issue only in exchange for<br \/>\na like principal amount of Initial 2006 Notes and Initial 2011 Notes and (iv)<br \/>\nany other Notes that have been executed by the Company in order to effect any<br \/>\ntransfer or exchange in accordance with the provisions of SECTION 2.15.<\/p>\n<p>         Except as provided in SECTION 2.01(D), the Notes shall be issuable only<br \/>\nin definitive, fully registered form without coupons and only in minimum<br \/>\ndenominations of $1,000 and integral multiples thereof.<\/p>\n<p>                                       18<\/p>\n<p>         The Trustee, with the approval of the Company, may appoint an<br \/>\nauthenticating agent to authenticate Notes. Any such appointment shall be<br \/>\nevidenced by an instrument signed by an authorized officer of the Trustee, a<br \/>\ncopy of which shall be furnished to the Company. An authenticating agent may<br \/>\nauthenticate Notes whenever the Trustee may do so. Each reference in this<br \/>\nIndenture to authentication by the Trustee includes authentication by such<br \/>\nagent, and shall comply with this Indenture. An authenticating agent has the<br \/>\nsame right as an Agent to deal with the Company or an Affiliate.<\/p>\n<p>         Section 2.03 Registrar and Paying Agent. The Company shall maintain an<br \/>\noffice or agency in the Borough of Manhattan, The City of New York where (a)<br \/>\nNotes may be presented or surrendered for registration of transfer or for<br \/>\nexchange (&#8220;Registrar&#8221;), (b) Notes may be presented or surrendered for payment<br \/>\n(&#8220;Paying Agent&#8221;) and (c) notices and demands in respect of Notes and this<br \/>\nIndenture may be served. The Registrar shall keep a register of the Notes and of<br \/>\ntheir transfer and exchange. The Registrar shall provide the Company a current<br \/>\ncopy of such register from time to time upon request of the Company. The Company<br \/>\nmay have one or more co-Registrars and one or more additional Paying Agents. The<br \/>\nCompany may change any Paying Agent, Registrar or co-Registrar without notice to<br \/>\nany Holder. The Company may not act as Paying Agent, but may act as Registrar or<br \/>\nco-Registrar.<\/p>\n<p>         The Company shall enter into an appropriate agency agreement with any<br \/>\nRegistrar or Paying Agent not a party to this Indenture, which shall incorporate<br \/>\nthe provisions of the TIA. The agreement shall implement the provisions of this<br \/>\nIndenture that relate to such Agent. The Company shall notify the Trustee in<br \/>\nwriting of the name and address of any such Agent. If the Company fails to<br \/>\nmaintain a Registrar or Paying Agent, or agent for service of notices and<br \/>\ndemands, or fails to give the foregoing notice, the Company shall notify the<br \/>\nTrustee and the Trustee shall to the extent that it is capable act as such for<br \/>\nso long as such failure continues.<\/p>\n<p>         The Company initially appoints the Trustee as Registrar and Paying<br \/>\nAgent in the Borough of Manhattan, The City of New York.<\/p>\n<p>         Section 2.04 Paying Agent To Hold Money in Trust. Before 10:00 A.M. New<br \/>\nYork City time on each payment date of the principal of and\/or interest on any<br \/>\nNotes, the Company shall deposit with the Paying Agent a sum sufficient to pay<br \/>\nsuch principal and interest so becoming due. The Company at any time may require<br \/>\na Paying Agent to pay all money held by it to the Trustee together with a<br \/>\ncomplete accounting of such sums, and the Trustee may at any time during the<br \/>\ncontinuance of any Event of Default under Section 6.01(a) or (b) hereof, upon<br \/>\nwritten request to a Paying Agent, require such Paying Agent to forthwith pay to<br \/>\nthe Trustee all sums so held in trust by such Paying Agent together with a<br \/>\ncomplete accounting of such sums. Upon doing so, the Paying Agent shall have no<br \/>\nfurther liability for the money. Funds deposited with the Paying Agent may be<br \/>\ninvested as agreed from time to time by the Company and the Paying Agent. All<br \/>\npayments made hereunder shall be in U.S. legal tender.<\/p>\n<p>         Section 2.05 Holder Lists. The Trustee shall preserve in as current a<br \/>\nform as is reasonably practicable the most recent list available to it of the<br \/>\nnames and addresses of Holders. If the Trustee is not the Registrar, the Company<br \/>\nshall furnish to the Trustee at least five Business Days before each Interest<br \/>\nPayment Date and the Stated Maturity and at such other times as the<\/p>\n<p>                                       19<\/p>\n<p>Trustee may reasonably request in writing, a list in such form and as of such<br \/>\ndate as the Trustee may require of the names and addresses of Holders.<\/p>\n<p>         Section 2.06 Replacement Notes. If a mutilated Note is surrendered to<br \/>\nthe Trustee or if the Holder of a Note claims that a Note has been lost,<br \/>\ndestroyed or wrongfully taken, the Company shall issue and the Trustee shall<br \/>\nauthenticate a replacement Note if the Trustee&#8217;s requirements for replacement<br \/>\nare met. An indemnity bond may be required by the Company or the Trustee that is<br \/>\nsufficient in the judgment of the Company and the Trustee to protect the<br \/>\nCompany, the Trustee or any Agent from any loss which any of them may suffer if<br \/>\na Note is replaced and evidence to their satisfaction of apparent loss,<br \/>\ndestruction or theft of such Note may be required by the Company, the Trustee or<br \/>\nany Agent. The Company and the Trustee may charge for their reasonable<br \/>\nout-of-pocket expenses (including reasonable attorneys&#8217; fees and expenses and<br \/>\nany applicable taxes) in replacing a Note pursuant to this SECTION 2.06. In the<br \/>\nevent any such mutilated, lost, destroyed or wrongfully taken Note has become<br \/>\ndue and payable, the Company in its discretion may pay such Note instead of<br \/>\nissuing a new Note in replacement thereof. If after the delivery of such new<br \/>\nNote, a bona fide purchaser of the original Note in lieu of which such new Note<br \/>\nwas issued presents for payment such original Note, the Company and the Trustee<br \/>\nshall be entitled to recover such new Note from the person to whom it was<br \/>\ndelivered or any transferee thereof, except a bona fide purchaser, and shall be<br \/>\nentitled to recover upon the security or indemnity provided therefor to the<br \/>\nextent of any loss, damage, cost or expense incurred by the Company or the<br \/>\nTrustee in connection therewith.<\/p>\n<p>         Every replacement Note is an additional obligation of the Company.<\/p>\n<p>         Section 2.07 Outstanding Notes. Notes outstanding at any time are all<br \/>\nNotes authenticated by the Trustee except for those canceled by it, those<br \/>\ndelivered to it for cancellation and those described in this SECTION 2.07 as not<br \/>\noutstanding.<\/p>\n<p>         A Note replaced pursuant to SECTION 2.06 hereof (other than a mutilated<br \/>\nNote surrendered for replacement) ceases to be outstanding unless and until the<br \/>\nTrustee receives proof satisfactory to it that such replaced Note is held by a<br \/>\nprotected purchaser.<\/p>\n<p>         If a Paying Agent holds on a Redemption Date or at Stated Maturity U.S.<br \/>\nlegal tender sufficient to pay the principal of, premium, if any, and accrued<br \/>\ninterest on Notes (or portions thereof) payable on that date, then on and after<br \/>\nthat date, such Notes (or portions thereof) cease to be outstanding and interest<br \/>\non them ceases to accrue.<\/p>\n<p>         Section 2.08 Treasury Notes. In determining whether the Holders of the<br \/>\nrequired principal amount of Notes have concurred in any direction, waiver,<br \/>\nconsent or notice, Notes owned by the Company or any of its Affiliates shall be<br \/>\nconsidered as though they are not outstanding, except that for the purposes of<br \/>\ndetermining whether the Trustee shall be protected in relying on any such<br \/>\ndirection, waiver or consent, only Notes which a Trust Officer of the Trustee<br \/>\nactually knows are so owned shall be so considered. The Company shall notify the<br \/>\nTrustee, in writing, when it or any of its Affiliates repurchases or otherwise<br \/>\nacquires Notes and of the aggregate principal amount of such Notes so<br \/>\nrepurchased or otherwise acquired.<\/p>\n<p>                                       20<\/p>\n<p>         Section 2.09 Temporary Notes. Until definitive Notes are ready for<br \/>\ndelivery, the Company may prepare and the Trustee shall authenticate temporary<br \/>\nNotes. Temporary Notes shall be substantially in the form, and shall carry all<br \/>\nrights and restrictions, of definitive Notes but may have variations that the<br \/>\nCompany considers appropriate for temporary Notes. Without unreasonable delay,<br \/>\nthe Company shall prepare and the Trustee shall authenticate definitive Notes in<br \/>\nexchange for temporary Notes upon surrender of such temporary Notes at the<br \/>\noffice or agency maintained pursuant to SECTION 2.03 hereof.<\/p>\n<p>         Section 2.10 Cancellation. The Company at any time may deliver Notes to<br \/>\nthe Trustee for cancellation. The Registrar and the Paying Agent shall forward<br \/>\nto the Trustee any Notes surrendered to them for transfer, exchange or payment.<br \/>\nThe Trustee shall cancel all Notes surrendered for transfer, exchange, payment<br \/>\nor cancellation and, unless the Company instructs the Trustee in writing to<br \/>\ndeliver the Notes to the Company, shall dispose of such Notes in accordance with<br \/>\nits normal practice. Subject to SECTION 2.06 hereof, the Company may not issue<br \/>\nnew Notes to replace Notes in respect of which it has previously paid all<br \/>\nprincipal, premium, if any, and interest accrued thereon, or delivered to the<br \/>\nTrustee for cancellation. The Trustee shall provide the Company with a list of<br \/>\nall Notes that have been canceled from time to time as requested in writing by<br \/>\nthe Company. If the Company shall acquire any of the Notes, such acquisition<br \/>\nshall not operate as a redemption or satisfaction of the Indebtedness<br \/>\nrepresented by such Notes unless and until the same are surrendered to the<br \/>\nTrustee for cancellation pursuant to this SECTION 2.10.<\/p>\n<p>         Section 2.11 Defaulted Interest. If the Company defaults in a payment<br \/>\nof principal or interest on Notes of a particular maturity, it shall pay<br \/>\ninterest on overdue principal and on overdue installments of interest (without<br \/>\nregard to any applicable grace periods) from time to time on demand at the rate<br \/>\nper annum borne by the applicable Notes, to the extent lawful.<\/p>\n<p>         If the Company defaults in a payment of interest on Notes of a<br \/>\nparticular maturity, it shall pay the defaulted interest, plus (to the extent<br \/>\nlawful) any interest payable on the defaulted interest, to the Persons who are<br \/>\nHolders of such Notes on a subsequent special Record Date, which date shall be<br \/>\nthe fifteenth day next preceding the date fixed by the Company for the payment<br \/>\nof defaulted interest or the next succeeding Business Day if such date is not a<br \/>\nBusiness Day. At least 15 days before the subsequent special Record Date, the<br \/>\nCompany shall mail to each Holder, as of a recent date selected by the Company,<br \/>\nwith a copy to the Trustee, a notice that states the subsequent special Record<br \/>\nDate, the payment date and the amount of defaulted interest, and interest<br \/>\npayable on such defaulted interest, if any, to be paid.<\/p>\n<p>         Notwithstanding the foregoing, any interest which is paid prior to the<br \/>\nexpiration of the 30-day period set forth in SECTION 6.01(A) hereof shall be<br \/>\npaid to Holders as of the Record Date for the Interest Payment Date for which<br \/>\ninterest has not been paid.<\/p>\n<p>         Section 2.12 Deposit of Moneys; Payments. Prior to 10:00 A.M., New York<br \/>\nCity time, on the relevant Interest Payment Date, Stated Maturity, Redemption<br \/>\nDate, Change of Control Purchase Date and Excess Proceeds Payment Date, the<br \/>\nCompany shall have deposited with the Paying Agent in immediately available<br \/>\nfunds money sufficient to make all cash payments due on such Interest Payment<br \/>\nDate, Stated Maturity, Redemption Date, Change of Control Purchase Date and<br \/>\nExcess Proceeds Payment Date, as the case may be (or if any such<\/p>\n<p>                                       21<\/p>\n<p>date is not a Business Day, the first preceding Business Day). The principal and<br \/>\ninterest on Global Notes shall be payable to the Depositary or its nominee, as<br \/>\nthe case may be, as the sole registered owner and the sole holder of the Global<br \/>\nNotes represented thereby. The principal and interest on Certificated Notes, if<br \/>\nany, shall be payable at the office of the Paying Agents. The Paying Agents<br \/>\nshall pay the Company any excess cash remaining on deposit after all payments<br \/>\nhave been made with respect to a given Interest Payment Date, Stated Maturity,<br \/>\nRedemption Date, Change of Control Purchase Date or Excess Proceeds Payment<br \/>\nDate, as the case may be. All payments made hereunder shall be in U.S. legal<br \/>\ntender.<\/p>\n<p>         Section 2.13 &#8220;CUSIP&#8221; Number. The Company in issuing the Notes may use<br \/>\n&#8220;CUSIP&#8221; number(s) and the Trustee shall use the &#8220;CUSIP&#8221; numbers(s) in notices of<br \/>\nredemption or exchange as a convenience to Holders; provided that neither the<br \/>\nCompany nor the Trustee shall have any responsibility for any defect in the<br \/>\n&#8220;CUSIP&#8221; number that appears on any Note, check, advice or payment or redemption<br \/>\nnotice, and any such notice may state that no representation is made as to the<br \/>\ncorrectness or accuracy of the &#8220;CUSIP&#8221; number(s) printed in the notice or on the<br \/>\nNotes, and that reliance may be placed only on the other identification numbers<br \/>\nprinted on the Notes and any such redemption or exchange shall not be affected<br \/>\nby any defect in or omission of such number(s). The Company shall promptly<br \/>\nnotify the Trustee of any changes in &#8220;CUSIP&#8221; numbers.<\/p>\n<p>         Section 2.14 Depositary. (a) The Company hereby appoints DTC to act as<br \/>\ndepositary (in such capacity, together with its successors in such capacity, the<br \/>\n&#8220;Depositary&#8221;) with respect to the Global Notes. The Trustee shall act as<br \/>\ncustodian of the Global Notes for the Depositary. So long as the Depositary or<br \/>\nits nominee, Cede &amp; Co., is the registered owner of the Global Notes, it shall<br \/>\nbe considered the Holder of the Notes represented thereby for all purposes<br \/>\nhereunder and under the Global Notes, and neither any members of, or<br \/>\nparticipants in, the Depositary (&#8220;Agent Members&#8221;) nor any other Persons on whose<br \/>\nbehalf Agent Members may act shall have any rights hereunder with respect to the<br \/>\nGlobal Notes or under the Global Notes. Notwithstanding the foregoing, nothing<br \/>\nherein shall prevent the Company, the Trustee or any agent of the Company or the<br \/>\nTrustee from giving effect to any written certification, proxy or other<br \/>\nauthorization furnished by the Depositary or its nominee, as the case may be, or<br \/>\nimpair, as between the Depositary, its Agent Members and any other Person on<br \/>\nwhose behalf an Agent Member may act, the operation of customary practices of<br \/>\nsuch Persons governing the exercise of the rights of a Holder of any Note.<\/p>\n<p>                  (b) The Company may remove or replace DTC or any successor as<br \/>\nDepositary for any reason upon thirty (30) days&#8217; notice to DTC or such<br \/>\nsuccessor. The Holders shall have no right to a depositary for the Notes.<\/p>\n<p>                  (c) Notwithstanding any other provision of this Indenture or<br \/>\nthe Notes, so long as DTC or its nominee is the registered owner of the Notes:<\/p>\n<p>                        (i) the provisions of the DTC Letter of Representations<br \/>\n         shall control over the provisions of this Indenture with respect to the<br \/>\n         matters covered thereby;<\/p>\n<p>                                       22<\/p>\n<p>                       (ii) presentation of Notes to the Trustee at redemption<br \/>\n         or at maturity shall be deemed made to the Trustee when the right to<br \/>\n         exercise ownership rights in the Notes through DTC or Agent Members is<br \/>\n         transferred by DTC on its books; and<\/p>\n<p>                      (iii) DTC may present notices, approvals, waivers or other<br \/>\n         communications required or permitted to be made by Holders under this<br \/>\n         Indenture on a fractionalized basis on behalf of some or all of those<br \/>\n         Persons entitled to exercise ownership rights in the Notes through DTC<br \/>\n         or Agent Members.<\/p>\n<p>         Section 2.15 Registration of Transfers and Exchanges. (a) Transfer and<br \/>\nExchange Generally. (i) The Notes are transferable only upon the surrender<br \/>\nthereof for registration of transfer. When a Note is presented to the Registrar<br \/>\nwith a duly executed instrument of assignment and transfer substantially in the<br \/>\nform of assignment attached to Exhibit A or B, as applicable, the Registrar<br \/>\nshall register the transfer as requested if such transfer complies with the<br \/>\nprovisions hereof. Prior to the due presentation for registration of transfer of<br \/>\nany Note, the Person in whose name such Note is registered shall be treated as<br \/>\nthe absolute owner of such Note for the purpose of receiving payment of<br \/>\nprincipal of, premium (if any) and interest on such Note (whether or not such<br \/>\npayment is overdue) and for all other purposes whatsoever, notwithstanding any<br \/>\nnotice to the contrary. Registration of transfer of any Note by the Registrar<br \/>\nshall be deemed to be an acknowledgment of such transfer by the Company.<\/p>\n<p>                       (ii) When Notes are presented to the Registrar with a<br \/>\n         written request to exchange such Notes for Notes of any authorized<br \/>\n         denominations and of a like aggregate principal amount, the Registrar<br \/>\n         shall make the exchange as requested if such exchange complies with the<br \/>\n         provisions of this SECTION 2.15(A).<\/p>\n<p>                      (iii) Following any request for transfer or exchange of<br \/>\n         one or more Notes made in compliance with clauses (i) or (ii), as the<br \/>\n         case may be, of this SECTION 2.15(A), the Company shall execute, and<br \/>\n         the Trustee shall authenticate and deliver, one or more new Notes of<br \/>\n         the same maturity, of a like principal amount and in such authorized<br \/>\n         denominations as may be requested. Any exchange or transfer shall be<br \/>\n         without charge, except that the Company may require payment by the<br \/>\n         Holder of a sum sufficient to cover any tax or other governmental<br \/>\n         charge that may be imposed in relation to a transfer or exchange other<br \/>\n         than any exchange pursuant to SECTION 2.09, 3.06, 4.12, 4.15 or 8.05<br \/>\n         hereof.<\/p>\n<p>                       (iv) Transfers or exchanges of the Global Notes and<br \/>\n         beneficial interests therein shall be subject to the provisions of<br \/>\n         SECTION 2.15(B) and the rules of the Depositary. Transfers or exchanges<br \/>\n         of Certificated Notes shall be subject to the provisions of SECTION<br \/>\n         2.15(C).<\/p>\n<p>                        (v) Except as otherwise provided herein, the Global<br \/>\n         Notes and each Certificated Note shall bear the Private Placement<br \/>\n         Legend as set forth in SECTION 2.16. By its acceptance of any Note<br \/>\n         bearing the Private Placement Legend, whether upon original issuance or<br \/>\n         subsequent transfer, each Holder of such a Note acknowledges the<br \/>\n         restrictions on transfer of such Note set forth in this Indenture and<br \/>\n         in the Private Placement Legend and agrees that it will transfer such<br \/>\n         Note only as provided in this <\/p>\n<p>                                       23<\/p>\n<p>         Indenture. Upon the specific written request of a Holder to remove the<br \/>\n         Private Placement Legend, the Registrar shall authenticate and deliver<br \/>\n         a Note of the same maturity and with an equivalent principal amount not<br \/>\n         bearing the Private Placement Legend if there is provided to the<br \/>\n         Company evidence reasonably satisfactory to the Company (which may, at<br \/>\n         the Company&#8217;s request, include an Opinion of Counsel) that neither the<br \/>\n         Private Placement Legend nor the restrictions on transfer set forth<br \/>\n         therein are required to ensure compliance with the Securities Act. Upon<br \/>\n         a written request for the registration of transfer or exchange of a<br \/>\n         Note bearing the Private Placement Legend pursuant to an effective<br \/>\n         registration statement under the Securities Act and in accordance with<br \/>\n         any applicable securities laws of any state of the United States, the<br \/>\n         Registrar shall authenticate and deliver a Note of the same maturity<br \/>\n         and with an equivalent principal amount not bearing the Private<br \/>\n         Placement Legend. If the Private Placement Legend has been removed from<br \/>\n         a Note as provided in this clause (v), the transfer of such Note shall<br \/>\n         not be subject to the restrictions on transfer set forth in the Private<br \/>\n         Placement Legend, and no other Note issued in exchange for all or any<br \/>\n         part of such Note shall bear the Private Placement Legend unless the<br \/>\n         Company has reasonable cause to believe that such other Note is a<br \/>\n         Restricted Security and instructs the Registrar in writing to cause the<br \/>\n         Private Placement Legend to appear thereon.<\/p>\n<p>                       (vi) None of the Company or the Trustee or the Registrar<br \/>\n         shall be liable for any delay by the Depositary in identifying the<br \/>\n         beneficial owners of the Notes, and each such Person may conclusively<br \/>\n         rely on, and shall be protected in relying on, instructions from the<br \/>\n         Depositary for all purposes (including with respect to the registration<br \/>\n         and delivery, and the respective principal amounts, of any Notes to be<br \/>\n         issued).<\/p>\n<p>                      (vii) Prior to the due presentation for registration of<br \/>\n         transfer of any Note, the Company, the Trustee, the Paying Agent, the<br \/>\n         Registrar or any co-Registrar may deem and treat the Person in whose<br \/>\n         name a Note is registered as the absolute owner of such Note for the<br \/>\n         purpose of receiving payment of principal of, premium, if any, and<br \/>\n         interest, if any, on such Note and for all other purposes whatsoever,<br \/>\n         whether or not such Note is overdue, and none of the Company, the<br \/>\n         Trustee, the Paying Agent, the Registrar or any co-Registrar shall be<br \/>\n         affected by notice to the contrary. So long as the Depositary or its<br \/>\n         nominee is the Holder of a Global Note, the Depositary or such nominee,<br \/>\n         as the case may be, will be considered the sole owner or Holder of the<br \/>\n         Notes represented by such Global Note for all purposes hereunder and<br \/>\n         under the Notes. Any Holder of a Global Note, and each Person with an<br \/>\n         interest in such Global Note, shall, by acceptance of such Global Note<br \/>\n         or such interest, agree that transfers of the beneficial interests in<br \/>\n         such Global Note may be effected only through a book-entry system<br \/>\n         maintained by the Holder of such Global Note (or its agent) and that<br \/>\n         ownership of a beneficial interest in such Global Note shall be<br \/>\n         required to be reflected in a book entry.<\/p>\n<p>                     (viii) Any Note issued upon any transfer or exchange<br \/>\n         pursuant to this SECTION 2.15 will evidence the same debt and will be<br \/>\n         entitled to the same benefits and, unless otherwise provided for in<br \/>\n         this Indenture, subject to the same restrictions under this Indenture<br \/>\n         as the Note or Notes surrendered upon such transfer or exchange.<\/p>\n<p>                                       24<\/p>\n<p>                       (ix) The Registrar shall not be required to register the<br \/>\n         transfer of or exchange any Note (A) selected for redemption in whole<br \/>\n         or in part pursuant to ARTICLE 3, except the unredeemed portion of any<br \/>\n         Note being redeemed in part, (B) for a period beginning fifteen (15)<br \/>\n         days before the mailing of a notice of redemption of Notes and ending<br \/>\n         on the date of such mailing or (C) between a Record Date and the next<br \/>\n         succeeding Interest Payment Date.<\/p>\n<p>                  (b) Transfers and Exchanges of the Global Notes and Beneficial<br \/>\nInterests Therein. (i) Subject to clauses (ii) through (viii) of this SECTION<br \/>\n2.15(B), transfers of Global Notes shall be limited to transfers in whole, but<br \/>\nnot in part, to the Depositary, its successors or their respective nominees. So<br \/>\nlong as the Global Notes remain outstanding and are held by or on behalf of the<br \/>\nDepositary, transfers and exchanges of beneficial interests in the Global Notes<br \/>\nshall be made in accordance with the provisions of this SECTION 2.15(B) and in<br \/>\naccordance with the rules and procedures of the Depositary to the extent<br \/>\napplicable (the &#8220;Applicable Procedures&#8221;).<\/p>\n<p>                       (ii) No restrictions shall apply with respect to the<br \/>\n         transfer or registration of transfer of (x) a beneficial interest in a<br \/>\n         Restricted Global Note to a transferee that takes delivery in the form<br \/>\n         of a beneficial interest in such Restricted Global Note or (y) a<br \/>\n         beneficial interest in a Regulation S Global Note to a transferee that<br \/>\n         takes delivery in the form of a beneficial interest in such Regulation<br \/>\n         S Global Note; provided that any transfer described in this clause (ii)<br \/>\n         shall be made in accordance with the Applicable Procedures.<\/p>\n<p>                      (iii) Any transfer of a beneficial interest in a<br \/>\n         Restricted Global Note to a transferee that will take delivery in the<br \/>\n         form of a beneficial interest in the applicable Regulation S Global<br \/>\n         Note prior to the termination of the Regulation S Distribution<br \/>\n         Compliance Period shall be registered, subject to the Applicable<br \/>\n         Procedures, only in accordance with this clause (iii). At any time<br \/>\n         prior to the termination of the Regulation S Distribution Compliance<br \/>\n         Period, upon (x) receipt by the Registrar of (A) instructions given in<br \/>\n         accordance with the Applicable Procedures from the Depositary or its<br \/>\n         nominee on behalf of an owner of a beneficial interest in the<br \/>\n         Restricted Global Note to transfer such beneficial interest to a Person<br \/>\n         that will take delivery in the form of a beneficial interest in the<br \/>\n         applicable Regulation S Global Note, (B) a written order of the<br \/>\n         Depositary or its nominee given in accordance with the Applicable<br \/>\n         Procedures containing account and other information with respect to<br \/>\n         such transfer and (C) a certificate of the transferor of the beneficial<br \/>\n         interest in such Restricted Global Note substantially in the form of<br \/>\n         Exhibit D and (y) satisfaction of all other applicable conditions<br \/>\n         imposed by this Indenture and the Applicable Procedures, the Registrar<br \/>\n         shall (1) reflect in the register for the applicable Notes a decrease<br \/>\n         in the principal amount of the applicable Restricted Global Note and an<br \/>\n         increase in the principal amount of the applicable Regulation S Global<br \/>\n         Note, each such adjustment to be equal to the beneficial interest<br \/>\n         transferred pursuant to this clause (iii) and (2) instruct the<br \/>\n         Depositary to make the corresponding adjustment to its records and<br \/>\n         debit the account of the appropriate Agent Members in accordance with<br \/>\n         the Applicable Procedures.<\/p>\n<p>                       (iv) Any transfer of a beneficial interest in a<br \/>\n         Restricted Global Note to a transferee that will take delivery in the<br \/>\n         form of a beneficial interest in the applicable Regulation S Global<br \/>\n         Note subsequent to the termination of the Regulation S Distribution<\/p>\n<p>                                       25<\/p>\n<p>         Compliance Period shall be registered, subject to the Applicable<br \/>\n         Procedures, only in accordance with this clause (iv). At any time<br \/>\n         subsequent to the termination of the Regulation S Distribution<br \/>\n         Compliance Period, upon (x) receipt by the Registrar of (A)<br \/>\n         instructions given in accordance with the Applicable Procedures from<br \/>\n         the Depositary or its nominee on behalf of an owner of a beneficial<br \/>\n         interest in a Restricted Global Note to transfer such beneficial<br \/>\n         interest to a Person that will take delivery in the form of a<br \/>\n         beneficial interest in the applicable Regulation S Global Note, (B) a<br \/>\n         written order of the Depositary or its nominee given in accordance with<br \/>\n         the Applicable Procedures containing account and other information with<br \/>\n         respect to such transfer and (C) a certificate of the transferor of the<br \/>\n         beneficial interest in such Restricted Global Note substantially in the<br \/>\n         form of Exhibit D (if transfer is made in reliance on Regulation S) or<br \/>\n         Exhibit E (if transfer is made in reliance on Rule 144) and (y)<br \/>\n         satisfaction of all other conditions imposed by the Applicable<br \/>\n         Procedures, the Registrar shall (1) reflect in the register for the<br \/>\n         applicable Notes a decrease in the principal amount of such Restricted<br \/>\n         Global Note and an increase in the principal amount of the applicable<br \/>\n         Regulation S Global Note, each such adjustment to equal the principal<br \/>\n         amount of the beneficial interest transferred pursuant to this clause<br \/>\n         (iv), and (2) instruct the Depositary to make the corresponding<br \/>\n         adjustment to its records and debit and credit the accounts of the<br \/>\n         appropriate Agent Members in accordance with the Applicable Procedures.<\/p>\n<p>                        (v) Any transfer of a beneficial interest in a<br \/>\n         Regulation S Global Note to a transferee that will take delivery in the<br \/>\n         form of a beneficial interest in the applicable Restricted Global Note,<br \/>\n         either prior or subsequent to the termination of the Regulation S<br \/>\n         Distribution Compliance Period, shall be registered, subject to the<br \/>\n         Applicable Procedures, only in accordance with this clause (v). At any<br \/>\n         time upon (x) receipt by the Registrar of (A) instructions given in<br \/>\n         accordance with the Applicable Procedures from the Depositary or its<br \/>\n         nominee on behalf of an owner of a beneficial interest in a Regulation<br \/>\n         S Global Note to transfer such beneficial interest to a Person that<br \/>\n         will take delivery in the form of a beneficial interest in the<br \/>\n         applicable Restricted Global Note, (B) a written order of the<br \/>\n         Depositary or its nominee given in accordance with the Applicable<br \/>\n         Procedures containing account and other information with respect to<br \/>\n         such transfer and (C) a certificate of the transferor of the beneficial<br \/>\n         interest in such Regulation S Global Note substantially in the form of<br \/>\n         Exhibit C and (y) satisfaction of all other conditions imposed by the<br \/>\n         Applicable Procedures, the Registrar shall (1) reflect in the register<br \/>\n         for the applicable Notes a decrease in the principal amount of such<br \/>\n         Regulation S Global Note and an increase in the principal amount of the<br \/>\n         applicable Restricted Global Note, each such adjustment to equal the<br \/>\n         principal amount of the beneficial interest transferred pursuant to<br \/>\n         this clause (v), and (2) instruct the Depositary to make the<br \/>\n         corresponding adjustment to its records and debit and credit the<br \/>\n         accounts of the appropriate Agent Members in accordance with the<br \/>\n         Applicable Procedures.<\/p>\n<p>                       (vi) Any transfer of a beneficial interest in a<br \/>\n         Restricted Global Note to a transferee that will take delivery in the<br \/>\n         form of one or more Certificated Notes shall be registered, subject to<br \/>\n         the Applicable Procedures, only in accordance with this clause (vi). At<br \/>\n         any time upon (x) receipt by the Registrar of (A) instructions given in<br \/>\n         accordance with the Applicable Procedures from the Depositary or its<br \/>\n         nominee on behalf of an owner of a beneficial interest in such<br \/>\n         Restricted Global Note to transfer such beneficial interest to a<\/p>\n<p>                                       26<\/p>\n<p>         Person that will take delivery in the form of one or more Certificated<br \/>\n         Notes, (B) a written order of the Depositary or its nominee given in<br \/>\n         accordance with the Applicable Procedures containing account and other<br \/>\n         information with respect to such transfer, (C) a certificate of such<br \/>\n         Person substantially in the form of Exhibit F and (D) unless such<br \/>\n         Restricted Global Note does not bear a Private Placement Legend, an<br \/>\n         Opinion of Counsel to the effect that such transfer is in compliance<br \/>\n         with the Securities Act, and (y) satisfaction of all other applicable<br \/>\n         conditions imposed by this Indenture and the Applicable Procedures, (1)<br \/>\n         the Registrar shall (A) reflect in the register for the applicable<br \/>\n         Notes a decrease in the principal amount of such Restricted Global Note<br \/>\n         in an amount equal to the beneficial interest transferred pursuant to<br \/>\n         this clause (vi) and (B) instruct the Depositary to make the<br \/>\n         corresponding adjustment to its records and debit the account of the<br \/>\n         appropriate Agent Member in accordance with the Applicable Procedures,<br \/>\n         and (2) the Company shall execute and the Trustee shall authenticate<br \/>\n         and deliver to or on behalf of such Person one or more Certificated<br \/>\n         Notes of like tenor and amount and, unless such Restricted Global Note<br \/>\n         does not bear a Private Placement Legend, bearing the Private Placement<br \/>\n         Legend.<\/p>\n<p>                      (vii) Any transfer of a beneficial interest in a<br \/>\n         Regulation S Global Note to a transferee that will take delivery in the<br \/>\n         form of one or more Certificated Notes prior to the termination of the<br \/>\n         Regulation S Distribution Compliance Period shall be registered,<br \/>\n         subject to the Applicable Procedures, only in accordance with this<br \/>\n         clause (vii). At any time prior to the termination of the Regulation S<br \/>\n         Distribution Compliance Period, upon (x) receipt by the Registrar of<br \/>\n         (A) instructions given in accordance with the Applicable Procedures<br \/>\n         from the Depositary or its nominee on behalf of an owner of a<br \/>\n         beneficial interest in such Regulation S Global Note to transfer such<br \/>\n         beneficial interest to a Person that will take delivery in the form of<br \/>\n         one or more Certificated Notes, (B) a written order of the Depositary<br \/>\n         or its nominee given in accordance with the Applicable Procedures<br \/>\n         containing account and other information with respect to such transfer,<br \/>\n         (C) a certificate of such Person substantially in the form of Exhibit F<br \/>\n         and (D) an Opinion of Counsel to the effect that such transfer is in<br \/>\n         compliance with the Securities Act and (y) satisfaction of all other<br \/>\n         conditions imposed by the Applicable Procedures, (1) the Registrar<br \/>\n         shall (A) reflect in the register for the applicable Notes a decrease<br \/>\n         in the principal amount of such Regulation S Global Note in an amount<br \/>\n         equal to the beneficial interest transferred pursuant to this clause<br \/>\n         (vii) and (B) instruct the Depositary to make the corresponding<br \/>\n         adjustment to its records and debit the account of the appropriate<br \/>\n         Agent Member in accordance with the Applicable Procedures, and (2) the<br \/>\n         Company shall execute and the Trustee shall authenticate and deliver to<br \/>\n         or on behalf of such Person one or more Certificated Notes of like<br \/>\n         tenor and amount bearing the Private Placement Legend.<\/p>\n<p>                     (viii) Notwithstanding any contrary provision contained<br \/>\n         herein, Certificated Notes shall be issued in exchange for the<br \/>\n         beneficial interests in a Global Note if at any time: (x) the Company<br \/>\n         advises the Trustee in writing that the Depositary is unwilling or<br \/>\n         unable to continue as depositary for such Global Note or is no longer<br \/>\n         eligible to act as such and in each case a successor depositary is not<br \/>\n         appointed by the Company within ninety (90) days of receipt by the<br \/>\n         Company of notice of such inability; (y) the Company, at its option,<br \/>\n         elects to terminate the book-entry system through the Depositary with<br \/>\n         respect to such Global Note; or (z) after the occurrence of an Event of<br \/>\n         Default, beneficial<\/p>\n<p>                                       27<\/p>\n<p>         owners holding interests representing a majority of the aggregate<br \/>\n         principal amount of Notes represented by such Global Note advise the<br \/>\n         Trustee in writing through the Depositary that the continuation of a<br \/>\n         book-entry system through the Depositary is no longer in such<br \/>\n         beneficial owners&#8217; best interests. Upon the occurrence of any of the<br \/>\n         events set forth in clauses (x), (y) and (z) immediately above, the<br \/>\n         Trustee, upon receipt of written notice thereof and a list of all<br \/>\n         Persons that hold a beneficial interest in such Global Note, shall<br \/>\n         notify, through the appropriate Agent Members at the expense of the<br \/>\n         Company, all Persons that hold a beneficial interest in such Global<br \/>\n         Note, of the issuance of Certificated Notes. Upon surrender by the<br \/>\n         Trustee, as custodian for the Depositary, of such Global Note and<br \/>\n         receipt from the Depositary of instructions for re-registration, the<br \/>\n         Company shall execute and the Trustee, upon the written instructions of<br \/>\n         the Company, shall authenticate and deliver Certificated Notes of like<br \/>\n         tenor and amount and, unless such Global Note does not bear a Private<br \/>\n         Placement Legend, bearing the Private Placement Legend. Certificated<br \/>\n         Notes issued in exchange for beneficial interests in such Global Note<br \/>\n         pursuant to this clause (viii) shall be registered in such names and in<br \/>\n         such authorized denominations as the Depositary, pursuant to<br \/>\n         instructions from Agent Members or otherwise, shall instruct the<br \/>\n         Trustee.<\/p>\n<p>                  (c) Transfers and Exchanges of Certificated Notes. (i) Any<br \/>\ntransfer of a Certificated Note bearing the Private Placement Legend to a<br \/>\ntransferee that takes delivery in the form of one or more Certificated Notes<br \/>\nshall be registered only in accordance with this clause (i). Upon (x) surrender<br \/>\nof any Certificated Note bearing the Private Placement Legend at the office of<br \/>\nthe Registrar, together with (A) an executed instrument of assignment of such<br \/>\nCertificated Note substantially in the form of assignment attached to such<br \/>\nCertificated Note, (B) a certificate of the transferee of such Certificated Note<br \/>\nsubstantially in the form of Exhibit F and (C) an Opinion of Counsel to the<br \/>\neffect that such transfer is in compliance with the Securities Act and (y)<br \/>\nsatisfaction of all other applicable conditions imposed by this Indenture, (1)<br \/>\nthe Trustee shall register such transfer and (2) the Company shall execute and<br \/>\nthe Trustee shall authenticate and deliver in the name of the transferee one or<br \/>\nmore Certificated Notes of any authorized denomination in the same aggregate<br \/>\nprincipal amount and of the same maturity as the transferred Certificated Note,<br \/>\neach such new Certificated Note bearing the Private Placement Legend; provided,<br \/>\nhowever, that Certificated Notes so delivered shall not be required to bear the<br \/>\nPrivate Placement Legend if there is provided to the Company evidence reasonably<br \/>\nsatisfactory to the Company (which may, at the Company&#8217;s request, include an<br \/>\nOpinion of Counsel) that neither the Private Placement Legend nor the<br \/>\nrestrictions on transfer set forth therein are required to ensure compliance<br \/>\nwith the Securities Act.<\/p>\n<p>                       (ii) Any transfer of a Certificated Note not bearing the<br \/>\n         Private Placement Legend to a transferee that takes delivery in the<br \/>\n         form of one or more Certificated Notes shall be registered only in<br \/>\n         accordance with this clause (ii). Upon (x) surrender of any<br \/>\n         Certificated Note not bearing the Private Placement Legend at the<br \/>\n         office of the Registrar, together with an executed instrument of<br \/>\n         assignment of such Certificated Note substantially in the form of<br \/>\n         assignment attached to such Certificated Note, and (y) satisfaction of<br \/>\n         all other applicable conditions imposed by this Indenture, (A) the<br \/>\n         Trustee shall register such transfer and (B) the Company shall execute<br \/>\n         and the Trustee shall authenticate and deliver in the name of the<br \/>\n         transferee one or more Certificated Notes of any authorized<br \/>\n         denomination in the same aggregate principal amount and of the same<\/p>\n<p>                                       28<\/p>\n<p>         maturity as the transferred Certificated Note. Each such new<br \/>\n         Certificated Note may at the request of the transferee, but shall not<br \/>\n         be required to, bear the Private Placement Legend.<\/p>\n<p>                      (iii) Any transfer of a Certificated Note bearing the<br \/>\n         Private Placement Legend to a transferee that takes delivery in the<br \/>\n         form of a beneficial interest in a Global Note shall be registered only<br \/>\n         in accordance with this clause (iii). Upon (x) surrender of any<br \/>\n         Certificated Note bearing the Private Placement Legend at the office of<br \/>\n         the Registrar, together with (A) an executed instrument of assignment<br \/>\n         of such Certificated Note substantially in the form of assignment<br \/>\n         attached to such Certificated Note, (B) written instructions from the<br \/>\n         transferor that such Certificated Note shall be registered in the name<br \/>\n         of the Depositary or its nominee and (C) a certificate of the<br \/>\n         transferor of such Certificated Note substantially in the form of<br \/>\n         Exhibit D (if the transferee will take delivery in the form of a<br \/>\n         beneficial interest in the applicable Regulation S Global Note) or<br \/>\n         Exhibit C (if the transferee will take delivery in the form of a<br \/>\n         beneficial interest in the applicable Restricted Global Note), and (y)<br \/>\n         satisfaction of all other applicable conditions imposed by this<br \/>\n         Indenture and the Applicable Procedures, the Registrar shall (1)<br \/>\n         register such transfer and cancel such Certificated Note, (2) reflect<br \/>\n         in the register for the applicable Notes an increase in the appropriate<br \/>\n         Global Note in an amount equal to the Certificated Note transferred<br \/>\n         pursuant to this clause (iii) and (3) instruct the Depositary to make<br \/>\n         the corresponding adjustment to its records and credit the account of<br \/>\n         the appropriate Agent Member in accordance with the Applicable<br \/>\n         Procedures.<\/p>\n<p>                       (iv) Any transfer of a Certificated Note not bearing the<br \/>\n         Private Placement Legend to a transferee that takes delivery in the<br \/>\n         form of a beneficial interest in a Global Note shall be registered only<br \/>\n         in accordance with this clause (iv). Upon (x) surrender of a<br \/>\n         Certificated Note not bearing the Private Placement Legend at the<br \/>\n         office of the Registrar, together with (A) an executed instrument of<br \/>\n         assignment of such Certificated Note substantially in the form of<br \/>\n         assignment attached to such Certificated Note and (B) written<br \/>\n         instructions from the transferor that such Certificated Note shall be<br \/>\n         registered in the name of the Depositary or its nominee, and (y)<br \/>\n         satisfaction of all other applicable conditions imposed by this<br \/>\n         Indenture and the Applicable Procedures, the Registrar shall (1)<br \/>\n         register such transfer and cancel such Certificated Note, (2) reflect<br \/>\n         in the register for the applicable Notes an increase in the appropriate<br \/>\n         Global Note in an amount equal to the Certificated Note transferred<br \/>\n         pursuant to this clause (iv) and (3) instruct the Depositary to make<br \/>\n         the corresponding adjustment to its records and credit the account of<br \/>\n         the appropriate Agent Member in accordance with the Applicable<br \/>\n         Procedures.<\/p>\n<p>                        (v) Any exchange of a Certificated Note for one or more<br \/>\n         Certificated Notes in different authorized denominations shall be<br \/>\n         registered only in accordance with this clause (v). Upon (x) surrender<br \/>\n         of a Certificated Note at the office of the Registrar, together with a<br \/>\n         written request to exchange such Certificated Note for one or more<br \/>\n         Certificated Notes in different authorized denominations, and (y)<br \/>\n         satisfaction of all other applicable conditions imposed by this<br \/>\n         Indenture, (A) the Registrar shall register such exchange and (B) the<br \/>\n         Company shall execute and the Trustee shall authenticate and deliver in<br \/>\n         the name of the registered owner one or more Certificated Notes in any<br \/>\n         authorized denomination with the same aggregate principal amount and<br \/>\n         maturity date.<\/p>\n<p>                                       29<\/p>\n<p>                       (vi) Any exchange of a Certificated Note for a beneficial<br \/>\n         interest in a Global Note shall be registered only in accordance with<br \/>\n         this clause (vi). Upon (x) surrender of a Certificated Note at the<br \/>\n         office of the Registrar, together with (A) a written request to<br \/>\n         exchange such Certificated Note for a beneficial interest in a Global<br \/>\n         Note, (B) written instructions from the registered owner that such<br \/>\n         Certificated Note shall be registered in the name of the Depositary or<br \/>\n         its nominee and (C) a certificate of the registered owner of such<br \/>\n         Certificated Note substantially in the form of Exhibit D (if the<br \/>\n         Certificated Note is being exchanged for a beneficial interest in the<br \/>\n         applicable Regulation S Global Note) or Exhibit C (if the Certificated<br \/>\n         Note is being exchanged for a beneficial interest in the applicable<br \/>\n         Restricted Global Note) and (y) satisfaction of all other applicable<br \/>\n         conditions imposed by this Indenture and the Applicable Procedures, the<br \/>\n         Registrar shall (1) register such exchange and cancel such Certificated<br \/>\n         Note, (2) reflect in the register for the applicable Notes an increase<br \/>\n         in the applicable Restricted Global Note in an amount equal to the<br \/>\n         Certificated Note exchanged pursuant to this clause (vi) and (3)<br \/>\n         instruct the Depositary to make the corresponding adjustment to its<br \/>\n         records and credit the account of the appropriate Agent Member in<br \/>\n         accordance with the Applicable Procedures.<\/p>\n<p>         Section 2.16 Restrictive Legends. Each Note that constitutes a<br \/>\nRestricted Security shall bear the following legend (the &#8220;Private Placement<br \/>\nLegend&#8221;) on the face thereof until September 28, 2003, unless otherwise agreed<br \/>\nto by the Company and the Holder thereof:<\/p>\n<p>         THE NOTE (OR ITS PREDECESSORS) EVIDENCED HEREBY WAS ORIGINALLY ISSUED<br \/>\nIN A TRANSACTION EXEMPT FROM, OR NOT SUBJECT TO, REGISTRATION UNDER SECTION 5 OF<br \/>\nTHE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE &#8220;SECURITIES ACT&#8221;), AND<br \/>\nTHE NOTE EVIDENCED HEREBY MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED IN<br \/>\nTHE ABSENCE OF SUCH REGISTRATION OR AN APPLICABLE EXEMPTION THEREFROM OR IN A<br \/>\nTRANSACTION NOT SUBJECT THERETO. EACH PURCHASER OF THE NOTE EVIDENCED HEREBY IS<br \/>\nHEREBY NOTIFIED THAT THE SELLER MAY BE RELYING ON THE EXEMPTION FROM THE<br \/>\nPROVISIONS OF SECTION 5 OF THE SECURITIES ACT PROVIDED BY RULE 144A THEREUNDER<br \/>\nOR ANOTHER EXEMPTION UNDER THE SECURITIES ACT. THE HOLDER OF THE NOTE EVIDENCED<br \/>\nHEREBY AGREES FOR THE BENEFIT OF THE COMPANY THAT (A) SUCH NOTE MAY BE RESOLD,<br \/>\nPLEDGED OR OTHERWISE TRANSFERRED ONLY (i)(a) TO A PERSON THE SELLER REASONABLY<br \/>\nBELIEVES IS A QUALIFIED INSTITUTIONAL BUYER (AS DEFINED IN RULE 144A UNDER THE<br \/>\nSECURITIES ACT) THAT PURCHASES FOR ITS OWN ACCOUNT OR FOR THE ACCOUNT OF A<br \/>\nQUALIFIED INSTITUTIONAL BUYER TO WHOM NOTICE IS GIVEN THAT THE RESALE, PLEDGE OR<br \/>\nTRANSFER IS BEING MADE IN A TRANSACTION MEETING THE REQUIREMENTS OF RULE 144A<br \/>\nUNDER THE SECURITIES ACT, (b) IN A TRANSACTION MEETING THE REQUIREMENTS OF RULE<br \/>\n144 UNDER THE SECURITIES ACT, (c) OUTSIDE THE UNITED STATES TO A FOREIGN PERSON<br \/>\nIN A TRANSACTION MEETING THE REQUIREMENTS OF RULE 904 OF REGULATION S UNDER THE<br \/>\nSECURITIES ACT OR (d) IN ACCORDANCE WITH ANOTHER EXEMPTION FROM THE REGISTRATION<br \/>\nREQUIREMENTS OF THE SECURITIES ACT, PROVIDED THAT IN THE CASE OF A TRANSFER,<br \/>\nPLEDGE OR SALE PURSUANT TO THIS CLAUSE (d) SUCH TRANSFER IS SUBJECT TO THE<br \/>\nRECEIPT BY THE REGISTRAR (AND THE COMPANY, IF IT SO REQUESTS) OF A <\/p>\n<p>                                       30<\/p>\n<p>CERTIFICATION OF THE TRANSFEROR AND AN OPINION OF COUNSEL TO THE EFFECT THAT<br \/>\nSUCH TRANSFER IS IN COMPLIANCE WITH THE SECURITIES ACT, (ii) TO THE COMPANY OR<br \/>\nITS AFFILIATES OR (iii) PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER<br \/>\nTHE SECURITIES ACT AND, IN EACH CASE, IN ACCORDANCE WITH ANY APPLICABLE<br \/>\nSECURITIES LAWS OF ANY STATE OF THE UNITED STATES OR ANY OTHER APPLICABLE<br \/>\nJURISDICTION AND THE INDENTURE GOVERNING THE NOTES AND (B) THE HOLDER WILL, AND<br \/>\nEACH SUBSEQUENT HOLDER IS REQUIRED TO, NOTIFY ANY PURCHASER FROM IT OF THE NOTE<br \/>\nEVIDENCED HEREBY OF THE RESALE RESTRICTIONS SET FORTH IN (A) ABOVE.<\/p>\n<p>         Each Global Note shall also bear the following legend:<\/p>\n<p>         THIS NOTE IS A GLOBAL NOTE WITHIN THE MEANING OF THE INDENTURE<br \/>\nHEREINAFTER REFERRED TO AND IS REGISTERED IN THE NAME OF A DEPOSITARY OR A<br \/>\nNOMINEE OF A DEPOSITARY OR A SUCCESSOR DEPOSITARY. THIS NOTE IS NOT EXCHANGEABLE<br \/>\nFOR NOTES REGISTERED IN THE NAME OF A PERSON OTHER THAN THE DEPOSITARY OR ITS<br \/>\nNOMINEE EXCEPT IN THE LIMITED CIRCUMSTANCES DESCRIBED IN THE INDENTURE, AND NO<br \/>\nTRANSFER OF THIS NOTE (OTHER THAN A TRANSFER OF THIS NOTE AS A WHOLE BY THE<br \/>\nDEPOSITARY TO A NOMINEE OF THE DEPOSITARY OR BY A NOMINEE OF THE DEPOSITARY TO<br \/>\nTHE DEPOSITARY OR ANOTHER NOMINEE OF THE DEPOSITARY) MAY BE REGISTERED EXCEPT IN<br \/>\nTHE LIMITED CIRCUMSTANCES DESCRIBED IN THE INDENTURE.<\/p>\n<p>         TRANSFERS OF THIS GLOBAL NOTE SHALL BE LIMITED TO TRANSFERS IN WHOLE,<br \/>\nBUT NOT IN PART, AND TRANSFERS OF INTERESTS IN THIS GLOBAL NOTE SHALL BE LIMITED<br \/>\nTO TRANSFERS MADE IN ACCORDANCE WITH THE RESTRICTIONS SET FORTH IN SECTION 2.15<br \/>\nOF THE INDENTURE.<\/p>\n<p>                                    ARTICLE 3<\/p>\n<p>                                   REDEMPTION<br \/>\n                                   &#8212;&#8212;&#8212;-<\/p>\n<p>         Section 3.01 Notices to Trustee. If the Company elects to redeem any of<br \/>\nthe Notes pursuant to paragraph 5 of such Notes, at least 60 days prior to the<br \/>\nRedemption Date or during such other period as the Trustee may agree to, the<br \/>\nCompany shall notify the Trustee in writing of the Redemption Date, the<br \/>\nprincipal amount of Notes of each maturity to be redeemed and the Redemption<br \/>\nPrice or Prices, and deliver to the Trustee an Officers&#8217; Certificate stating<br \/>\nthat such redemption will comply with the conditions contained herein and in the<br \/>\nNotes, as appropriate.<\/p>\n<p>         Section 3.02 Selection of Notes To Be Redeemed. (a) In the event that<br \/>\nless than all of the Notes of a given maturity are to be redeemed at any time,<br \/>\nselection of such Notes to be redeemed shall be made by the Trustee on a pro<br \/>\nrata basis, by lot or by such method as the Trustee shall deem fair and<br \/>\nequitable; provided, however, that no Notes of a principal amount of $1,000 or<br \/>\nless shall be redeemed in part. The Trustee shall make the selection from the<br \/>\noutstanding Notes of that maturity not previously called for redemption. The<br \/>\nTrustee shall <\/p>\n<p>                                       31<\/p>\n<p>promptly notify the Company in writing of the Notes selected for<br \/>\nredemption and, in the case of any Notes selected for partial redemption, the<br \/>\nprincipal amount of the Notes to be redeemed. In the event of a partial<br \/>\nredemption by lot, the Trustee shall select the particular Notes to be redeemed<br \/>\nnot less than 30 nor more than 60 days prior to the relevant Redemption Date<br \/>\nfrom the Outstanding Notes of that maturity not previously called for<br \/>\nredemption. The Company may redeem Notes in denominations of $1,000 only in<br \/>\nwhole. The Trustee may select for redemption portions (equal to $1,000 or any<br \/>\nintegral multiple of $1,000) of the principal of Notes that have denominations<br \/>\nlarger than $1,000. A new Note in a principal amount equal to the unredeemed<br \/>\nportion thereof will be issued in the name of the Holder thereof upon delivery<br \/>\nof the original Note to the Paying Agent and cancellation of the original Note.<br \/>\nOn and after the Redemption Date, interest will cease to accrue on Notes or<br \/>\nportions thereof called for redemption as long as the Company has made a deposit<br \/>\nwith the Paying Agent in U.S. legal tender in satisfaction of the applicable<br \/>\nRedemption Price pursuant to this Indenture.<\/p>\n<p>                  (b) For all purposes of this Indenture, unless the context<br \/>\notherwise requires, all provisions relating to redemption of Notes shall relate,<br \/>\nin the case of any Note redeemed or to be redeemed only in part, to the portion<br \/>\nof the principal amount of that Note which has been or is to be redeemed.<\/p>\n<p>         Section 3.03 Notice of Redemption. Notice of redemption shall be mailed<br \/>\nby first class mail at least 30 but not more than 60 calendar days before the<br \/>\nRedemption Date to each Holder of Notes to be redeemed at the registered address<br \/>\nof such Holder. If any Note is to be redeemed in part only, the notice of<br \/>\nredemption that relates to such Note shall state the portion of the principal<br \/>\namount thereof to be redeemed. If the Company elects to have the Trustee give<br \/>\nnotice of redemption, the Trustee shall give notice in the name of the Company<br \/>\nand at the Company&#8217;s expense; provided, however, that the Company shall furnish<br \/>\nthe Trustee all information required to be contained in the notice.<\/p>\n<p>         The notice shall identify the Notes to be redeemed and shall state:<\/p>\n<p>                  (1) the Redemption Date;<\/p>\n<p>                  (2) the Redemption Price and the amount of accrued interest,<br \/>\n         if any, to be paid;<\/p>\n<p>                  (3) whether or not the Company is redeeming all outstanding<br \/>\n         Notes of that maturity and if any Note is being redeemed in part, the<br \/>\n         portion of the principal amount (equal to $1,000 in principal amount or<br \/>\n         any integral multiple thereof) of such Note to be redeemed and that, on<br \/>\n         and after the Redemption Date, upon surrender of such Note, a new Note<br \/>\n         or Notes in principal amount equal to the unredeemed portion thereof<br \/>\n         will be issued;<\/p>\n<p>                  (4) the name, address and telephone number of the Paying<br \/>\n         Agent;<\/p>\n<p>                  (5) that Notes called for redemption must be surrendered to<br \/>\n         the Paying Agent at the address specified in such notice to collect the<br \/>\n         Redemption Price plus accrued interest, if any;<\/p>\n<p>                                       32<\/p>\n<p>                  (6) that, unless the Company defaults in making the redemption<br \/>\n         payment, interest on Notes called for redemption ceases to accrue on<br \/>\n         and after the Redemption Date and the only remaining right of the<br \/>\n         Holders is to receive payment of the Redemption Price plus accrued<br \/>\n         interest to the Redemption Date upon surrender of the Notes to the<br \/>\n         Paying Agent;<\/p>\n<p>                  (7) the subparagraph of the Notes pursuant to which the Notes<br \/>\n         called for redemption are being redeemed;<\/p>\n<p>                  (8) if fewer than all the Notes of that maturity are to be<br \/>\n         redeemed, the identification of the particular Notes (or portion<br \/>\n         thereof) to be redeemed, as well as the aggregate principal amount of<br \/>\n         Notes of that maturity to be redeemed and the aggregate principal<br \/>\n         amount of Notes of that maturity to be outstanding after such partial<br \/>\n         redemption; and<\/p>\n<p>                  (9) the CUSIP or ISIN number, if any, listed in the notice or<br \/>\n         printed on the Notes of that maturity, and that no representation is<br \/>\n         made as to the accuracy or correctness of such CUSIP or ISIN number.<\/p>\n<p>         Section 3.04 Effect of Notice of Redemption. Once the notice of<br \/>\nredemption described in SECTION 3.03 hereof is mailed, Notes called for<br \/>\nredemption become due and payable on the Redemption Date and at the Redemption<br \/>\nPrice, including any premium, plus accrued interest to the Redemption Date, if<br \/>\nany. Upon surrender to the Paying Agent, such Notes shall be paid at the<br \/>\nRedemption Price, including any premium, plus accrued interest to the Redemption<br \/>\nDate, if any; provided that if the Redemption Date is after a Record Date and on<br \/>\nor prior to the related Interest Payment Date, the accrued interest shall be<br \/>\npayable to the Holder of the redeemed Notes registered on the relevant Record<br \/>\nDate.<\/p>\n<p>         Section 3.05 Deposit of Redemption Price. On or prior to 10:00 a.m.,<br \/>\nNew York City time, on the relevant Redemption Date, the Company shall have<br \/>\ndeposited with the Paying Agent in immediately available funds U.S. legal tender<br \/>\nsufficient to pay the Redemption Price of and accrued interest, if any, on all<br \/>\nNotes to be redeemed on that date. The Paying Agent shall return to the Company<br \/>\nany money deposited with the Paying Agent by the Company in excess of the amount<br \/>\nnecessary to pay the Redemption Price of and accrued interest, if any, on all<br \/>\nNotes to be redeemed.<\/p>\n<p>         On and after any Redemption Date, if U.S. legal tender sufficient to<br \/>\npay the Redemption Price of and accrued interest, if any, on Notes called for<br \/>\nredemption shall have been made available in accordance with the preceding<br \/>\nparagraph, the Notes called for redemption will cease to accrue interest and the<br \/>\nonly right of the Holders of such Notes will be to receive payment of the<br \/>\nRedemption Price of and, subject to the proviso in SECTION 3.04 hereof, accrued<br \/>\nand unpaid interest on such Notes to the Redemption Date, if any. If any Note<br \/>\ncalled for redemption shall not be so paid, interest will continue to accrue and<br \/>\nbe paid, from the Redemption Date until such redemption payment is made, on the<br \/>\nunpaid principal of the Note and any interest not paid on such unpaid principal,<br \/>\nin each case, at the rate and in the manner provided for in SECTION 2.11 hereof.<\/p>\n<p>                                       33<\/p>\n<p>         Section 3.06 Notes Redeemed in Part. Upon surrender of a Note that is<br \/>\nredeemed in part, the Company shall execute and the Trustee shall authenticate,<br \/>\nat the expense of the Company, for a Holder a new Note equal in principal amount<br \/>\nto the unredeemed portion of the Note surrendered; provided that each new Note<br \/>\nwill be in a principal amount of $1,000 or an integral multiple of $1,000.<\/p>\n<p>                                    ARTICLE 4<\/p>\n<p>                                    COVENANTS<br \/>\n                                    &#8212;&#8212;&#8212;<\/p>\n<p>         Section 4.01 Payment of Notes. The Company shall pay the principal of<br \/>\nand interest (including all Additional Interest as provided in the Registration<br \/>\nRights Agreement) on the Notes on the dates and in the manner provided in the<br \/>\nNotes and this Indenture. An installment of principal or interest shall be<br \/>\nconsidered paid on the date it is due if the Trustee or Paying Agent holds, for<br \/>\nthe benefit of the Holders, on that date money designated for and sufficient to<br \/>\npay such installment in full and is not prohibited from paying such money to the<br \/>\nHolders pursuant to the terms of this Indenture.<\/p>\n<p>         The Company shall pay interest on overdue principal and interest on<br \/>\noverdue interest, to the extent lawful as provided for in SECTION 2.11 hereof.<\/p>\n<p>         Section 4.02 Reports. Whether or not required by the rules and<br \/>\nregulations of the Commission, so long as any Notes are outstanding, the Company<br \/>\nshall file with the Commission, to the extent such filings are accepted by the<br \/>\nCommission, and shall furnish (within 15 days after such filing) to the Trustee<br \/>\nand to the Holders all quarterly and annual reports and other information,<br \/>\ndocuments and reports that would be required to be filed with the Commission<br \/>\npursuant to Section 13 of the Exchange Act if the Company were required to file<br \/>\nunder such section. In addition, the Company shall make such information<br \/>\navailable to prospective purchasers of the Notes, securities analysts and<br \/>\nbroker-dealers who request it in writing. Delivery of such reports, information<br \/>\nand documents to the Trustee is for informational purposes only and the<br \/>\nTrustee&#8217;s receipt of such shall not constitute constructive notice of any<br \/>\ninformation contained therein or determinable from information contained<br \/>\ntherein, including the Company&#8217;s compliance with any of its covenants hereunder<br \/>\n(as to which the Trustee is entitled to rely exclusively on Officers&#8217;<br \/>\nCertificates).<\/p>\n<p>         Section 4.03 Waiver of Stay, Extension or Usury Laws. The Company<br \/>\ncovenants (to the extent that it may lawfully do so) that it will not at any<br \/>\ntime insist upon, or plead (as a defense or otherwise) or in any manner<br \/>\nwhatsoever claim or take the benefit or advantage of, any stay or extension law<br \/>\nor any usury law or other law which would prohibit or forgive the Company from<br \/>\npaying all or any portion of the principal of, premium, if any, and\/or interest<br \/>\non the Notes as contemplated herein, wherever enacted, now or at any time<br \/>\nhereafter in force, or which may affect the covenants or the performance of this<br \/>\nIndenture; and the Company hereby expressly waives all benefit or advantage of<br \/>\nany such law, and covenants that it will not hinder, delay or impede the<br \/>\nexecution of any power herein granted to the Trustee, but will suffer and permit<br \/>\nthe execution of every such power as though no such law had been enacted.<\/p>\n<p>                                       34<\/p>\n<p>         Section 4.04 Compliance Certificate; Notice of Default; Tax<br \/>\nInformation. (a) The Company shall deliver to the Trustee, within 90 days after<br \/>\nthe end of each fiscal year of the Company, commencing with the fiscal year<br \/>\nending December 31, 2001, an Officers&#8217; Certificate (one of the signers of which<br \/>\nshall be the principal executive officer, principal financial officer or<br \/>\nprincipal accounting officer of the Company) stating that to the best of his or<br \/>\nher knowledge no Default or Event of Default has occurred, listing all<br \/>\nRestricted Payments for such year, and if a Default or Event of Default shall<br \/>\nhave occurred, describing all of such Defaults or Events of Default of which he<br \/>\nor she may have knowledge and what action the Company is taking or proposes to<br \/>\ntake with respect thereto. The Officers&#8217; Certificate shall also notify the<br \/>\nTrustee if the Company elects to change the manner in which it fixes its fiscal<br \/>\nyear end.<\/p>\n<p>                  (b) The annual financial statements delivered pursuant to<br \/>\nSECTION 4.02 shall be accompanied by a written report addressed to the Trustee<br \/>\nof the Company&#8217;s independent accountants (who shall be a firm of established<br \/>\nnational reputation) that in conducting their audit of such financial statements<br \/>\nnothing has come to their attention that would lead them to believe that a<br \/>\nDefault or Event of Default has occurred under this Indenture insofar as they<br \/>\nrelate to accounting matters or, if any such violation has occurred, specifying<br \/>\nthe nature and period of existence thereof, it being understood that such<br \/>\naccountants shall not be liable directly or indirectly to any Person for any<br \/>\nfailure to obtain knowledge of any such violation.<\/p>\n<p>                  (c) If (i) any Default or Event of Default has occurred and is<br \/>\ncontinuing or (ii) any Holder seeks to exercise any remedy hereunder with<br \/>\nrespect to a claimed default under this Indenture or the Holder&#8217;s Notes, the<br \/>\nCompany shall deliver to the Trustee, at its address set forth in SECTION 10.02<br \/>\nhereof, by registered or certified mail or by telegram or facsimile transmission<br \/>\nfollowed by hard copy by registered or certified mail an Officers&#8217; Certificate<br \/>\nspecifying such Default or Event of Default, notice or other action, the status<br \/>\nthereof and what action the Company is taking or proposes to take, which<br \/>\nOfficers&#8217; Certificate shall be so delivered within five (5) Business Days of its<br \/>\nbecoming aware of such occurrence.<\/p>\n<p>         Section 4.05 Payment of Taxes and Other Claims. The Company shall pay<br \/>\nor discharge or cause to be paid or discharged, before the same shall become<br \/>\ndelinquent, (i) all material taxes, assessments and governmental charges<br \/>\n(including withholding taxes and any penalties, interest and additions to taxes)<br \/>\nlevied or imposed upon it or any of its Subsidiaries or properties of it or any<br \/>\nof its Subsidiaries and (ii) all lawful claims for labor, materials and supplies<br \/>\nthat, if unpaid, might by law become a Lien upon the property of it or any of<br \/>\nits Subsidiaries; provided, however, that the Company shall not be required to<br \/>\npay or discharge or cause to be paid or discharged any such tax, assessment,<br \/>\ncharge or claim whose amount, applicability or validity is being contested in<br \/>\ngood faith by appropriate proceedings properly instituted and diligently<br \/>\nconducted for which adequate reserves, to the extent required under GAAP, have<br \/>\nbeen taken.<\/p>\n<p>         Section 4.06 Corporate Existence. Subject to Article 5 hereof, the<br \/>\nCompany shall do or cause to be done all things necessary to preserve and keep<br \/>\nin full force and effect (i) its corporate existence, and the corporate,<br \/>\npartnership or limited liability company or other existence of each Subsidiary,<br \/>\nin accordance with the respective organizational documents (as the same may be<br \/>\namended from time to time) of each Subsidiary and the material rights (charter<br \/>\nand statutory), licenses and franchises of the Company and its Subsidiaries<br \/>\nexcept where the failure to preserve<\/p>\n<p>                                       35<\/p>\n<p>and keep in full force and effect any such rights, licenses and franchises shall<br \/>\nnot have a material adverse effect on the financial condition, business,<br \/>\noperations or prospects of the Company and its Subsidiaries taken as a whole;<br \/>\nand provided that the Company shall not be required to preserve any such right,<br \/>\nlicense or franchise, or the corporate, limited liability company, partnership<br \/>\nor other existence of any of the Subsidiaries, if the Board of Directors of the<br \/>\nCompany shall determine that the preservation thereof is no longer desirable in<br \/>\nthe conduct of the business of the Company and its Subsidiaries, taken as a<br \/>\nwhole.<\/p>\n<p>         Section 4.07 Maintenance of Office or Agency. The Company shall<br \/>\nmaintain an office or agency in the Borough of Manhattan, The City of New York,<br \/>\nwhere Notes may be surrendered for registration of transfer or exchange or for<br \/>\npresentation for payment and where notices and demands to or upon the Company in<br \/>\nrespect of the Notes and this Indenture may be served. The Company shall give<br \/>\nprompt written notice to the Trustee of the location, and any change in the<br \/>\nlocation, of such office or agency. If at any time the Company shall fail to<br \/>\nmaintain any such required office or agency or shall fail to furnish the Trustee<br \/>\nwith the address thereof, such presentations, surrenders, notices and demands<br \/>\nmay be made or served at the address of the Trustee as set forth in SECTION<br \/>\n10.02 hereof.<\/p>\n<p>         The Company may also from time to time designate one or more other<br \/>\noffices or agencies where the Notes may be presented or surrendered for any or<br \/>\nall such purposes and may from time to time rescind such designations. The<br \/>\nCompany shall give prompt written notice to the Trustee of such designation or<br \/>\nrescission and of any change in the location of any such other office or agency.<\/p>\n<p>         The Company hereby initially designates the Corporate Trust Office of<br \/>\nthe Trustee as such office of the Company in the Borough of Manhattan, The City<br \/>\nof New York.<\/p>\n<p>         Section 4.08 Compliance with Laws. The Company shall comply, and shall<br \/>\ncause each of its Subsidiaries to comply, with all applicable statutes, rules,<br \/>\nregulations, orders and restrictions of the United States of America and all<br \/>\nother sovereign nations, all states and municipalities thereof, and of any<br \/>\ngovernmental department, commission, board, regulatory authority, bureau, agency<br \/>\nand instrumentality of the foregoing, in respect of the conduct of their<br \/>\nrespective businesses and the ownership of their respective properties, except<br \/>\nfor such noncompliances as would not in the aggregate have a material adverse<br \/>\neffect on the financial condition or results of operations of the Company and<br \/>\nits Subsidiaries taken as a whole.<\/p>\n<p>         Section 4.09 Maintenance of Properties and Insurance. (a) The Company<br \/>\nshall cause all material properties owned by or leased by it or any of its<br \/>\nSubsidiaries used or useful to the conduct of the Company&#8217;s business or the<br \/>\nbusiness of any of its Subsidiaries to be maintained and kept in normal<br \/>\ncondition, repair and working order and supplied with all necessary equipment<br \/>\nand shall cause to be made all necessary repairs, renewals, replacements,<br \/>\nbetterments and improvements thereof, all as in its judgment may be necessary,<br \/>\nso that the business carried on in connection therewith may be properly and<br \/>\nadvantageously conducted at all times; provided, however, that nothing in this<br \/>\nSECTION 4.09 shall prevent the Company or any of its Subsidiaries from<br \/>\ndiscontinuing the use, operation or maintenance of any of such properties, or<br \/>\ndisposing of any of them, if such discontinuance or disposal is, in the judgment<br \/>\nof the Board of Directors of<\/p>\n<p>                                       36<\/p>\n<p>the Company or of the Board of Directors of the Subsidiary of the Company<br \/>\nconcerned, desirable in the conduct of the business of the Company or any<br \/>\nSubsidiary of the Company.<\/p>\n<p>                  (b) The Company shall maintain, and shall cause the<br \/>\nSubsidiaries to maintain, insurance with responsible carriers against such risks<br \/>\nand in such amounts, and with such deductibles, retentions, self-insured amounts<br \/>\nand co-insurance provisions, as, in the reasonable judgment of the Company, may<br \/>\nbe necessary.<\/p>\n<p>         Section 4.10 Limitation on Restricted Payments. Prior to the occurrence<br \/>\nof the Fall-Away Event, the Company shall not, and shall not permit any of its<br \/>\nSubsidiaries to, directly or indirectly, make any Restricted Payment if at the<br \/>\ntime of such Restricted Payment: (i) a Default or Event of Default shall have<br \/>\noccurred and be continuing or shall occur as a consequence thereof; (ii) after<br \/>\ngiving effect to the proposed Restricted Payment, the amount of such Restricted<br \/>\nPayment, when added to the aggregate amount of all Restricted Payments made<br \/>\nafter September 25, 2000, exceeds the sum of: (a) 50% of the Company&#8217;s<br \/>\nConsolidated Net Income accrued during the period (taken as a single period)<br \/>\ncommencing on July 1, 1997 to and including the fiscal quarter ended immediately<br \/>\nprior to the date of such Restricted Payment (or, if such aggregate Consolidated<br \/>\nNet Income shall be a deficit, minus 100% of such aggregate deficit); (b) the<br \/>\nnet cash proceeds from the issuance and sale of the Company&#8217;s Capital Stock<br \/>\n(other than to a Subsidiary of the Company) that is not Disqualified Stock<br \/>\nduring the period (taken as a single period) commencing with the Issue Date; and<br \/>\n(c) $50,000,000; or (iii) the Company would not be able to incur an additional<br \/>\n$1.00 of Indebtedness pursuant to SECTION 4.11 hereof.<\/p>\n<p>         Notwithstanding the foregoing, the Company may: (w) pay any dividend<br \/>\nwithin 60 days after the date of declaration thereof if the payment thereof<br \/>\nwould have complied with the limitations of this SECTION 4.10 on the date of<br \/>\ndeclaration; (x) retire shares of the Company&#8217;s Capital Stock or the Company&#8217;s<br \/>\nor a Subsidiary of the Company&#8217;s Indebtedness out of the proceeds of a<br \/>\nsubstantially concurrent sale (other than to a Subsidiary of the Company) of<br \/>\nshares of the Company&#8217;s Capital Stock (other than Disqualified Stock); (y) make<br \/>\nInvestments in Joint Ventures which, when added to the aggregate amount of all<br \/>\nsuch other Investments made after September 25, 2000 pursuant to this clause (y)<br \/>\n(or such other Investments as would have been made pursuant to this clause (y)<br \/>\nhad such clause been in effect) do not exceed 5% of Consolidated Tangible Assets<br \/>\nat such time (with each such Investment being valued as of the date made and<br \/>\nwithout regard to subsequent changes in value); and (z) make Investments which,<br \/>\nwhen added to the aggregate amount of all such other Investments made after<br \/>\nSeptember 25, 2000 pursuant to this clause (z) (or such other Investments as<br \/>\nwould have been made pursuant to this clause (z) had such clause been in effect)<br \/>\ndo not exceed 2.5% of Consolidated Tangible Assets at such time (with each such<br \/>\nInvestment being valued as of the date made and without regard to subsequent<br \/>\nchanges in value); provided, however, that each Restricted Payment described in<br \/>\nclause (w) or (x) above shall be taken into account for purposes of computing<br \/>\nthe aggregate amount of all Restricted Payments pursuant to clause (ii) of the<br \/>\nimmediately preceding paragraph.<\/p>\n<p>         Section 4.11 Limitation on Additional Indebtedness and Subsidiary<br \/>\nPreferred Stock. (a) After the Issue Date and prior to the occurrence of the<br \/>\nFall-Away Event, (i) the Company shall not, and shall not permit any of its<br \/>\nSubsidiaries to, directly or indirectly, create, incur, issue, assume,<br \/>\nguarantee, extend the Stated Maturity of, or otherwise become liable with<br \/>\nrespect to<\/p>\n<p>                                       37<\/p>\n<p>(collectively, &#8220;incur&#8221;), any Indebtedness (including, without limitation,<br \/>\nAcquired Indebtedness) and (ii) the Company shall not permit any of its<br \/>\nSubsidiaries to issue (except to the Company or any of its Wholly Owned<br \/>\nSubsidiaries) or create any Preferred Stock or permit any Person (other than the<br \/>\nCompany or a Wholly Owned Subsidiary) to own or hold any interest in any<br \/>\nPreferred Stock of any such Subsidiary; provided, however, that the Company may<br \/>\nincur Indebtedness and the Company may permit its Subsidiaries to issue or<br \/>\ncreate Preferred Stock if, after giving effect thereto, the Company&#8217;s EBITDA<br \/>\nCoverage Ratio on the date thereof would be at least 2.5 to 1, determined on a<br \/>\npro forma basis as if the incurrence of such additional Indebtedness or the<br \/>\nissuance of such Preferred Stock (declared to have an aggregate principal amount<br \/>\nequal to the aggregate liquidation value of such Preferred Stock), as the case<br \/>\nmay be, and the application of the net proceeds therefrom, had occurred at the<br \/>\nbeginning of the four-quarter period used to calculate the Company&#8217;s EBITDA<br \/>\nCoverage Ratio.<\/p>\n<p>                  (b) Notwithstanding the foregoing, and irrespective of the<br \/>\nEBITDA Coverage Ratio, in addition to Existing Indebtedness: (i) the Company may<br \/>\nincur Indebtedness pursuant to the Notes issued on the Issue Date and the<br \/>\nExchange Notes issued in exchange for such Notes; (ii) the Company and its<br \/>\nSubsidiaries may incur Refinancing Indebtedness in exchange for, or the net<br \/>\nproceeds of which are applied to refund, refinance or extend, Existing<br \/>\nIndebtedness or other Indebtedness that was permitted by this Indenture to be<br \/>\nincurred under this SECTION 4.11 except for Indebtedness incurred under clause<br \/>\n(iii) or (iv) of this paragraph (b); (iii) the Company may incur any<br \/>\nIndebtedness to any Subsidiary or any Subsidiary may incur any Indebtedness to<br \/>\nthe Company or to any Subsidiary; (iv) the Company and its Subsidiaries may<br \/>\nincur any Indebtedness evidenced by letters of credit which are used in the<br \/>\nordinary course of business of the Company and its Subsidiaries to secure<br \/>\nworkers&#8217; compensation and other insurance coverages; (v) the Company and its<br \/>\nSubsidiaries may incur Capitalized Lease Obligations and Attributable<br \/>\nIndebtedness, in each case excluding Existing Indebtedness but including all<br \/>\nRefinancing Indebtedness incurred in exchange for, or the net proceeds of which<br \/>\nare applied to refund, refinance or extend, any Indebtedness incurred pursuant<br \/>\nto this clause (v), in an aggregate principal amount at any one time outstanding<br \/>\nnot to exceed 10% of Consolidated Tangible Assets at such time; and (vi) the<br \/>\nSubsidiaries of the Company may incur Indebtedness, including all Refinancing<br \/>\nIndebtedness incurred in exchange for, or the net proceeds of which are applied<br \/>\nto refund, refinance or extend, any Indebtedness incurred pursuant to this<br \/>\nclause (vi), in an aggregate principal amount at any time outstanding not to<br \/>\nexceed $250,000,000, in addition to Existing Indebtedness and other Indebtedness<br \/>\npermitted to be incurred by Subsidiaries of the Company pursuant to the<br \/>\nforegoing clauses (ii) &#8211; (v).<\/p>\n<p>                  (c) Notwithstanding the foregoing, the Company may permit any<br \/>\nSubsidiary which is a partnership formed to operate a single healthcare facility<br \/>\nto issue or create Preferred Stock; provided that the aggregate amount of all<br \/>\nsuch Preferred Stock outstanding after giving effect to such issuance or<br \/>\ncreation shall not exceed 1% of Consolidated Tangible Assets as of the date of<br \/>\nsuch issuance or creation.<\/p>\n<p>                  (d) Any limitations on the rights of the Company or its<br \/>\nSubsidiaries set forth in paragraph (b) or (c) of this SECTION 4.11 shall be of<br \/>\nno force and effect after the occurrence of the Fall-Away Event.<\/p>\n<p>                                       38<\/p>\n<p>         Section 4.12 Limitation on Asset Sales. (a) Prior to the occurrence of<br \/>\nthe Fall-Away Event, the Company shall not, and shall not permit any of its<br \/>\nSubsidiaries to, consummate any Asset Sale unless (i) the Company or such<br \/>\nSubsidiary receives consideration at the time of such Asset Sale at least equal<br \/>\nto the Fair Market Value of the assets included in such Asset Sale, (ii)<br \/>\nimmediately before and immediately after giving effect to such Asset Sale, no<br \/>\nDefault or Event of Default shall have occurred and be continuing and (iii) at<br \/>\nleast 75% of the consideration received by the Company or such Subsidiary<br \/>\ntherefor is in the form of cash paid at the closing thereof, provided, however,<br \/>\nthat this clause (iii) shall not apply if, after giving effect to such Asset<br \/>\nSale, the aggregate principal amount of all notes or similar debt obligations<br \/>\nand Fair Market Value of all equity securities received by the Company from all<br \/>\nAsset Sales since September 25, 2000 (other than such notes or similar debt<br \/>\nobligations and such equity securities converted into or otherwise disposed of<br \/>\nfor cash and applied in accordance with the second succeeding sentence) would<br \/>\nnot exceed 2.5% of Consolidated Tangible Assets at such time. The amount<br \/>\n(without duplication) of any (x) Indebtedness (other than Subordinated<br \/>\nIndebtedness) of the Company or such Subsidiary that is expressly assumed by the<br \/>\ntransferee in such Asset Sale and with respect to which the Company or such<br \/>\nSubsidiary, as the case may be, is unconditionally released by the holder of<br \/>\nsuch Indebtedness and (y) any notes, securities or similar obligations or items<br \/>\nof property received from such transferee that are immediately converted, sold<br \/>\nor exchanged by the Company or such Subsidiary for cash (to the extent of the<br \/>\ncash actually so received), shall be deemed to be cash for purposes of this<br \/>\nSECTION 4.12. If at any time any non-cash consideration received by the Company<br \/>\nor such Subsidiary, as the case may be, in connection with any Asset Sale is<br \/>\nconverted into or sold or otherwise disposed of for cash (other than interest<br \/>\nreceived with respect to any such non-cash consideration), then the date of such<br \/>\nconversion or disposition shall be deemed to constitute the date of an Asset<br \/>\nSale hereunder and the Net Proceeds thereof shall be applied in accordance with<br \/>\nthis SECTION 4.12. A transfer of assets by the Company to a Wholly Owned<br \/>\nSubsidiary or by a Wholly Owned Subsidiary to the Company or to another Wholly<br \/>\nOwned Subsidiary will not be deemed to be an Asset Sale, and a transfer of<br \/>\nassets that constitutes a Restricted Payment and that is permitted under SECTION<br \/>\n4.10 hereof will not be deemed to be an Asset Sale.<\/p>\n<p>                  (b) Prior to the occurrence of the Fall-Away Event, if the<br \/>\nCompany or any Subsidiary engages in an Asset Sale, the Company or such<br \/>\nSubsidiary shall, no later than 360 days after such Asset Sale, (i) apply all or<br \/>\nany of the Net Proceeds therefrom to repay Indebtedness that ranks pari passu<br \/>\nwith the Notes and is secured by the assets disposed of in the Asset Sale or to<br \/>\nrepay Bank Debt in accordance with the applicable provisions thereof, (ii)<br \/>\ninvest all or any part of the Net Proceeds therefrom in the lines of business of<br \/>\nthe Company or any of its Subsidiaries immediately prior to such investment or<br \/>\n(iii) any combination of clauses (i) and (ii) above. The amount of such Net<br \/>\nProceeds not applied or invested as provided in this paragraph (b) will<br \/>\nconstitute &#8220;Excess Proceeds.&#8221;<\/p>\n<p>                  (c) Prior to the occurrence of the Fall-Away Event, when the<br \/>\naggregate amount of Excess Proceeds equals or exceeds $5,000,000, the Company<br \/>\nshall be required to make an offer to purchase (an &#8220;Asset Sale Offer&#8221;) from all<br \/>\nHolders, an aggregate principal amount of Notes equal to the amount of such<br \/>\nExcess Proceeds as follows:<\/p>\n<p>                        (i) The Company shall make an Asset Sale Offer to all<br \/>\n         Holders in accordance with the procedures set forth in this SECTION<br \/>\n         4.12 to purchase the maximum principal amount (expressed as a multiple<\/p>\n<p>                                       39<\/p>\n<p>         of $1,000) of Notes that may be purchased out of the amount (the &#8220;Asset<br \/>\n         Sale Payment Amount&#8221;) of such Excess Proceeds.<\/p>\n<p>                       (ii) The offer price for the Notes shall be payable in<br \/>\n         cash in an amount equal to 100% of the principal amount of the Notes<br \/>\n         tendered pursuant to such Asset Sale Offer, plus accrued and unpaid<br \/>\n         interest and Additional Interest, if any, to the date such Asset Sale<br \/>\n         Offer is consummated (the &#8220;Asset Sale Purchase Price&#8221;), in accordance<br \/>\n         with the procedures set forth in this SECTION 4.12. To the extent that<br \/>\n         the aggregate Asset Sale Purchase Price of Notes tendered pursuant to<br \/>\n         an Asset Sale Offer is less than the Asset Sale Payment Amount relating<br \/>\n         thereto (such shortfall constituting a &#8220;Net Proceeds Deficiency&#8221;), the<br \/>\n         Company may use such Net Proceeds Deficiency, or a portion thereof, for<br \/>\n         general corporate purposes.<\/p>\n<p>                      (iii) If the aggregate Asset Sale Purchase Price of Notes<br \/>\n         validly tendered and not withdrawn by holders thereof exceeds the Asset<br \/>\n         Sale Payment Amount, Notes to be purchased shall be selected on a pro<br \/>\n         rata basis.<\/p>\n<p>                       (iv) Upon completion of such Asset Sale Offer in<br \/>\n         accordance with the foregoing provisions, the amount of Excess Proceeds<br \/>\n         with respect to which such Asset Sale Offer was made shall be deemed to<br \/>\n         be zero.<\/p>\n<p>                  In the event that any other Indebtedness of the Company which<br \/>\nranks pari passu with the Notes (&#8220;Other Debt&#8221;) requires an offer to purchase to<br \/>\nbe made to repurchase such Other Debt upon the consummation of an Asset Sale,<br \/>\nthe Company may apply the Excess Proceeds to both purchase such Other Debt and<br \/>\nto make an Asset Sale Offer, provided, that the purchase price of such Other<br \/>\nDebt does not exceed 100% of the aggregate principal amount or accreted value<br \/>\nthereof plus interest thereon. With respect to any Excess Proceeds, the Company<br \/>\nshall make the Asset Sale Offer in respect thereof at the same time as the<br \/>\nanalogous offer to purchase is made pursuant to any Other Debt and the purchase<br \/>\ndate in respect thereof shall be the same as the purchase date in respect<br \/>\nthereof pursuant to any Other Debt.<\/p>\n<p>                  With respect to any Asset Sale Offer effected pursuant to this<br \/>\nSECTION 4.12, to the extent the aggregate principal amount of Notes and Other<br \/>\nDebt, if any, tendered pursuant to such Asset Sale Offer and the concurrent<br \/>\noffer to purchase with respect to such Other Debt exceeds the Excess Proceeds,<br \/>\nsuch Notes and Other Debt, if any, shall be purchased pro rata based on the<br \/>\naggregate principal amount of such Notes and such Other Debt tendered by each<br \/>\nholder thereof.<\/p>\n<p>                  (d) If the Company is required to make an Asset Sale Offer,<br \/>\nthe Company shall, within 30 days following the date specified in clause (c)<br \/>\nabove, notify the Trustee thereof and give written notice of such Asset Sale<br \/>\nOffer to each Holder by first-class mail, postage prepaid, at the address of<br \/>\nsuch Holder appearing in the register maintained by the Registrar, stating:<\/p>\n<p>                  (1) that an Asset Sale Offer is being made pursuant to this<br \/>\n         SECTION 4.12;<\/p>\n<p>                  (2) that such Holders have the right to require the Company to<br \/>\n         apply the Excess Proceeds to repurchase the Notes at a purchase price<br \/>\n         in cash equal to 100% of the principal amount thereof plus accrued and<br \/>\n         unpaid interest, if any, to the purchase date which shall be no earlier<\/p>\n<p>                                       40<\/p>\n<p>         than 30 days and not later than 60 days from the date such notice is<br \/>\n         mailed (the &#8220;Excess Proceeds Payment Date&#8221;);<\/p>\n<p>                  (3) that any Note not tendered or accepted for payment will<br \/>\n         continue to accrue interest;<\/p>\n<p>                  (4) that any Notes accepted for payment pursuant to the Asset<br \/>\n         Sale Offer shall cease to accrue interest after the Excess Proceeds<br \/>\n         Payment Date;<\/p>\n<p>                  (5) that Holders accepting the offer to have their Notes<br \/>\n         purchased pursuant to the Asset Sale Offer will be required to<br \/>\n         surrender the Notes, with the form entitled &#8220;Option of Holder to Elect<br \/>\n         Purchase&#8221; on the reverse of the Note completed, to the Paying Agent at<br \/>\n         the address specified in the notice prior to the close of business on<br \/>\n         the Business Day preceding the Excess Proceeds Payment Date;<\/p>\n<p>                  (6) that Holders will be entitled to withdraw their acceptance<br \/>\n         of the Asset Sale Offer if the Paying Agent receives, not later than<br \/>\n         the close of business on the third Business Day preceding the Excess<br \/>\n         Proceeds Payment Date, a telegram, facsimile transmission or letter<br \/>\n         setting forth the name of the Holder, the principal amount of the Notes<br \/>\n         delivered for purchase and a statement that such Holder is withdrawing<br \/>\n         his or her election to have such Notes purchased;<\/p>\n<p>                  (7) that if the aggregate principal amount of Notes<br \/>\n         surrendered by Holders exceeds the amount of Excess Proceeds, the<br \/>\n         Company shall select the Notes to be purchased on a pro rata basis so<br \/>\n         that the aggregate amount of Notes so purchased equals the amount of<br \/>\n         Excess Proceeds (with such adjustments as may be deemed appropriate by<br \/>\n         the Company so that only Notes in denominations of $1,000 or integral<br \/>\n         multiples thereof shall be purchased);<\/p>\n<p>                  (8) that Holders whose Notes are being purchased only in part<br \/>\n         will be issued new Notes equal in principal amount to the unpurchased<br \/>\n         portion of the Notes surrendered; provided that each Note purchased and<br \/>\n         each such new Note issued shall be in an original principal amount of<br \/>\n         $1,000 or an integral multiple thereof;<\/p>\n<p>                  (9)      the calculations used in determining the amount of<br \/>\n         Excess Proceeds to be applied to the purchase of such Notes;<\/p>\n<p>                  (10)     any other procedures that a Holder must follow to<br \/>\n         accept an Asset Sale Offer or effect withdrawal of such acceptance; and<\/p>\n<p>                  (11)     the name and address of the Paying Agent.<\/p>\n<p>                  On the Excess Proceeds Payment Date, the Company shall, to the<br \/>\nextent lawful, (1) accept for payment, on a pro rata basis to the extent<br \/>\nnecessary, Notes or portions thereof tendered pursuant to the Asset Sale Offer,<br \/>\n(2) deposit with the Paying Agent US legal tender sufficient to pay the purchase<br \/>\nprice plus accrued and unpaid interest, if any, on the Notes to be purchased or<br \/>\nportions thereof, (3) deliver or cause to be delivered to the Trustee Notes so<br \/>\naccepted together with an Officers&#8217; Certificate stating that such Notes or<br \/>\nportions thereof were accepted for payment by the Company in accordance with the<\/p>\n<p>                                       41<\/p>\n<p>terms of this SECTION 4.12. The Paying Agent shall promptly mail to each Holder<br \/>\nof Notes so accepted payment in an amount equal to the purchase price for such<br \/>\nNotes, and the Company shall execute and issue, and the Trustee shall promptly<br \/>\nauthenticate and make available for delivery to such Holder, a new Note equal in<br \/>\nprincipal amount to any unpurchased portion of the Notes surrendered; provided<br \/>\nthat each Note purchased and each such new Note issued shall be in an original<br \/>\nprincipal amount of $1,000 or an integral multiple thereof.<\/p>\n<p>                  (e) The Company shall comply with the requirements of Rule<br \/>\n14e-1 under the Exchange Act and other securities laws and regulations<br \/>\nthereunder to the extent such laws and regulations are applicable in connection<br \/>\nwith the repurchase of Notes pursuant to an Asset Sale Offer. To the extent that<br \/>\nthe provisions of any securities laws or regulations conflict with this SECTION<br \/>\n4.12, the Company shall comply with the applicable securities laws and<br \/>\nregulations and shall not be deemed to have breached its obligations under this<br \/>\nSECTION 4.12 by virtue thereof.<\/p>\n<p>         Section 4.13 Limitation on Transactions with Affiliates. Prior to the<br \/>\noccurrence of the Fall-Away Event, neither the Company nor any of its<br \/>\nSubsidiaries shall, directly or indirectly, in one transaction or a series of<br \/>\ntransactions, make any loan, advance, guarantee or capital contribution to, or<br \/>\nfor the benefit of, or sell, lease, transfer or otherwise dispose of any of its<br \/>\nproperties or assets to, or for the benefit of, or purchase or lease any<br \/>\nproperty or assets from, or enter into or amend any contract, agreement or<br \/>\nunderstanding with, or for the benefit of, any Affiliate of the Company or any<br \/>\nof its Subsidiaries or any Person (or any Affiliate of such Person) holding 10%<br \/>\nor more of the Common Equity of the Company or any of its Subsidiaries, other<br \/>\nthan transactions in the ordinary course between the Company and its<br \/>\nSubsidiaries or among Subsidiaries of the Company (an &#8220;Affiliate Transaction&#8221;),<br \/>\nunless: (i) the terms of such Affiliate Transaction are fair and reasonable to<br \/>\nthe Company or such Subsidiary, as the case may be, and are at least as<br \/>\nfavorable as the terms which could be obtained by the Company or such<br \/>\nSubsidiary, as the case may be, in a comparable transaction made on an<br \/>\narm&#8217;s-length basis between unaffiliated parties; (ii) with respect to any such<br \/>\nAffiliate Transaction involving aggregate payments in excess of $5,000,000, the<br \/>\nCompany delivers an Officers&#8217; Certificate to the Trustee certifying that such<br \/>\nAffiliate Transaction complies with clause (i) above and a Secretary&#8217;s<br \/>\nCertificate which sets forth and authenticates a resolution that has been<br \/>\nadopted by a vote of a majority of the disinterested members of the Board of<br \/>\nDirectors approving such Affiliate Transaction; and (iii) with respect to any<br \/>\nsuch Affiliate Transaction involving aggregate payments in excess of<br \/>\n$25,000,000, the Company delivers to the Trustee the certificates specified in<br \/>\nclause (ii) above and an opinion of an independent investment banking firm of<br \/>\nnational standing in the United States, stating that such Affiliate Transaction<br \/>\nis fair from a financial point of view to the Company or such Subsidiary, as the<br \/>\ncase may be; provided, however, that the foregoing clauses (ii) and (iii) shall<br \/>\nnot apply to transactions between the Company or any of its Subsidiaries and<br \/>\nMedCenterDirect, Inc. or Source Medical Solutions, Inc.<\/p>\n<p>         Section 4.14 Limitation on Liens Prior to the Fall-Away Event. Prior to<br \/>\nthe occurrence of the Fall-Away Event, the Company will not create or suffer to<br \/>\nexist any Lien (other than Permitted Liens) on any of its assets, unless<br \/>\ncontemporaneously therewith:<\/p>\n<p>                                       42<\/p>\n<p>                        (i) in the case of any Lien securing an obligation that<br \/>\n         ranks pari passu with the Notes, effective provision is made to secure<br \/>\n         the Notes at least equally and ratably with or prior to such obligation<br \/>\n         with a Lien on the same collateral; and<\/p>\n<p>                       (ii) in the case of any Lien securing an obligation that<br \/>\n         is subordinated in right of payment to the Notes, effective provision<br \/>\n         is made to secure the Notes with a Lien on the same collateral that is<br \/>\n         prior to the Lien securing such subordinated obligation.<\/p>\n<p>                  Notwithstanding the above, the Company may, without securing<br \/>\nthe Notes, create or assume any Indebtedness which is secured by a Lien which<br \/>\nwould otherwise be subject to the foregoing restrictions, provided that after<br \/>\ngiving effect thereto, the Exempted Debt then outstanding does not exceed 10% of<br \/>\nthe total Consolidated Tangible Assets of the Company and its Subsidiaries at<br \/>\nsuch time.<\/p>\n<p>         Section 4.15 Purchase of Notes upon a Change of Control Prior to the<br \/>\nFall-Away Event. (a) Upon the occurrence of a Change of Control and if the<br \/>\nFall-Away Event has not occurred prior to the expiration of the 30-day period<br \/>\nimmediately after the occurrence of such Change of Control, the Company shall be<br \/>\nobligated to make an offer to purchase (the &#8220;Change of Control Offer&#8221;) the<br \/>\noutstanding Notes of each Holder in whole or in part in integral multiples of<br \/>\n$1,000, at a purchase price (the &#8220;Change of Control Purchase Price&#8221;) in cash in<br \/>\nan amount equal to 101% of the principal amount thereof, plus accrued interest,<br \/>\nif any, to the date of purchase (the &#8220;Change of Control Purchase Date&#8221;),<br \/>\npursuant to the procedures set forth below.<\/p>\n<p>                  (b) Within 30 days following any Change of Control, and if the<br \/>\nFall-Away Event has not occurred within the 30-day period immediately after the<br \/>\noccurrence of such Change of Control, the Company shall notify the Trustee<br \/>\nthereof and give written notice of such Change of Control to each Holder by<br \/>\nfirst-class mail, postage prepaid, at the address of such Holder appearing in<br \/>\nthe register maintained by the Registrar, stating, among other things:<\/p>\n<p>                  (1) that the Change of Control Offer is being made pursuant to<br \/>\n         this SECTION 4.15;<\/p>\n<p>                  (2) that such Holders have the right to require the Company to<br \/>\n         repurchase such Notes at the Change of Control Purchase Price on the<br \/>\n         Change of Control Purchase Date which shall be no earlier than 30 days<br \/>\n         and not later than 60 days from the date such notice is mailed;<\/p>\n<p>                  (3) that any Note not tendered or accepted for payment will<br \/>\n         continue to accrue interest;<\/p>\n<p>                  (4) that, unless the Company defaults in its payment of the<br \/>\n         Change of Control Purchase Price, any Note accepted for payment<br \/>\n         pursuant to the Change of Control Offer shall cease to accrue interest<br \/>\n         after the Change of Control Purchase Date;<\/p>\n<p>                  (5) that Holders accepting the offer to have their Notes<br \/>\n         purchased pursuant to a Change of Control Offer will be required to<br \/>\n         surrender the Notes, with the form entitled &#8220;Option of Holder to Elect<br \/>\n         Purchase&#8221; on the reverse of the Note completed, to the Paying Agent at<\/p>\n<p>                                       43<\/p>\n<p>         the address specified in the notice prior to the close of business on<br \/>\n         the Business Day preceding the Change of Control Purchase Date;<\/p>\n<p>                  (6) that Holders will be entitled to withdraw their acceptance<br \/>\n         of the Change of Control Offer if the Paying Agent receives, not later<br \/>\n         than the close of business on the third Business Day preceding the<br \/>\n         Change of Control Purchase Date, a telegram, facsimile transmission or<br \/>\n         letter setting forth the name of the Holder, the principal amount of<br \/>\n         the Notes delivered for purchase and a statement that such Holder is<br \/>\n         withdrawing his or her election to have such Notes purchased;<\/p>\n<p>                  (7) any other procedures that a Holder must follow to accept a<br \/>\n         Change of Control Offer or effect withdrawal of such acceptance; and<\/p>\n<p>                  (8) the name and address of the Paying Agent.<\/p>\n<p>                  On the Change of Control Payment Date, the Company shall, to<br \/>\nthe extent lawful, (1) accept for payment Notes or portions thereof tendered<br \/>\npursuant to the Change of Control Offer, (2) deposit with the Paying Agent U.S.<br \/>\nlegal tender sufficient to pay the purchase price of all Notes or portions<br \/>\nthereof so tendered and (3) deliver or cause to be delivered to the Trustee<br \/>\nNotes so accepted together with an Officers&#8217; Certificate stating that such Notes<br \/>\nor portions thereof were accepted for payment by the Company pursuant to this<br \/>\nSECTION 4.15. The Paying Agent shall promptly mail to each Holder of Notes so<br \/>\naccepted payment in an amount equal to the purchase price for such Notes, and<br \/>\nthe Company shall execute and issue, and the Trustee shall promptly authenticate<br \/>\nand mail to such Holder, a new Note equal in principal amount to any unpurchased<br \/>\nportion of the Notes surrendered; provided that each such new Note shall be<br \/>\nissued in an original principal amount of $1,000 or an integral multiple<br \/>\nthereof.<\/p>\n<p>                  (c) The Company shall comply with the requirements of Rule<br \/>\n14e-1 under the Exchange Act and other securities laws and regulations<br \/>\nthereunder to the extent such laws and regulations are applicable in connection<br \/>\nwith the repurchase of Notes pursuant to a Change of Control Offer. To the<br \/>\nextent that the provisions of any securities laws or regulations conflict with<br \/>\nthis SECTION 4.15, the Company shall comply with the applicable securities laws<br \/>\nand regulations and shall not be deemed to have breached its obligations under<br \/>\nthis SECTION 4.15 by virtue thereof.<\/p>\n<p>         Section 4.16 Limitation on Restrictions on Distributions from<br \/>\nSubsidiaries. Prior to the occurrence of the Fall-Away Event, the Company shall<br \/>\nnot, and shall not permit any of its Subsidiaries to, create or otherwise cause<br \/>\nor suffer to exist or become effective any consensual encumbrance or restriction<br \/>\n(other than encumbrances or restrictions imposed by law or by judicial or<br \/>\nregulatory action or by provisions in leases or other agreements that restrict<br \/>\nthe assignability thereof) on the ability of any Subsidiary of the Company to<br \/>\n(i) pay dividends or make any other distributions on its Capital Stock or any<br \/>\nother interest or participation in, or measured by, its profits, owned by the<br \/>\nCompany or any of its other Subsidiaries, or pay interest on or principal of any<br \/>\nIndebtedness owed to the Company or any of its other Subsidiaries, (ii) make<br \/>\nloans or advances to the Company or any of its other Subsidiaries or (iii)<br \/>\ntransfer any of its properties or assets to the Company or any of its other<br \/>\nSubsidiaries, in each case except for encumbrances or restrictions existing<br \/>\nunder or by reason of (a) applicable law, (b) the Credit Agreements, <\/p>\n<p>                                       44<\/p>\n<p>(c) Existing Indebtedness, (d) any restrictions under any agreement evidencing<br \/>\nany Acquired Indebtedness that was permitted to be incurred pursuant to this<br \/>\nIndenture and which was not incurred in anticipation or contemplation of the<br \/>\nrelated acquisition, provided that such restrictions and encumbrances only apply<br \/>\nto assets that were subject to such restrictions and encumbrances prior to the<br \/>\nacquisition of such assets by the Company or its Subsidiaries, (e) restrictions<br \/>\nor encumbrances replacing those permitted by clause (b), (c) or (d) above which,<br \/>\ntaken as a whole, are not materially more restrictive, (f) this Indenture, (g)<br \/>\nany restrictions and encumbrances arising in connection with Refinancing<br \/>\nIndebtedness; provided, however, that any restrictions or encumbrances of the<br \/>\ntype described in this clause (g) that arise under such Refinancing Indebtedness<br \/>\nare not, taken as a whole, materially more restrictive than those under the<br \/>\nagreement creating or evidencing the Indebtedness being refunded or refinanced,<br \/>\n(h) any restrictions with respect to a Subsidiary of the Company imposed<br \/>\npursuant to an agreement that has been entered into for the sale or other<br \/>\ndisposition of all or substantially all of the Capital Stock or assets of such<br \/>\nSubsidiary, (i) any agreement restricting the sale or other disposition of<br \/>\nproperty securing Indebtedness if such agreement does not expressly restrict the<br \/>\nability of a Subsidiary of the Company to pay dividends or make loans or<br \/>\nadvances and (j) customary restrictions in purchase money debt or leases<br \/>\nrelating to the property covered thereby.<\/p>\n<p>         Section 4.17 Limitations on Layering Indebtedness. Prior to the<br \/>\noccurrence of the Fall-Away Event, the Company will not, and will not permit any<br \/>\nof its Subsidiaries to, directly or indirectly, incur any Indebtedness that<br \/>\npurports to be by its terms subordinated to any other Indebtedness of the<br \/>\nCompany or such Subsidiary, as the case may be, unless such Indebtedness is also<br \/>\nexpressly subordinated to the Notes to the same extent and in the same manner as<br \/>\nsuch Indebtedness is subordinated to such other Indebtedness.<\/p>\n<p>         Section 4.18 Limitations on Liens After the Fall-Away Event. After the<br \/>\noccurrence of the Fall-Away Event, the Company shall not, nor shall it permit<br \/>\nany Subsidiary to, directly or indirectly, create or incur any Lien of any kind<br \/>\nsecuring Indebtedness for money borrowed upon any assets, whether now owned or<br \/>\nhereafter acquired, of the Company or any such Subsidiary without equally and<br \/>\nratably securing the Notes by a Lien ranking ratably with and equally to such<br \/>\nsecured Indebtedness, except that the foregoing restriction shall not apply to:<br \/>\n(i) Liens on assets of any corporation existing at the time such corporation<br \/>\nbecomes a Subsidiary; (ii) Liens on assets existing at the time of acquisition<br \/>\nthereof, or to secure the payment of the purchase price of such assets, or to<br \/>\nsecure Indebtedness incurred or guaranteed by the Company or a Subsidiary for<br \/>\nthe purpose of financing the purchase price of such assets or improvements or<br \/>\nconstruction thereon, which Indebtedness is incurred or guaranteed prior to, at<br \/>\nthe time of or within 360 days after such acquisition (or in the case of real<br \/>\nproperty, completion of such improvement or construction or commencement of full<br \/>\noperation of such property, whichever is later); (iii) Liens on any assets of a<br \/>\ncorporation existing at the time such corporation is merged into or consolidated<br \/>\nwith the Company or a Subsidiary or at the time of a purchase, lease or other<br \/>\nacquisition of the assets of a corporation or firm as an entirety or<br \/>\nsubstantially as an entirety by the Company or a Subsidiary; (iv) Liens on any<br \/>\nassets of the Company or a Subsidiary in favor of the United States of America<br \/>\nor any state thereof, or in favor of any other country, or in favor of any<br \/>\npolitical subdivision of any of the foregoing, to secure certain payments<br \/>\npursuant to any contract or statute or to secure any Indebtedness incurred or<br \/>\nguaranteed for the purpose of financing all or any part of the purchase price<br \/>\n(or, in the case of real property, the cost of construction) of the assets<br \/>\nsubject to such Liens (including, but not limited to, Liens incurred in<\/p>\n<p>                                       45<\/p>\n<p>connection with industrial revenue or similar financing involving a political<br \/>\nsubdivision, agency or authority thereof); (v) Liens relating to accounts<br \/>\nreceivable of the Company or any of its Subsidiaries which have been sold,<br \/>\nassigned or otherwise transferred to another Person in a transaction classified<br \/>\nas a sale of accounts receivable in accordance with GAAP (to the extent the sale<br \/>\nby the Company or the applicable Subsidiary is deemed to give rise to a Lien in<br \/>\nfavor of the purchaser thereof in such accounts receivable or the proceeds<br \/>\nthereof); or (vi) any other Permitted Lien.<\/p>\n<p>         Notwithstanding the above, the Company or any Subsidiary may, without<br \/>\nsecuring the Notes, create or assume any Indebtedness which is secured by a Lien<br \/>\nthat would otherwise be subject to the foregoing restriction, provided that<br \/>\nafter giving effect thereto the Exempted Debt (not including Attributable<br \/>\nIndebtedness in respect of Sale and Leaseback Transactions involving leases not<br \/>\nexceeding five years) then outstanding does not exceed 10% of the total<br \/>\nConsolidated Tangible Assets at such time.<\/p>\n<p>         Section 4.19 Limitation on Sale and Leaseback Transactions. After the<br \/>\noccurrence of the Fall-Away Event, neither the Company nor any Subsidiary shall,<br \/>\ndirectly or indirectly, enter into a Sale and Leaseback Transaction (except such<br \/>\ntransactions involving leases not exceeding five years) in respect of any of<br \/>\ntheir assets unless (i) the Company or such Subsidiary would be entitled<br \/>\npursuant to clauses (i) through (vi) contained in SECTION 4.18 to create, incur<br \/>\nor permit to exist a lien on the assets to be leased in an amount at least equal<br \/>\nto the Attributable Debt in respect of such transaction without equally and<br \/>\nratably securing the Notes, or (ii) the proceeds from the sale of the assets to<br \/>\nbe leased are at least equal to their fair market value and the proceeds are<br \/>\napplied to the purchase or acquisition (or, in the case of real property, the<br \/>\nconstruction) of assets or to the retirement of indebtedness.<\/p>\n<p>                                    ARTICLE 5<\/p>\n<p>                                SURVIVING ENTITY<br \/>\n                                &#8212;&#8212;&#8212;&#8212;&#8212;-<\/p>\n<p>         Section 5.01 Limitations on Mergers and Consolidations Prior to the<br \/>\nFall-Away Event. Prior to the occurrence of the Fall-Away Event, the Company<br \/>\nshall not consolidate or merge with or into, or sell, lease, convey or otherwise<br \/>\ndispose of all or substantially all of its assets, or assign any of its<br \/>\nobligations under the Notes or this Indenture, to any Person unless: (i) the<br \/>\nPerson formed by or surviving such consolidation or merger (if other than the<br \/>\nCompany), or to which such sale, lease, conveyance or other disposition or<br \/>\nassignment shall be made (collectively, the &#8220;Successor&#8221;), is a corporation<br \/>\norganized and existing under the laws of the United States or any State thereof<br \/>\nor the District of Columbia, and the Successor assumes by supplemental indenture<br \/>\nin a form satisfactory to the Trustee all of the obligations of the Company<br \/>\nunder the Notes and this Indenture; (ii) immediately after giving effect to such<br \/>\nconsolidation, merger, sale, lease, conveyance or other disposition or<br \/>\nassignment and the use of any net proceeds therefrom on a pro forma basis, no<br \/>\nDefault or Event of Default shall have occurred and be continuing; (iii)<br \/>\nimmediately after giving effect to such consolidation,<\/p>\n<p>                                       46<\/p>\n<p>merger, sale, lease, conveyance or other disposition or assignment and the use<br \/>\nof any net proceeds therefrom on a pro forma basis, the Consolidated Net Worth<br \/>\nof the Company or the Successor, as the case may be, would be at least equal to<br \/>\nthe Consolidated Net Worth of the Company immediately prior to such transaction;<br \/>\n(iv) immediately after giving effect to such consolidation, merger, sale, lease,<br \/>\nconveyance or other disposition or assignment and the use of any net proceeds<br \/>\ntherefrom on a pro forma basis, the EBITDA Coverage Ratio of the Company or the<br \/>\nSuccessor, as the case may be, would be such that the Company or the Successor,<br \/>\nas the case may be, would be entitled to incur at least $1.00 of additional<br \/>\nIndebtedness under the EBITDA Coverage Ratio test in SECTION 4.11 hereof; and<br \/>\n(v) the Company shall have delivered to the Trustee an Officers&#8217; Certificate and<br \/>\nan Opinion of Counsel, each stating that such consolidation, merger, sale,<br \/>\nlease, conveyance or other disposition or assignment complies with the<br \/>\nprovisions of this Indenture.<\/p>\n<p>         Section 5.02 Limitations on Mergers and Consolidations After the<br \/>\nFall-Away Event. After the occurrence of the Fall-Away Event, the Company shall<br \/>\nnot consolidate with or merge into any other Person, or convey, transfer or<br \/>\nlease its properties and assets substantially as an entirety to any other<br \/>\nPerson, and the Company shall not permit any other Person to consolidate with or<br \/>\nmerge into the Company or convey, transfer or lease its properties and assets<br \/>\nsubstantially as an entirety to the Company, unless (a) either the Company shall<br \/>\nbe the continuing corporation, or the successor entity (if other than the<br \/>\nCompany) formed by such consolidation or merger or into which the properties and<br \/>\nassets of the Company substantially as an entirety are transferred or leased<br \/>\nshall be a corporation, partnership, limited liability company or trust<br \/>\norganized and existing under the laws of the United States of America, any State<br \/>\nthereof or the District of Columbia and shall expressly assume, by a<br \/>\nsupplemental indenture, executed and delivered to the Trustee, in a form<br \/>\nsatisfactory to the Trustee, all the obligations of the Company under the Notes<br \/>\nand this Indenture, and (b) immediately after giving effect to such transaction<br \/>\nand treating any Indebtedness that becomes an obligation of the Company or a<br \/>\nSubsidiary as a result of such transaction as having been incurred by the<br \/>\nCompany or such Subsidiary at the time of such transaction, no Default or Event<br \/>\nof Default shall have occurred and be continuing.<\/p>\n<p>         Section 5.03 Successor Substituted. Upon any consolidation, merger,<br \/>\nconveyance or any transfer of all or substantially all of the assets of the<br \/>\nCompany in accordance with SECTION 5.01 or SECTION 5.02 hereof, the surviving<br \/>\nentity formed by such consolidation or into which the Company or any such<br \/>\nSubsidiary is merged or to which such transfer is made shall succeed to, and be<br \/>\nsubstituted for, and may exercise every right and power of, the Company or such<br \/>\nSubsidiary, as the case may be, under this Indenture with the same effect as if<br \/>\nsuch surviving entity had been named as the Company or such Subsidiary, as the<br \/>\ncase may be, herein, and thereafter the predecessor entity shall be relieved of<br \/>\nall obligations and covenants under this Indenture and the Notes.<\/p>\n<p>                                    ARTICLE 6<\/p>\n<p>                              DEFAULTS AND REMEDIES<br \/>\n                              &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<\/p>\n<p>         Section 6.01 Events of Default. An &#8220;Event of Default&#8221; means each one of<br \/>\nthe following events which shall have occurred and be continuing (whatever the<br \/>\nreason for such Event of Default and whether it shall be voluntary or<br \/>\ninvoluntary or be effected by operation of law or pursuant to any judgment,<br \/>\ndecree or order of any court or any order, rule or regulation of any<br \/>\nadministrative or governmental body) with respect to the Notes of a single<br \/>\nmaturity:<\/p>\n<p>                                       47<\/p>\n<p>                  (a) default in the payment of any installment of interest upon<br \/>\n         any of such Notes as and when the same shall become due and payable,<br \/>\n         and continuance of such default for a period of 30 days;<\/p>\n<p>                  (b) default in the payment of all or any part of the<br \/>\n         principal, or premium, if any, on any of such Notes as and when the<br \/>\n         same shall become due and payable either at its Stated Maturity, upon<br \/>\n         any redemption, by declaration or otherwise;<\/p>\n<p>                  (c) failure by the Company to comply with its obligations or<br \/>\n         covenants with respect to such Notes described under SECTION 4.12,<br \/>\n         SECTION 4.15 or ARTICLE 5 hereof;<\/p>\n<p>                  (d) failure on the part of the Company duly to observe or<br \/>\n         perform any other of the covenants or agreements on the part of the<br \/>\n         Company in such Notes or this Indenture (other than the covenants<br \/>\n         referred to in clauses (a), (b) and (c) above) for a period of 60 days<br \/>\n         after the date on which written notice specifying such failure, stating<br \/>\n         that such notice is a &#8220;Notice of Default&#8221; under this Indenture and<br \/>\n         demanding that the Company remedy the same, shall have been given by<br \/>\n         registered or certified mail, return receipt requested, to the Company<br \/>\n         by the Trustee, or to the Company and the Trustee by the holders of at<br \/>\n         least 25% in aggregate principal amount of such outstanding Notes;<\/p>\n<p>                  (e) default under any bond, debenture, note or other evidence<br \/>\n         of indebtedness for money borrowed by the Company or any Subsidiary of<br \/>\n         the Company or under any mortgage, indenture or instrument under which<br \/>\n         there may be issued or by which there may be secured or evidenced any<br \/>\n         indebtedness for money borrowed by the Company or any Subsidiary of the<br \/>\n         Company, whether such Indebtedness now exists or shall hereafter be<br \/>\n         created, if (i) such default results in such Indebtedness becoming or<br \/>\n         being declared due and payable prior to the date on which it would<br \/>\n         otherwise become due and payable, (ii) the principal amount of such<br \/>\n         Indebtedness, together with the principal amount of any other such<br \/>\n         Indebtedness which has been so accelerated, aggregates $25,000,000 or<br \/>\n         more at any one time outstanding and (iii) such Indebtedness is not<br \/>\n         discharged, or such acceleration is not rescinded or annulled, within a<br \/>\n         period of 10 days after there shall have been given to the Company by<br \/>\n         the Trustee or to the Company and the Trustee by the holders of at<br \/>\n         least 25% in aggregate principal amount of such outstanding Notes a<br \/>\n         written notice specifying such default and requiring the Company to<br \/>\n         cause such Indebtedness to be discharged or cause such acceleration to<br \/>\n         be rescinded or annulled;<\/p>\n<p>                  (f) a court having jurisdiction in the premises shall enter a<br \/>\n         decree or order for relief in respect of the Company or any Significant<br \/>\n         Subsidiary in an involuntary case under any applicable bankruptcy,<br \/>\n         insolvency or other similar law now or hereafter in effect, or<br \/>\n         appointing a receiver, liquidator, assignee, custodian, trustee,<br \/>\n         sequestrator or similar official of the Company or any Significant<br \/>\n         Subsidiary for any substantial part of its or their property or<br \/>\n         ordering the winding up or liquidation of its or their affairs, and<br \/>\n         such decree or order shall remain unstayed and in effect for a period<br \/>\n         of 60 consecutive days; or<\/p>\n<p>                  (g) the Company or any Significant Subsidiary shall commence a<br \/>\n         voluntary case under any applicable bankruptcy, insolvency or other<\/p>\n<p>                                       48<\/p>\n<p>         similar law now or hereafter in effect, or consent to the entry of an<br \/>\n         order for relief in an involuntary case under any such law, or consent<br \/>\n         to the appointment or taking possession by a receiver, liquidator,<br \/>\n         assignee, custodian, trustee, sequestrator (or similar official) of the<br \/>\n         Company or any Significant Subsidiary or for any substantial part of<br \/>\n         its or their property, or make any general assignment for the benefit<br \/>\n         of creditors.<\/p>\n<p>         Section 6.02 Acceleration. If an Event of Default (other than an Event<br \/>\nof Default specified in SECTION 6.01(F) or 6.01(G) hereof relating to the<br \/>\nCompany) shall have occurred and be continuing under this Indenture with respect<br \/>\nto the Notes of a particular maturity, the Trustee, by written notice to the<br \/>\nCompany, or the Holders of at least 25% in aggregate principal amount of such<br \/>\nNotes then outstanding by written notice to the Company and the Trustee, may<br \/>\ndeclare all amounts owing under such Notes to be due and payable. Upon<br \/>\neffectiveness of such acceleration, the aggregate principal of, premium, if any,<br \/>\nand interest on such outstanding Notes shall immediately become due and payable.<br \/>\nAt any time after such acceleration but before a judgment or decree based on<br \/>\nsuch acceleration is obtained by the Trustee, or any Holder, the Holders of a<br \/>\nmajority in aggregate principal amount of the outstanding Notes of such<br \/>\nmaturity, by written notice to the Company and the Trustee, may rescind and<br \/>\nannul such acceleration if:<\/p>\n<p>                  (a) the Company has paid or deposited with the Trustee a sum<br \/>\n         sufficient to pay:<\/p>\n<p>                  (1) all overdue interest on such Notes;<\/p>\n<p>                  (2) all unpaid principal of and premium, if any, on any of<br \/>\n         such outstanding Notes that has become due otherwise than by such<br \/>\n         declaration of acceleration and interest thereon at the rate borne by<br \/>\n         such Notes;<\/p>\n<p>                  (3) to the extent that payment of such interest is lawful,<br \/>\n         interest upon overdue interest and overdue principal at the rate borne<br \/>\n         by such Notes; and<\/p>\n<p>                  (4) all sums paid or advanced by the Trustee under this<br \/>\n         Indenture and the reasonable compensation, expenses, disbursements and<br \/>\n         advances of the Trustee, its agents and counsel;<\/p>\n<p>                  (b) all Events of Default, other than the non-payment of<br \/>\namounts of principal of, premium, if any, or interest on such Notes that have<br \/>\nbecome due solely by such declaration of acceleration, have been cured or<br \/>\nwaived; and<\/p>\n<p>                  (c) in the event of the cure or waiver of an Event of Default<br \/>\nwith respect to the Company of the type described in SECTION 6.01(F) OR 6.01(G)<br \/>\nhereof, the Trustee shall have received an Officers&#8217; Certificate and an Opinion<br \/>\nof Counsel that such Event of Default has been cured or waived.<\/p>\n<p>                  No such rescission shall affect any subsequent Default or<br \/>\nimpair any right consequent thereto.<\/p>\n<p>                  In case an Event of Default with respect to the Company of the<br \/>\ntype described in SECTION 6.01(F) OR 6.01(G) hereof shall occur, the aggregate<\/p>\n<p>                                       49<\/p>\n<p>principal of, premium, if any, and interest on the outstanding Notes shall<br \/>\nimmediately become due and payable without any declaration or other act on the<br \/>\npart of the Trustee or the Holders.<\/p>\n<p>         Section 6.03 Other Remedies. If an Event of Default occurs and is<br \/>\ncontinuing with respect to the Notes of a particular maturity, the Trustee may<br \/>\npursue any available remedy by proceeding at law or in equity to collect the<br \/>\npayment of principal of, or premium, if any, and interest on such Notes or to<br \/>\nenforce the performance of any provision of such Notes or this Indenture and may<br \/>\ntake any necessary action requested of it as Trustee to settle, compromise,<br \/>\nadjust or otherwise conclude any proceedings to which it is a party.<\/p>\n<p>         The Trustee may maintain a proceeding even if it does not possess any<br \/>\nof such Notes or does not produce any of them in the proceeding. A delay or<br \/>\nomission by the Trustee or any Holder in exercising any right or remedy accruing<br \/>\nupon an Event of Default shall not impair the right or remedy or constitute a<br \/>\nwaiver of or acquiescence in the Event of Default. No remedy is exclusive of any<br \/>\nother remedy. All available remedies are cumulative to the extent permitted by<br \/>\nlaw.<\/p>\n<p>         Section 6.04 Waiver of Existing Defaults and Events of Default. Subject<br \/>\nto SECTIONS 2.08, 6.02, 6.07 and 8.02 hereof, the Holders of a majority in<br \/>\nprincipal amount of the Notes of a single maturity then outstanding have the<br \/>\nright to waive existing Defaults as to such Notes under or compliance with any<br \/>\nprovision of this Indenture or such Notes except a continuing Default in the<br \/>\npayment of the principal of, or interest or premium, if any, on any such Note as<br \/>\nspecified in clauses (a) and (b) of SECTION 6.01 hereof or in respect of a<br \/>\ncovenant or a provision which cannot be modified or amended without the consent<br \/>\nof all Holders as provided for in SECTION 8.02 hereof. The Company shall deliver<br \/>\nto the Trustee an Officers&#8217; Certificate stating that the requisite percentage of<br \/>\nHolders have consented to such waiver and attach copies of such consents. In<br \/>\ncase of any such waiver, the Company, the Trustee and the Holders shall be<br \/>\nrestored to their former positions and rights hereunder and under such Notes,<br \/>\nrespectively. This paragraph of this SECTION 6.04 shall be in lieu of ss.<br \/>\n316(a)(1)(B) of the TIA and such ss. 316(a)(1)(B) of the TIA is hereby expressly<br \/>\nexcluded from this Indenture and the Notes, as permitted by the TIA.<\/p>\n<p>         Upon any such waiver, such Default shall cease to exist and be deemed<br \/>\nto have been cured and not to have occurred, and any Event of Default arising<br \/>\ntherefrom shall be deemed to have been cured and not to have occurred for every<br \/>\npurpose of this Indenture, but no such waiver shall extend to any subsequent or<br \/>\nother Default or Event of Default or impair any right consequent thereto.<\/p>\n<p>         Section 6.05 Control by Majority. Subject to SECTION 2.08 hereof, the<br \/>\nHolders of a majority in principal amount of the then outstanding Notes of a<br \/>\nsingle maturity shall have the right to direct the time, method and place of<br \/>\nconducting any proceeding for exercising any remedy available to the Trustee or<br \/>\nexercising any trust or power conferred on the Trustee by this Indenture. The<br \/>\nTrustee, however, may refuse to follow any direction that conflicts with law or<br \/>\nthis Indenture or that the Trustee determines in its reasonable judgment may be<br \/>\nunduly prejudicial to the rights of another Holder of such Notes not taking part<br \/>\nin such direction, and the Trustee shall have the right to decline to follow any<br \/>\nsuch direction if the Trustee, being advised by counsel, determines that the<br \/>\naction so directed may not lawfully be taken or if the Trustee in good faith<\/p>\n<p>                                       50<\/p>\n<p>shall, by a Trust Officer, determine that the proceedings so directed may<br \/>\ninvolve it in personal liability; provided that the Trustee may take any other<br \/>\naction deemed proper by the Trustee which is not inconsistent with such<br \/>\ndirection. In the event the Trustee takes any action or follows any direction<br \/>\npursuant to this Indenture, the Trustee shall be entitled to indemnification<br \/>\nsatisfactory to it in its sole discretion against any loss or expense caused by<br \/>\ntaking such action or following such direction. This SECTION 6.05 shall be in<br \/>\nlieu of Section 316(a)(1)(A) of the TIA, and such Section 316(a)(1)(A) of the<br \/>\nTIA is hereby expressly excluded from this Indenture and the Notes, as permitted<br \/>\nby the TIA.<\/p>\n<p>         Section 6.06 Limitation on Suits. Subject to SECTION 6.07 hereof, no<br \/>\nHolder has any right to institute any proceeding with respect to this Indenture<br \/>\nor any remedy hereunder unless:<\/p>\n<p>                  (1)      the Holder gives the Trustee written notice of a<br \/>\n         continuing Event of Default with respect to the Notes of the maturity<br \/>\n         owned by such Holder;<\/p>\n<p>                  (2) the Holders of at least 25% in aggregate principal amount<br \/>\n         of the outstanding Notes of that maturity make a written request to the<br \/>\n         Trustee to pursue the remedy;<\/p>\n<p>                  (3) such Holder or Holders offer to the Trustee indemnity<br \/>\n         reasonably satisfactory to the Trustee against any loss, liability or<br \/>\n         expense which may be incurred in compliance with such request;<\/p>\n<p>                  (4)      the Trustee fails to institute such proceeding within<br \/>\n         60 calendar days after receipt of such notice and the offer of<br \/>\n         indemnity; and<\/p>\n<p>                  (5) the Trustee has not received directions inconsistent with<br \/>\n         such written request during such 60-day period by the Holders of a<br \/>\n         majority in aggregate principal amount of such then outstanding Notes.<\/p>\n<p>                  A Holder may not use this Indenture to prejudice the rights of<br \/>\nanother Holder of the same maturity of Notes or to obtain a preference or<br \/>\npriority over another Holder of the same maturity of Notes.<\/p>\n<p>         Section 6.07 Rights of Holders To Receive Payment. Notwithstanding any<br \/>\nother provision of this Indenture, the right of any Holder to receive payment of<br \/>\nprincipal of, or premium, if any, or accrued interest on any Note held by such<br \/>\nHolder on or after the respective due dates expressed in such Note, or to bring<br \/>\nsuit for the enforcement of any such payment on or after such respective dates,<br \/>\nis absolute and unconditional (subject to the terms of this Indenture) and shall<br \/>\nnot be impaired or affected without the consent of such Holder.<\/p>\n<p>         Section 6.08 Collection Suit by Trustee. If an Event of Default occurs<br \/>\nand is continuing, the Trustee may recover judgment in its own name and as<br \/>\ntrustee of an express trust against the Company for the whole amount of unpaid<br \/>\nprincipal, premium, if any, and accrued interest remaining unpaid, together<br \/>\nwith, to the extent that payment of such interest is lawful, interest on overdue<br \/>\nprincipal and interest on overdue installments of interest, in each case at the<br \/>\nrate set forth in the Notes with respect to which such Event of Default has<br \/>\noccurred, and such further amounts as shall be sufficient to cover the costs and<br \/>\nexpenses of collection, including the <\/p>\n<p>                                       51<\/p>\n<p>reasonable  compensation,  expenses,  disbursements  and  advances  of  the<br \/>\nTrustee, its agents and counsel.<\/p>\n<p>         Section 6.09 Trustee May File Proofs of Claim. The Trustee may file<br \/>\nsuch proofs of claim and other papers or documents as may be necessary or<br \/>\nadvisable in order to have the claims of the Trustee (including any claim for<br \/>\nthe reasonable compensation, expenses, disbursements and advances of the<br \/>\nTrustee, its agents and counsel) and the Holders allowed in any judicial<br \/>\nproceedings relative to the Company (or any other obligor upon the Notes), its<br \/>\ncreditors or its property and shall be entitled and empowered to collect and<br \/>\nreceive any monies or other property payable or deliverable on any such claims<br \/>\nand to distribute the same after deduction of its charges and expenses to the<br \/>\nextent that any such charges and expenses are not paid out of the estate in any<br \/>\nsuch proceedings and any custodian in any such judicial proceeding is hereby<br \/>\nauthorized by each Holder to make such payments to the Trustee, and in the event<br \/>\nthat the Trustee shall consent to the making of such payments directly to the<br \/>\nHolders, to pay to the Trustee any amount due to it for the reasonable<br \/>\ncompensation, expenses, disbursements and advances of the Trustee, its agents<br \/>\nand counsel, and any other amounts due the Trustee under SECTION 7.07 hereof.<\/p>\n<p>         Nothing herein contained shall be deemed to authorize the Trustee to<br \/>\nauthorize or consent to or accept or adopt on behalf of any Holder any plan of<br \/>\nreorganization, arrangement, adjustment or composition affecting the Holder&#8217;s<br \/>\nNotes or the rights of any Holder thereof, or to authorize the Trustee to vote<br \/>\nin respect of the claim of any Holder in any such proceedings.<\/p>\n<p>         Section 6.10        Priorities.  If the Trustee collects any money<br \/>\npursuant to this ARTICLE 6, it shall pay out the money in the following order:<\/p>\n<p>                  FIRST:  to the Trustee for amounts due under Section 7.07<br \/>\n         hereof;<\/p>\n<p>                  SECOND:  if the Holders are forced to proceed against the<br \/>\n         Company directly without the Trustee, to Holders for their collection<br \/>\n         costs; and<\/p>\n<p>                  THIRD: to Holders of the Notes with respect to which such<br \/>\n         money has been collected, for amounts due and unpaid on such Notes for<br \/>\n         principal, premium, if any, and interest as to each, ratably, without<br \/>\n         preference or priority of any kind as to Notes of that maturity,<br \/>\n         according to the amounts due and payable on such Notes.<\/p>\n<p>         The Trustee, upon prior written notice to the Company, may fix a Record<br \/>\nDate and payment date for any payment to Holders pursuant to this SECTION 6.10.<\/p>\n<p>         Section 6.11 Undertaking for Costs. In any suit for the enforcement of<br \/>\nany right or remedy under this Indenture or in any suit against the Trustee for<br \/>\nany action taken or omitted by it as Trustee, a court in its discretion may<br \/>\nrequire the filing by any party litigant in the suit of an undertaking to pay<br \/>\nthe costs of the suit, and the court in its discretion may assess reasonable<br \/>\ncosts, including reasonable attorneys&#8217; fees, against any party litigant in the<br \/>\nsuit, having due regard to the merits and good faith of the claims or defenses<br \/>\nmade by the party litigant. This Section 6.11 does not apply to a suit by the<br \/>\nTrustee, a suit by a Holder pursuant to Section 6.07 hereof or a suit by Holders<br \/>\nof more than 10% in principal amount of the Notes of a particular maturity then<br \/>\noutstanding.<\/p>\n<p>                                       52<\/p>\n<p>                                    ARTICLE 7<\/p>\n<p>                                     TRUSTEE<br \/>\n                                     &#8212;&#8212;-<\/p>\n<p>         Section 7.01 Duties of Trustee. (a) If an Event of Default actually<br \/>\nknown to a Trust Officer of the Trustee has occurred and is continuing, the<br \/>\nTrustee shall exercise such rights and powers vested in it by this Indenture and<br \/>\nuse the same degree of care and skill in their exercise as a prudent Person<br \/>\nwould exercise under the circumstances in the conduct of such Person&#8217;s own<br \/>\naffairs.<\/p>\n<p>                  (b) Except during the continuance of a Default or an Event of<br \/>\n         Default:<\/p>\n<p>                  (1) The Trustee need perform only those duties and obligations<br \/>\n         that are specifically set forth in this Indenture.<\/p>\n<p>                  (2) In the absence of bad faith on its part, the Trustee may<br \/>\n         conclusively rely, as to the truth of the statements and the<br \/>\n         correctness of the opinions expressed therein, upon certificates or<br \/>\n         opinions furnished to the Trustee and conforming to the requirements of<br \/>\n         this Indenture, but, in the case of any such certificates or opinions<br \/>\n         which by any provision hereof are specifically required to be furnished<br \/>\n         to the Trustee, the Trustee shall be under a duty to examine the same<br \/>\n         to determine whether or not they conform to the requirements of this<br \/>\n         Indenture.<\/p>\n<p>                  (c) Notwithstanding anything to the contrary herein contained,<br \/>\nthe Trustee may not be relieved from liability for its own negligent action, its<br \/>\nown negligent failure to act, or its own willful misconduct, except that:<\/p>\n<p>                  (A) This paragraph does not limit the effect of paragraph (b)<br \/>\nof this SECTION 7.01.<\/p>\n<p>                  (B) The Trustee shall not be liable for any error of judgment<br \/>\n         made in good faith by a Trust Officer of the Trustee, unless it is<br \/>\n         proved that the Trustee was negligent in ascertaining the pertinent<br \/>\n         facts.<\/p>\n<p>                  (C) The Trustee shall not be liable with respect to any action<br \/>\n         it takes or omits to take in good faith in accordance with a direction<br \/>\n         received by it pursuant to SECTION 6.02, 6.04 or 6.05 hereof.<\/p>\n<p>                  (d) No provision of this Indenture shall require the Trustee<br \/>\nto expend or risk its own funds or otherwise incur any financial liability in<br \/>\nthe performance of any of its duties hereunder or to take or omit to take any<br \/>\naction under this Indenture or take any action at the request or direction of<br \/>\nHolders if it shall have reasonable grounds for believing that repayment of such<br \/>\nfunds is not assured to it or it does not receive from such Holders an indemnity<br \/>\nreasonably satisfactory to it against such risk, liability, loss, fee or expense<br \/>\nwhich might be incurred by it in compliance with such request or direction.<\/p>\n<p>                                       53<\/p>\n<p>                  (e) Whether or not expressly so provided, the provisions of<br \/>\nthe TIA and paragraphs (a), (b), (c) and (d) of this SECTION 7.01 shall govern<br \/>\nevery provision of this Indenture that in any way relates to the Trustee.<\/p>\n<p>                  (f) The Trustee shall not be liable for interest on any money<br \/>\nreceived by it except as the Trustee may agree in writing with the Company.<br \/>\nMoney held in trust by the Trustee need not be segregated from other funds<br \/>\nexcept to the extent required by the law or as otherwise agreed to in writing by<br \/>\nthe Trustee and the Company.<\/p>\n<p>                  (g) Unless otherwise specifically provided in this Indenture,<br \/>\nany demand, request direction or notice from the Company shall be sufficient if<br \/>\nsigned by an Officer of the Company.<\/p>\n<p>         Section 7.02 Rights of Trustee.  Subject to SECTION 7.01 hereof:<\/p>\n<p>                  (1) The Trustee may conclusively rely on any document believed<br \/>\n         by it in good faith to be genuine and to have been signed or presented<br \/>\n         by the proper Person. The Trustee need not investigate any fact or<br \/>\n         matter stated in the document.<\/p>\n<p>                  (2) Before the Trustee acts or refrains from acting with<br \/>\n         respect to any matters contemplated by this Indenture or the Notes it<br \/>\n         may require an Officers&#8217; Certificate or an Opinion of Counsel, or both,<br \/>\n         which shall conform to the provisions of SECTION 10.05 hereof. The<br \/>\n         Trustee shall be fully protected and shall not be liable for any action<br \/>\n         it takes or omits to take in good faith in reliance on such Officers&#8217;<br \/>\n         Certificate or Opinion of Counsel.<\/p>\n<p>                  (3) The Trustee may act through agents, attorneys, custodians<br \/>\n         or nominees and shall not be responsible for the misconduct or<br \/>\n         negligence of any agent, attorney, custodian or nominee appointed with<br \/>\n         due care by it hereunder.<\/p>\n<p>                  (4) The Trustee shall not be liable for any action it takes or<br \/>\n         omits to take in good faith which it reasonably believes to be<br \/>\n         authorized or within its rights or powers under this Indenture.<\/p>\n<p>                  (5) Before the Trustee acts or refrains from acting with<br \/>\n         respect to any matters contemplated by this Indenture or the Notes, the<br \/>\n         Trustee may consult with counsel of its selection, and the advice or<br \/>\n         opinion of such counsel, accountant, appraiser or other expert adviser<br \/>\n         whether retained or employed by the Company or the Trustee shall be<br \/>\n         full and complete authorization and protection from liability in<br \/>\n         respect of any action taken, omitted or suffered by it hereunder in<br \/>\n         good faith and in reliance thereon.<\/p>\n<p>                  (6) The Trustee shall not be bound to make any investigation<br \/>\n         into the facts or matters stated in any resolution, certificate,<br \/>\n         statement, instrument, opinion, report, notice, request, direction,<br \/>\n         consent, order, bond, debenture or other paper or document, but the<br \/>\n         Trustee, in its discretion, may make such further inquiry or<br \/>\n         investigation into such facts or matters as it may see fit, and if the<br \/>\n         Trustee shall determine in good faith to make such further inquiry or<br \/>\n         investigation, it shall be entitled to examine the books, records and<br \/>\n         premises of the Company, personally or by agent or attorney at the sole<br \/>\n         cost of the<\/p>\n<p>                                       54<\/p>\n<p>         Company and shall incur no liability or additional liability of any<br \/>\n         kind by reason of such inquiry or investigation.<\/p>\n<p>                  (7) In no event shall the Trustee be liable for the selection<br \/>\n         of investments or for investment losses incurred thereon. The Trustee<br \/>\n         shall have no liability in respect of losses incurred as a result of<br \/>\n         the liquidation of any such investment prior to its Stated Maturity or<br \/>\n         the failure of the party directing such investment to provide timely<br \/>\n         written investment direction. The Trustee shall have no obligation to<br \/>\n         invest or reinvest any amounts held hereunder in the absence of<br \/>\n         specific written investment direction.<\/p>\n<p>                  (8) The rights, privileges, immunities and protections<br \/>\n         afforded to the Trustee pursuant to this Indenture (including, without<br \/>\n         limitation, the right to be indemnified) shall also be afforded to the<br \/>\n         Trustee in each of its capacities hereunder and each Paying Agent,<br \/>\n         Registrar, Co-Registrar, Custodian, transfer agent or tender agent and<br \/>\n         each agent or other Person employed to act hereunder.<\/p>\n<p>                  (9) The Trustee shall not be deemed to have notice of any<br \/>\n         Default or Event of Default unless a Trust Officer of the Trustee has<br \/>\n         actual knowledge thereof or unless written notice of any event which is<br \/>\n         in fact such a default is received by the Trustee at the Corporate<br \/>\n         Trust Office of the Trustee, and such notice references the Notes and<br \/>\n         this Indenture.<\/p>\n<p>                  (10) The Trustee may request that the Company deliver an<br \/>\n         Officers&#8217; Certificate setting forth the names of individuals and\/or<br \/>\n         titles of officers authorized at such time to take specified actions<br \/>\n         pursuant to this Indenture, which Officers&#8217; Certificate may be signed<br \/>\n         by any person authorized to sign an Officers&#8217; Certificate, including<br \/>\n         any person specified as so authorized in any such certificate<br \/>\n         previously delivered and not superseded.<\/p>\n<p>         Section 7.03 Individual Rights of Trustee. The Trustee in its<br \/>\nindividual or any other capacity may become the owner or pledgee of Notes and<br \/>\nmay make loans to, accept deposits from, perform services for or otherwise deal<br \/>\nwith the Company, or any Affiliates thereof, with the same rights it would have<br \/>\nif it were not Trustee. Any Agent may do the same with like rights. The Trustee,<br \/>\nhowever, shall be subject to SECTIONS 7.10 and 7.11 hereof.<\/p>\n<p>         Section 7.04 Trustee&#8217;s Disclaimer. The Trustee shall not be responsible<br \/>\nfor and makes no representation as to the validity or adequacy of this Indenture<br \/>\nor the Notes or any recitals therein, it shall not be accountable for the<br \/>\nCompany&#8217;s use of the proceeds from the sale of Notes or any money paid to the<br \/>\nCompany pursuant to the terms of this Indenture and it shall not be responsible<br \/>\nfor any statement in the Notes other than its certificate of authentication.<\/p>\n<p>         Section 7.05 Notice of Defaults. If a Default or an Event of Default<br \/>\noccurs and is continuing and is known to a Trust Officer of the Trustee, the<br \/>\nTrustee shall mail to each Holder notice of the uncured Default or Event of<br \/>\nDefault within 5 days after obtaining knowledge thereof. Except in the case of a<br \/>\nDefault or an Event of Default in payment of principal of, premium, if any, or<br \/>\ninterest on, any Note, including an accelerated payment and the failure to make<br \/>\npayment on the Change of Control Payment Date pursuant to a Change of Control<br \/>\nOffer or on the Excess Proceeds Payment Date pursuant to an Asset Sale Offer,<br \/>\nand except in the case of<\/p>\n<p>                                       55<\/p>\n<p>a failure to comply with ARTICLE 5 hereof, the Trustee may withhold the notice<br \/>\nif and so long as a committee of its Trust Officers in good faith determines<br \/>\nthat withholding the notice is in the best interest of the Holders. This SECTION<br \/>\n7.05 shall be in lieu of the proviso to Section 315(b) of the TIA, and such<br \/>\nproviso of Section 315(b) of the TIA is hereby expressly excluded from this<br \/>\nIndenture and the Notes, as permitted by the TIA.<\/p>\n<p>         Section 7.06 Reports by Trustee to Holders. If required by TIA Section<br \/>\n313(a), within 60 days after May 15 of any year, commencing on May 15, 2002, the<br \/>\nTrustee shall transmit by mail to each Holder a brief report dated as of such<br \/>\nMay 15 that complies with TIA Section 313(a). The Trustee also shall comply with<br \/>\nthe reporting requirements of TIA Sections 313(b), (c) and (d).<\/p>\n<p>         A copy of each such report at the time of such mailing to Holders shall<br \/>\nbe mailed to the Company and, if the Notes are listed on a stock exchange, filed<br \/>\nwith the Commission and each stock exchange on which the Notes are listed as<br \/>\nprovided by TIA Section 313(d). The Company shall promptly notify the Trustee<br \/>\nwhen the Notes are listed on any stock exchange and any delisting thereof.<\/p>\n<p>         Section 7.07 Compensation and Indemnity. The Company shall pay to the<br \/>\nTrustee from time to time such compensation as may from time to time be agreed<br \/>\nin writing between the Company and the Trustee for its services hereunder (which<br \/>\ncompensation shall not be limited by any provision of law in regard to the<br \/>\ncompensation of a trustee of an express trust). Except as otherwise provided<br \/>\nherein, the Company shall reimburse the Trustee upon request for all reasonable<br \/>\ndisbursements, expenses and advances incurred or made by it in connection with<br \/>\nits duties under this Indenture, including the reasonable compensation,<br \/>\ndisbursements and expenses of the Trustee&#8217;s agents, counsel, custodians and<br \/>\nnominees, except for any such disbursement or expense as may be attributable to<br \/>\nthe Trustee&#8217;s negligence, bad faith or willful misconduct.<\/p>\n<p>         The Company shall indemnify each of the Trustee and its officers,<br \/>\ndirectors, employees and agents and any predecessor Trustee and its officers,<br \/>\ndirectors, employees and agents for, and hold it or them harmless against, any<br \/>\nand all loss, damage, claim, liability or reasonable expense, including taxes<br \/>\n(other than franchise taxes and taxes based on the income of the Trustee)<br \/>\nincurred by it or them in connection with the acceptance or performance of its<br \/>\nduties under this Indenture and any other documents and transactions in<br \/>\nconnection therewith including the reasonable costs and expenses of defending<br \/>\nitself against any claim (whether asserted by the Company, or any Holder or any<br \/>\nother Person) or liability in connection with the exercise or performance of any<br \/>\nof its or their powers or duties hereunder (including, without limitation,<br \/>\nsettlement costs, provided any settlement with respect to which indemnification<br \/>\nis sought shall have been consented to by the Company). The Trustee shall notify<br \/>\nthe Company in writing promptly of any claim asserted against the Trustee for<br \/>\nwhich it may seek indemnity. However, the failure by the Trustee to so notify<br \/>\nthe Company shall not relieve the Company of its obligations hereunder except to<br \/>\nthe extent the Company is prejudiced thereby. This SECTION 7.07 shall survive<br \/>\nthe termination of this Indenture and the earlier resignation or removal of the<br \/>\nTrustee.<\/p>\n<p>         Notwithstanding the foregoing, the Company need not reimburse the<br \/>\nTrustee for any expense or indemnify it against any loss, damage, claim or<br \/>\nliability incurred by the Trustee<\/p>\n<p>                                       56<\/p>\n<p>through its negligence, bad faith or willful misconduct. To secure the payment<br \/>\nobligations of the Company in this SECTION 7.07, the Trustee shall have a lien<br \/>\nprior to the Notes on all money or property held or collected by the Trustee<br \/>\nexcept such money or property held in trust to pay principal of and interest on<br \/>\nparticular Notes.<\/p>\n<p>         When the Trustee incurs expenses or renders services after an Event of<br \/>\nDefault specified in SECTION 6.01(F) or 6.01(G) hereof occurs, the expenses<br \/>\n(including the reasonable charges and expenses of its counsel) and the<br \/>\ncompensation for the services are intended to constitute expenses of<br \/>\nadministration under any Federal or state bankruptcy, insolvency or similar law.<\/p>\n<p>         The obligation of the Company under this SECTION 7.07 shall survive the<br \/>\nresignation or removal of the Trustee and the satisfaction and discharge of this<br \/>\nIndenture.<\/p>\n<p>         Section 7.08 Replacement of Trustee. The Trustee may resign by so<br \/>\nnotifying the Company in writing. The Holders of a majority in principal amount<br \/>\nof the then outstanding Notes of a particular maturity may remove the Trustee<br \/>\nwith respect to such Notes by notifying the removed Trustee and the Company in<br \/>\nwriting and may appoint a successor Trustee with the Company&#8217;s written consent.<br \/>\nThe Company may remove the Trustee at its election if:<\/p>\n<p>                  (1) the Trustee fails to comply with SECTION 7.10 hereof;<\/p>\n<p>                  (2) the Trustee is adjudged a bankrupt or an insolvent or an<br \/>\n         order for relief is entered with respect to the Trustee under any<br \/>\n         Bankruptcy Law;<\/p>\n<p>                  (3) a receiver or other public officer takes charge or control<br \/>\n         of the Trustee or its property or affairs; or<\/p>\n<p>                  (4) the Trustee otherwise becomes incapable of acting.<\/p>\n<p>         If the Trustee resigns or is removed or if a vacancy exists in the<br \/>\noffice of Trustee for any reason, the Company shall promptly appoint a successor<br \/>\nTrustee.<\/p>\n<p>         No resignation or removal of the Trustee shall become effective until<br \/>\nthe acceptance of appointment by the successor Trustee. If a successor Trustee<br \/>\ndoes not take office within 30 days after the retiring Trustee resigns or is<br \/>\nremoved, the retiring Trustee, the Company or the Holders of a majority in<br \/>\nprincipal amount of the outstanding Notes of a particular maturity may petition<br \/>\nany court of competent jurisdiction at the expense of the Company for the<br \/>\nappointment of a successor Trustee with respect to such Notes.<\/p>\n<p>         If the Trustee fails to comply with SECTION 7.10 hereof, any Holder may<br \/>\npetition any court of competent jurisdiction for the removal of the Trustee and<br \/>\nthe appointment of a successor Trustee if the Trustee fails after written<br \/>\nrequest thereof by such Holder to comply with such SECTION 7.10.<\/p>\n<p>         A successor Trustee shall deliver a written acceptance of its<br \/>\nappointment to the retiring Trustee and to the Company. Immediately following<br \/>\nsuch delivery, the resignation or removal of the retiring Trustee shall become<br \/>\neffective and the retiring Trustee shall, subject to its rights under SECTION<br \/>\n7.07 hereof, transfer all property held by it as Trustee to the successor<br \/>\nTrustee, <\/p>\n<p>                                       57<\/p>\n<p>and the successor Trustee, after any and all amounts then due and owing the<br \/>\nTrustee hereunder have been paid in full, shall have all the rights, powers and<br \/>\nduties of the Trustee under this Indenture. A successor Trustee shall mail<br \/>\nnotice of its succession to each Holder. Notwithstanding replacement of the<br \/>\nTrustee pursuant to this SECTION 7.08, the Company&#8217;s obligations under SECTION<br \/>\n7.07 hereof shall continue for the benefit of the retiring Trustee.<\/p>\n<p>         Section 7.09 Successor Trustee by Consolidation, Merger or Conversion.<br \/>\nIf the Trustee consolidates with, merges or converts into, or transfers all or<br \/>\nsubstantially all of its corporate trust assets to, another corporation, subject<br \/>\nto SECTION 7.10 hereof, the successor corporation without any further act shall<br \/>\nbe the successor Trustee. In case at the time such successor or successors by<br \/>\nmerger, conversion or consolidation to the Trustee shall succeed to the trusts<br \/>\ncreated by this Indenture any of the Notes shall have been authenticated but not<br \/>\ndelivered, any such successor to the Trustee may adopt the certificate of<br \/>\nauthentication of any predecessor trustee, and deliver such Notes so<br \/>\nauthenticated; and in case at that time any of the Notes shall not have been<br \/>\nauthenticated, any such successor to the Trustee may authenticate such Notes<br \/>\neither in the name of any predecessor hereunder or in the name of the successor<br \/>\nto the Trustee; and in all such cases such certificates shall have the full<br \/>\nforce which, under any provision of the Notes or in this Indenture, the<br \/>\ncertificate of the Trustee shall have.<\/p>\n<p>         Section 7.10 Eligibility; Disqualification. This Indenture shall always<br \/>\nhave a Trustee which shall be eligible to act as Trustee under TIA Sections<br \/>\n310(a)(1) and 310(a)(2). The Trustee shall have a combined capital and surplus<br \/>\nof at least $50,000,000 as set forth in its most recent published annual report<br \/>\nof condition. If the Trustee has or shall acquire any &#8220;conflicting interest&#8221;<br \/>\nwithin the meaning of TIA Section 310(b), the Trustee and the Company shall<br \/>\ncomply with the provisions of TIA Section 310(b); provided, however, that there<br \/>\nshall be excluded from the operation of TIA Section 310(b)(1) any indenture or<br \/>\nindentures under which other securities or certificates of interest or<br \/>\nparticipation in other securities of the Company are outstanding if the<br \/>\nrequirements for such exclusion set forth in TIA Section 310(b)(1) are met. If<br \/>\nat any time the Trustee shall cease to be eligible in accordance with the<br \/>\nprovisions of this SECTION 7.10, the Trustee shall resign immediately in the<br \/>\nmanner and with the effect hereinbefore specified in this ARTICLE 7.<\/p>\n<p>         Section 7.11 Preferential Collection of Claims Against Company. The<br \/>\nTrustee shall comply with TIA Section 311(a), excluding any creditor<br \/>\nrelationship listed in TIA Section 311(b). A Trustee who has resigned or been<br \/>\nremoved shall be subject to TIA Section 311(a) to the extent indicated therein.<\/p>\n<p>                                    ARTICLE 8<\/p>\n<p>               MODIFICATIONS, AMENDMENTS, SUPPLEMENTS AND WAIVERS<br \/>\n               &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<\/p>\n<p>         Section 8.01 Without Consent of Holders. The Company, when authorized<br \/>\nby a Board Resolution of the Company, and the Trustee may modify, amend or<br \/>\nsupplement this Indenture or the Notes, as to a single maturity of Notes or as<br \/>\nto all of the Notes, without notice to or consent of any Holder:<\/p>\n<p>                                       58<\/p>\n<p>                  (1) to cure any ambiguity, or to correct or supplement any<br \/>\n         provision in this Indenture or such Notes or make any other provisions<br \/>\n         with respect to matters or questions arising under this Indenture or<br \/>\n         such Notes; provided that, in each case, such provisions shall not<br \/>\n         adversely affect the interest of the Holders of such Notes;<\/p>\n<p>                  (2) to provide for uncertificated Notes in addition to or in<br \/>\n         place of certificated Notes;<\/p>\n<p>                  (3) to provide for the assumption by a successor corporation<br \/>\n         of the Company&#8217;s obligations under this Indenture;<\/p>\n<p>                  (4) to add guarantees with respect to the Notes;<\/p>\n<p>                  (5) to secure the Notes;<\/p>\n<p>                  (6) to add to the covenants of the Company or the Events of<br \/>\n         Default for the benefit of Holders;<\/p>\n<p>                  (7) to surrender any right or power conferred on the Company;<br \/>\n         or<\/p>\n<p>                  (8) to make any other change that does not adversely affect<br \/>\n         the rights of any Holder or to comply with any requirement of the<br \/>\n         Commission in connection with the qualification of this Indenture under<br \/>\n         the Trust Indenture Act.<\/p>\n<p>         Section 8.02 With Consent of Holders. Subject to SECTION 6.07 hereof,<br \/>\nthe Company and the Trustee may modify, amend or supplement this Indenture or<br \/>\nthe Notes, as to a single maturity of Notes or as to all of the Notes, with the<br \/>\nwritten consent of the Holders of a majority in principal amount of the then<br \/>\noutstanding Notes to be affected thereby (including consents obtained in<br \/>\nconnection with a tender offer or exchange offer for, or purchase of, such<br \/>\nNotes). Subject to SECTIONS 6.04 and 6.07 hereof, the Holders of a majority in<br \/>\nprincipal amount of such then outstanding Notes may waive compliance by the<br \/>\nCompany with any provision of this Indenture (as to such Notes) or such Notes.<br \/>\nHowever, without the consent of each Holder affected (including consents<br \/>\nobtained in connection with a tender offer or exchange offer for, or purchase<br \/>\nof, such Notes), a modification, amendment, supplement or waiver, including a<br \/>\nwaiver pursuant to SECTION 6.04 hereof, may not:<\/p>\n<p>                  (1) change the Stated Maturity of the principal of, or any<br \/>\n         installment of interest on, such Note or alter the optional redemption<br \/>\n         provisions thereof;<\/p>\n<p>                  (2) reduce the principal amount of, or premium, if any, or<br \/>\n         interest on, such Note or extend the time of payments under such Notes;<\/p>\n<p>                  (3) modify the ranking of such Notes in a manner adverse to<br \/>\n         the Holder;<\/p>\n<p>                  (4) change the place or currency of payment of principal of,<br \/>\n         or premium, if any, or interest on, such Note;<\/p>\n<p>                                       59<\/p>\n<p>                  (5) alter the provisions with respect to the obligation of the<br \/>\n         Company to make a Change of Control Offer in accordance with SECTION<br \/>\n         4.15 hereof or to make an Asset Sale Offer in accordance with SECTION<br \/>\n         4.12 hereof;<\/p>\n<p>                  (6) impair the right to institute suit for the enforcement of<br \/>\n         any payment on or with respect to such Note; or<\/p>\n<p>                  (7) reduce the percentage in principal amount of such<br \/>\n         outstanding Notes, the consent of whose Holders is required for<br \/>\n         modification or amendment of this Indenture as to such Notes or for<br \/>\n         waiver of compliance with certain provisions of this Indenture or for<br \/>\n         waiver of certain Defaults or Events of Default.<\/p>\n<p>         After an amendment, supplement or waiver under this SECTION 8.02<br \/>\nbecomes effective, the Company shall mail to the Holders of such Notes a notice<br \/>\nbriefly describing the amendment, supplement or waiver. Any failure of the<br \/>\nCompany to mail such notice, or any defect therein, shall not, however, in any<br \/>\nway impair or affect the validity of any such supplemental indenture.<\/p>\n<p>         Upon the request of the Company, accompanied by a Board Resolution<br \/>\nauthorizing the execution of any such supplemental indenture, and upon the<br \/>\nreceipt by the Trustee of evidence reasonably satisfactory to the Trustee of the<br \/>\nconsent of the Holders as aforesaid and upon receipt by the Trustee of the<br \/>\ndocuments described in SECTION 8.06 hereof, the Trustee shall join with the<br \/>\nCompany in the execution of such supplemental indenture unless such supplemental<br \/>\nindenture affects the Trustee&#8217;s own rights, duties or immunities under this<br \/>\nIndenture, in which case the Trustee may in its own discretion, but shall not be<br \/>\nobligated to, enter into such supplemental indenture.<\/p>\n<p>         It shall not be necessary for the consent of the Holders under this<br \/>\nSECTION 8.02 to approve the particular form of any proposed amendment,<br \/>\nsupplement or waiver, but it shall be sufficient if such consent approves the<br \/>\nsubstance thereof.<\/p>\n<p>         Section 8.03 Compliance with TIA. Every amendment to or supplement of<br \/>\nthis Indenture or the Notes shall comply with the TIA as then in effect.<\/p>\n<p>         Section 8.04 Revocation and Effect of Consents. Until an amendment,<br \/>\nwaiver or supplement becomes effective, a consent to it by a Holder is a<br \/>\ncontinuing consent by the Holder and every subsequent Holder of a Note or<br \/>\nportion of a Note that evidences the same debt as the consenting Holder&#8217;s Note,<br \/>\neven if notation of the consent is not made on any Note. Subject to the<br \/>\nfollowing paragraph, any such Holder or subsequent Holder may revoke the consent<br \/>\nas to such Holder&#8217;s Note or portion of such Note by notice to the Trustee or the<br \/>\nCompany received before the date on which the Trustee receives an Officers&#8217;<br \/>\nCertificate certifying that the Holders of the requisite principal amount of<br \/>\nNotes have consented (and not theretofore revoked such consent) to the<br \/>\namendment, supplement or waiver.<\/p>\n<p>         The Company may, but shall not be obligated to, fix a Record Date for<br \/>\nthe purpose of determining the Holders entitled to consent to any amendment,<br \/>\nsupplement or waiver. If a Record Date is fixed, then notwithstanding the last<br \/>\nsentence of the immediately preceding paragraph, those Persons who were Holders<br \/>\nat such Record Date (or their duly designated proxies), and only those Persons,<br \/>\nshall be entitled to revoke any consent previously given, <\/p>\n<p>                                       60<\/p>\n<p>whether or not such Persons shall continue to be Holders after such Record Date.<br \/>\nNo such consent shall be valid or effective for more than 90 days after such<br \/>\nRecord Date.<\/p>\n<p>         After an amendment, supplement or waiver becomes effective, it shall<br \/>\nbind every Holder of such Notes, unless it makes a change described in any of<br \/>\nclauses (1) through (7) of Section 8.02 hereof, in which case, the amendment,<br \/>\nsupplement or waiver shall bind only each Holder of such a Note who has<br \/>\nconsented to it and every subsequent Holder of such a Note or portion of such a<br \/>\nNote that evidences the same debt as the consenting Holder&#8217;s Note; provided that<br \/>\nany such waiver shall not, without the consent of such Holder, impair or affect<br \/>\nthe right of any Holder to receive payment of principal of and interest on such<br \/>\na Note, on or after the respective due dates expressed in such Note, or to bring<br \/>\nsuit for the enforcement of any such payment on or after such respective dates.<\/p>\n<p>         Section 8.05 Notation on or Exchange of Notes. If an amendment,<br \/>\nsupplement or waiver changes the terms of a Note, the Trustee may request the<br \/>\nHolder to deliver it to the Trustee. In such case, the Trustee shall place an<br \/>\nappropriate notation on the Note about the changed terms and return it to the<br \/>\nHolder. Alternatively, if the Company or the Trustee so determine, in exchange<br \/>\nfor the Note the Company shall issue and the Trustee shall authenticate a new<br \/>\nNote that reflects the changed terms. Failure to make the appropriate notation<br \/>\nor issue a new Note shall not affect the validity and effect of such amendment,<br \/>\nsupplement or waiver.<\/p>\n<p>         Section 8.06 Trustee To Sign Amendments, etc. The Trustee shall be<br \/>\nentitled to receive, and shall be fully protected in relying upon, an Officers&#8217;<br \/>\nCertificate and an Opinion of Counsel stating that the execution of any<br \/>\namendment, supplement or waiver authorized pursuant to this ARTICLE 8 is<br \/>\nauthorized or permitted by this Indenture and that such amendment, supplement or<br \/>\nwaiver constitutes the legal, valid and binding obligation of the Company,<br \/>\nenforceable in accordance with its terms (subject to customary exceptions). The<br \/>\nTrustee may, but shall not be obligated to, execute any such amendment,<br \/>\nsupplement or waiver which affects the Trustee&#8217;s own rights, duties or<br \/>\nimmunities under this Indenture or otherwise.<\/p>\n<p>                                    ARTICLE 9<\/p>\n<p>                       DISCHARGE OF INDENTURE; DEFEASANCE<br \/>\n                       &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;-<\/p>\n<p>         Section 9.01 Satisfaction and Discharge of Indenture. This Indenture<br \/>\nshall be discharged and shall cease to be of further effect (except those<br \/>\nobligations referred to in the penultimate paragraph of this SECTION 9.01) as to<br \/>\na designated maturity of Notes hereunder (each provision hereof referring only<br \/>\nto such designated maturity of Notes) and the Trustee, on written demand of and<br \/>\nat the expense of the Company, shall execute proper instruments acknowledging<br \/>\nsatisfaction and discharge of this Indenture, when either:<\/p>\n<p>                  (a) all Notes theretofore authenticated and delivered (other<br \/>\n         than (i) Notes which have been destroyed, lost or stolen and which have<br \/>\n         been replaced or paid as provided in SECTION 2.06 hereof and (ii) Notes<br \/>\n         for whose payment money has theretofore been deposited in trust or<br \/>\n         segregated and held in trust by the Company and thereafter repaid to<br \/>\n         the Company or discharged from such trust) have been delivered to the<br \/>\n         Trustee for cancellation; or<\/p>\n<p>                                       61<\/p>\n<p>                  (b) (i) either (A) pursuant to ARTICLE 3 hereof, the Company<br \/>\n         shall have given notice to the Trustee and mailed a notice of<br \/>\n         redemption to each Holder of the redemption of all of the Notes under<br \/>\n         arrangements satisfactory to the Trustee for the giving of such notice<br \/>\n         or (B) all Notes not theretofore delivered to the Trustee for<br \/>\n         cancellation have become due and payable; (ii) the Company has<br \/>\n         irrevocably deposited or caused to be deposited with the Trustee in<br \/>\n         trust for the purpose an amount in U.S. legal tender sufficient to pay<br \/>\n         and discharge the entire Indebtedness on such Notes not theretofore<br \/>\n         delivered to the Trustee for cancellation, for the principal of,<br \/>\n         premium, if any, and interest to the date of such deposit; (iii) no<br \/>\n         Default or Event of Default with respect to this Indenture or the Notes<br \/>\n         shall have occurred and be continuing on the date of such deposit or<br \/>\n         shall occur as a result of such deposit and such deposit will not<br \/>\n         result in a breach or violation of, or constitute a default under, any<br \/>\n         other material instrument to which the Company is a party or by which<br \/>\n         it is bound (other than a Default or Event of Default resulting from<br \/>\n         the incurrence of Indebtedness, all or a portion of which will be used<br \/>\n         to defease the Notes concurrently with such incurrence); (iv) the<br \/>\n         Company has paid or caused to be paid all other sums payable hereunder<br \/>\n         by the Company; and (v) the Company has delivered to the Trustee (A)<br \/>\n         irrevocable instructions to apply the deposited money toward payment of<br \/>\n         the Notes at the Stated Maturity thereof, and (B) an Officers&#8217;<br \/>\n         Certificate and an Opinion of Counsel each stating that all conditions<br \/>\n         precedent herein provided for relating to the satisfaction and<br \/>\n         discharge of this Indenture have been complied with and that such<br \/>\n         satisfaction and discharge does not result in a default under any<br \/>\n         material agreement or instrument then known to such counsel which binds<br \/>\n         or affects the Company.<\/p>\n<p>         Notwithstanding the foregoing paragraph, the Company&#8217;s obligations in<br \/>\nARTICLE 2 and SECTIONS 4.01, 4.07, 7.07 and 8.06 hereof shall survive until the<br \/>\nNotes are no longer outstanding pursuant to the last paragraph of SECTION 2.07<br \/>\nhereof. After the Notes are no longer outstanding pursuant to SECTION 2.07<br \/>\nhereof, the Company&#8217;s obligations under SECTIONS 7.07 and 8.06 shall survive.<\/p>\n<p>         After such delivery or irrevocable deposit, the Trustee upon request<br \/>\nshall acknowledge in writing the discharge of the Company&#8217;s obligations under<br \/>\nthe Notes and this Indenture except for those surviving obligations specified<br \/>\nabove.<\/p>\n<p>         Section 9.02 Legal Defeasance. (a) The Company may, at its option by a<br \/>\nBoard Resolution of the Board of Directors of the Company, at any time, elect to<br \/>\nhave this SECTION 9.02 be applied to all outstanding Notes of a designated<br \/>\nmaturity upon compliance with the conditions set forth in SECTION 9.04 hereof.<\/p>\n<p>                  (b) Upon the Company&#8217;s exercise under paragraph (a) hereof of<br \/>\nthe option applicable to this paragraph (b), the Company shall, subject to the<br \/>\nsatisfaction of the conditions set forth in SECTION 9.04 hereof, be deemed to<br \/>\nhave been discharged from its obligations with respect to all outstanding Notes<br \/>\nof a designated maturity on the date the conditions set forth below are<br \/>\nsatisfied (hereinafter, &#8220;Legal Defeasance&#8221;), each such reference below being<br \/>\nonly to such designated maturity of Notes. For this purpose, Legal Defeasance<br \/>\nmeans that the Company shall be deemed to have paid and discharged the entire<br \/>\nIndebtedness represented by the outstanding Notes, which shall thereafter be<br \/>\ndeemed to be &#8220;outstanding&#8221; only for the purposes of <\/p>\n<p>                                       62<\/p>\n<p>SECTION 9.05 hereof and the other Sections of this Indenture referred to in<br \/>\nclauses (i) and (ii) below, and to have satisfied all its other obligations<br \/>\nunder such Notes and this Indenture (and the Trustee, on demand of and at the<br \/>\nexpense of the Company, shall execute proper instruments acknowledging the<br \/>\nsame), except for the following provisions, which shall survive until otherwise<br \/>\nterminated or discharged hereunder: (i) the rights of Holders of outstanding<br \/>\nNotes to receive, solely from the trust fund described in SECTION 9.05 hereof<br \/>\nand as more fully set forth in such Section, payments in respect of the<br \/>\nprincipal of, premium, if any, and interest on such Notes when such payments are<br \/>\ndue on the Stated Maturity thereof (or, upon redemption, if applicable), (ii)<br \/>\nthe Company&#8217;s obligations with respect to such Notes under ARTICLE 2 and SECTION<br \/>\n4.07 hereof, (iii) the rights, powers, trusts, duties and immunities of the<br \/>\nTrustee hereunder and the Company&#8217;s obligations in connection therewith and (iv)<br \/>\nthis ARTICLE 9. Subject to compliance with this ARTICLE 9, the Company may<br \/>\nexercise its option under this SECTION 9.02 notwithstanding the prior exercise<br \/>\nof its option under SECTION 9.03 below with respect to the Notes.<\/p>\n<p>         Section 9.03 Covenant Defeasance. (a) The Company may, at its option by<br \/>\na Board Resolution of the Board of Directors of the Company, at any time, elect<br \/>\nto have this SECTION 9.03 be applied to all outstanding Notes of a designated<br \/>\nmaturity upon compliance with the conditions set forth in SECTION 9.04 hereof,<br \/>\neach such reference below being only to such designated maturity of Notes.<\/p>\n<p>                  (b) Upon the Company&#8217;s exercise under paragraph (a) hereof of<br \/>\nthe option applicable to this paragraph (b), the Company shall, subject to the<br \/>\nsatisfaction of the conditions set forth in SECTION 9.04 hereof, be released<br \/>\nfrom its obligations under the covenants contained in SECTIONS 4.05, 4.08 and<br \/>\n4.09 through 4.19, inclusive, and ARTICLE 5 hereof with respect to the<br \/>\noutstanding Notes on and after the date the conditions set forth below are<br \/>\nsatisfied (hereinafter, &#8220;Covenant Defeasance&#8221;), and the Notes shall thereafter<br \/>\nbe deemed not &#8220;outstanding&#8221; for the purposes of any direction, waiver, consent<br \/>\nor declaration or act of Holders (and the consequences of any thereof) in<br \/>\nconnection with such covenants, but shall continue to be deemed &#8220;outstanding&#8221;<br \/>\nfor all other purposes hereunder. For this purpose, such Covenant Defeasance<br \/>\nmeans that, with respect to the outstanding Notes, the Company may omit to<br \/>\ncomply with and shall have no liability in respect of any term, condition or<br \/>\nlimitation set forth in any such covenant, whether directly or indirectly, by<br \/>\nreason of any reference elsewhere herein to any such covenant or by reason of<br \/>\nany reference in any such covenant to any other provision herein or in any other<br \/>\ndocument and such omission to comply shall not constitute a Default or an Event<br \/>\nor Default under Section 6.01(c) or 6.01(d) hereof, but, except as specified<br \/>\nabove, the remainder of this Indenture, and such Notes shall be unaffected<br \/>\nthereby. In addition, upon the Company&#8217;s exercise under paragraph (a) hereof of<br \/>\nthe option applicable to this paragraph (b), subject to the satisfaction of the<br \/>\nconditions set forth in SECTION 9.04 hereof, SECTION 6.01(C) and 6.01(D) shall<br \/>\nnot constitute Events of Default.<\/p>\n<p>         Section 9.04 CONDITIONS TO LEGAL DEFEASANCE OR COVENANT DEFEASANCE. The<br \/>\nfollowing shall be the conditions to the application of either SECTION 9.02 or<br \/>\n9.03 hereof to the outstanding Notes of such designated maturity:<\/p>\n<p>         In order to exercise either Legal Defeasance or Covenant Defeasance:<\/p>\n<p>                                       63<\/p>\n<p>                  (a) the Company must irrevocably deposit or cause to be<br \/>\n         deposited with the Trustee, as trust funds in trust, specifically<br \/>\n         pledged as security for, and dedicated solely to, the benefit of the<br \/>\n         Holders, cash in U.S. dollars, or U.S. Government Obligations, or in<br \/>\n         the case of Covenant Defeasance, corporate obligations rated at least<br \/>\n         &#8220;A&#8221; by S&amp;P or at least &#8220;A&#8221; by Moody&#8217;s or a combination thereof, in such<br \/>\n         amounts as will be sufficient, in the opinion of a nationally<br \/>\n         recognized firm of independent public accountants, to pay and discharge<br \/>\n         the principal of, premium, if any, and interest on the outstanding<br \/>\n         Notes on the Stated Maturity thereof (or upon redemption, if<br \/>\n         applicable) of such principal, premium, if any, or installment of<br \/>\n         interest;<\/p>\n<p>                  (b) no Default or Event of Default with respect to the Notes<br \/>\n         shall have occurred and be continuing on the date of such deposit or,<br \/>\n         insofar as an event of bankruptcy under clause (f) or (g) of SECTION<br \/>\n         6.01 hereof is concerned, at any time during the period ending on the<br \/>\n         91st day after the date of such deposit;<\/p>\n<p>                  (c) such Legal Defeasance or Covenant Defeasance shall not<br \/>\n         result in a breach or violation of, or constitute a default under, this<br \/>\n         Indenture or any material agreement or instrument to which the Company<br \/>\n         is a party or by which it is bound;<\/p>\n<p>                  (d) in the case of Legal Defeasance, the Company shall have<br \/>\n         delivered to the Trustee an Opinion of Counsel stating that the Company<br \/>\n         has received from, or there has been published by, the Internal Revenue<br \/>\n         Service a ruling, or since the Issue Date, there has been a change in<br \/>\n         applicable federal income tax law, in either case to the effect that,<br \/>\n         and based thereon such opinion shall confirm that, the Holders of the<br \/>\n         outstanding Notes of such maturity will not recognize income, gain or<br \/>\n         loss for federal income tax purposes as a result of such defeasance and<br \/>\n         will be subject to federal income tax on the same amounts, in the same<br \/>\n         manner and at the same times as would have been the case if such<br \/>\n         defeasance had not occurred; and<\/p>\n<p>                  (e) in the case of Covenant Defeasance, the Company shall have<br \/>\n         delivered to the Trustee an Opinion of Counsel to the effect that the<br \/>\n         Holders of outstanding Notes of such maturity will not recognize<br \/>\n         income, gain or loss for federal income tax purposes as a result of<br \/>\n         such defeasance and will be subject to federal income tax on the same<br \/>\n         amounts, in the same manner and at the same times as would have been<br \/>\n         the case if such defeasance had not occurred; and<\/p>\n<p>                  (f) the Company shall have delivered to the Trustee an<br \/>\n         Officers&#8217; Certificate and an Opinion of Counsel, each stating that all<br \/>\n         conditions precedent provided for herein relating to either the Legal<br \/>\n         Defeasance or the Covenant Defeasance, as the case may be, have been<br \/>\n         complied with.<\/p>\n<p>         Section 9.05 Application of Trust Money. All money and U.S. Government<br \/>\nObligations deposited with the Trustee pursuant to SECTION 9.01 or 9.04<br \/>\nhereof in respect of the outstanding Notes of such designated maturity shall be<br \/>\nheld in trust and applied by the Trustee, in accordance with the provisions of<br \/>\nsuch Notes and this Indenture, to the payment, either directly or through any<br \/>\nPaying Agent as the Trustee may determine, to the Holders of such Notes, of all<br \/>\nsums due and to become due thereon in respect of principal, premium, if any, and<\/p>\n<p>                                       64<\/p>\n<p>accrued interest, but such money need not be segregated from other funds except<br \/>\nto the extent required by law.<\/p>\n<p>         Anything in this ARTICLE 9 to the contrary notwithstanding, the Trustee<br \/>\nshall deliver or pay to the Company from time to time upon a written request of<br \/>\nthe Company in the form of an Officers&#8217; Certificate any money or U.S. Government<br \/>\nObligations held by it as provided in SECTION 9.01 or 9.04 hereof which, in the<br \/>\nopinion of a nationally-recognized firm of independent public accountants<br \/>\nexpressed in a written certification thereof delivered to the Trustee, are in<br \/>\nexcess of the amount thereof which would then be required to be deposited to<br \/>\neffect an equivalent Legal Defeasance or Covenant Defeasance.<\/p>\n<p>         Section 9.06 Repayment to the Company. Subject to SECTIONS 9.01, 9.02,<br \/>\n9.03, 9.04, 9.05 and 9.07, the Trustee and the Paying Agent shall promptly pay<br \/>\nto the Company upon request any excess U.S. legal tender or U.S. Government<br \/>\nObligations held by them at any time and thereupon shall be relieved from all<br \/>\nliability with respect to such money. The Trustee and the Paying Agent shall pay<br \/>\nto the Company upon request any money held by them for the payment of principal,<br \/>\npremium, if any, or interest that remains unclaimed for two years; provided that<br \/>\nthe Trustee or such Paying Agent, before being required to make any payment, may<br \/>\nat the expense of the Company cause to be published once in a newspaper of<br \/>\ngeneral circulation in the City of New York or mail to each Holder entitled to<br \/>\nsuch money notice that such money remains unclaimed, and that after a date<br \/>\nspecified therein which shall be at least 30 days from the date of such<br \/>\npublication or mailing, any unclaimed balance of such money then remaining will<br \/>\nbe repaid to the Company. After payment to the Company, Holders entitled to such<br \/>\nmoney must look to the Company for payment as general creditors unless an<br \/>\napplicable law designates another Person.<\/p>\n<p>         Section 9.07 Reinstatement. If the Trustee or Paying Agent is unable to<br \/>\napply any money or U.S. Government Obligations in accordance with SECTION 9.01,<br \/>\n9.02 or 9.03 hereof by reason of any legal proceeding or by reason of any order<br \/>\nor judgment of any court or governmental authority enjoining, restraining or<br \/>\notherwise prohibiting such application, the Company&#8217;s obligations under this<br \/>\nIndenture as to such designated maturity of Notes shall be revived and<br \/>\nreinstated as though no deposit had occurred pursuant to this ARTICLE 9 until<br \/>\nsuch time as the Trustee or Paying Agent is permitted to apply all such money<br \/>\nand U.S. Government Obligations in accordance with SECTION 9.01 hereof;<br \/>\nprovided, however, that if the Company has made any payment of principal of,<br \/>\npremium, if any, or accrued interest on any Notes because of the reinstatement<br \/>\nof their obligations, the Company shall be subrogated to the rights of the<br \/>\nHolders of such Notes to receive such payment from the money and U.S. Government<br \/>\nObligations held by the Trustee or Paying Agent.<\/p>\n<p>                                   ARTICLE 10<\/p>\n<p>                                  MISCELLANEOUS<br \/>\n                                  &#8212;&#8212;&#8212;&#8212;-<\/p>\n<p>         Section 10.01 TIA Controls. If any provision of this Indenture limits,<br \/>\nqualifies or conflicts with another provision which is required to be included<br \/>\nin this Indenture by the TIA, the required provision shall control.<\/p>\n<p>                                       65<\/p>\n<p>         Section 10.02 Notices. Any notices or other communications required or<br \/>\npermitted hereunder shall be in writing, and shall be sufficiently given if made<br \/>\nby hand delivery, by telecopier or registered or certified mail, postage<br \/>\nprepaid, return receipt requested, addressed as follows:<\/p>\n<p>         If to the Company:<\/p>\n<p>                  HEALTHSOUTH Corporation<br \/>\n                  One HealthSouth Parkway<br \/>\n                  Birmingham, Alabama  35243<br \/>\n                  Telephone No.:  (205) 969-4977<br \/>\n                  Facsimile No.:  (205) 969-4730<br \/>\n                  Attention:  William W. Horton<\/p>\n<p>         If to the Trustee:<\/p>\n<p>                  National City Bank<br \/>\n                  101 South Fifth Street<br \/>\n                  3rd Floor<br \/>\n                  Louisville, KY 40202<br \/>\n                  Telephone No.:  (502) 581-7354<br \/>\n                  Facsimile No.:  (502) 581-4198<br \/>\n                  Attention:  Corporate Trust Office<\/p>\n<p>         The Company or the Trustee by written notice to the other may designate<br \/>\nadditional or different addresses for subsequent notices or communications. Any<br \/>\nnotice or communication to the Company or the Trustee, shall be deemed to have<br \/>\nbeen given or made when actually received.<\/p>\n<p>         Any notice or communication mailed to a Holder shall be mailed by<br \/>\nfirst-class mail, postage prepaid, at the address shown on the register kept by<br \/>\nthe Registrar.<\/p>\n<p>         Failure to mail a notice or communication to a Holder or any defect in<br \/>\nit shall not affect its sufficiency with respect to other Holders. If a notice<br \/>\nor communication to a Holder is mailed in the manner provided above, it shall be<br \/>\ndeemed duly given, whether or not the addressee receives it.<\/p>\n<p>         In case by reason of the suspension of regular mail service, or by<br \/>\nreason of any other cause, it shall be impossible to mail any notice as required<br \/>\nby this Indenture, then such method of notification as shall be made with the<br \/>\napproval of the Trustee shall constitute a sufficient mailing of such notice.<\/p>\n<p>         Section 10.03 Communications by Holders with Other Holders. Holders may<br \/>\ncommunicate pursuant to TIA Section 312(b) with other Holders with respect to<br \/>\ntheir rights under this Indenture or the Notes. The Company, the Trustee, the<br \/>\nRegistrar and anyone else shall have the protection of TIA Section 312(c).<\/p>\n<p>                                       66<\/p>\n<p>         Section 10.04 Certificate and Opinion as to Conditions Precedent. Upon<br \/>\nany request or application by the Company to the Trustee to take any action<br \/>\nunder this Indenture, the Company shall furnish to the Trustee:<\/p>\n<p>                  (1) an Officers&#8217; Certificate (which shall include the<br \/>\n         statements set forth in SECTION 10.05 hereof) stating that, in the<br \/>\n         opinion of the signers, all conditions precedent, if any, provided for<br \/>\n         in this Indenture relating to the proposed action have been complied<br \/>\n         with; and<\/p>\n<p>                  (2) an Opinion of Counsel (which shall include the statements<br \/>\n         set forth in SECTION 10.05 hereof) stating that, in the opinion of such<br \/>\n         counsel, all such conditions precedent, if any, provided for in this<br \/>\n         Indenture relating to the proposed action have been complied with.<\/p>\n<p>         Section 10.05 Statements Required in Certificate and Opinion. Each<br \/>\ncertificate and opinion with respect to compliance with a condition or covenant<br \/>\nprovided for in this Indenture shall include:<\/p>\n<p>                  (1) a statement that the person making such certificate or<br \/>\n         opinion has read such covenant or condition and the definitions<br \/>\n         relating thereto;<\/p>\n<p>                  (2) a brief statement as to the nature and scope of the<br \/>\n         examination or investigation upon which the statements or opinions<br \/>\n         contained in such certificate or opinion are based;<\/p>\n<p>                  (3) a statement that, in the opinion of such person, it or he<br \/>\n         has made such examination or investigation as is reasonably necessary<br \/>\n         to enable such person to express an informed opinion as to whether or<br \/>\n         not such covenant or condition has been complied with; and<\/p>\n<p>                  (4) a statement as to whether or not, in the opinion of such<br \/>\n         person, such covenant or condition has been complied with; provided,<br \/>\n         however, that with respect to matters of fact, an Opinion of Counsel<br \/>\n         may rely on an Officers&#8217; Certificate or certificates of public<br \/>\n         officials.<\/p>\n<p>         Section 10.06 Rules by Trustee and Agents. The Trustee may make<br \/>\nreasonable rules for action by or at meetings of Holders. The Registrar and<br \/>\nPaying Agent may make reasonable rules for their functions.<\/p>\n<p>         Section 10.07 Business Days; Legal Holidays. A &#8220;Business Day&#8221; is a day<br \/>\nthat is not a Legal Holiday. A &#8220;Legal Holiday&#8221; is a Saturday, a Sunday, a<br \/>\nfederally-recognized holiday or a day on which banking institutions are not<br \/>\nrequired to be open in the State of New York. If a payment date is a Legal<br \/>\nHoliday at a place of payment, payment may be made at that place on the next<br \/>\nsucceeding day that is not a Legal Holiday, and no interest shall accrue for the<br \/>\nintervening period.<\/p>\n<p>         Section 10.08 Governing Law. THIS INDENTURE AND THE NOTES SHALL BE<br \/>\nGOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE <\/p>\n<p>                                       67<\/p>\n<p>STATE OF NEW YORK, AS APPLIED TO CONTRACTS MADE AND PERFORMED WITHIN THE STATE<br \/>\nOF NEW YORK, WITHOUT REGARD TO PRINCIPLES OF CONFLICTS OF LAW. EACH OF THE<br \/>\nPARTIES HERETO AGREES TO SUBMIT TO THE JURISDICTION OF THE COURTS OF THE STATE<br \/>\nOF NEW YORK IN ANY ACTION OR PROCEEDING ARISING OUT OF OR RELATING TO THIS<br \/>\nINDENTURE OR THE NOTES.<\/p>\n<p>         Section 10.09 Waiver of Trial by Jury. The Company hereby irrevocably<br \/>\nwaives any and all rights to trial by jury in any legal proceeding arising out<br \/>\nof or relating to this Indenture.<\/p>\n<p>         Section 10.10 Submission to Jurisdiction. The Company hereby consents<br \/>\nto the non-exclusive jurisdiction of a state or federal court situated in New<br \/>\nYork, New York in connection with any dispute arising hereunder or under the<br \/>\nNotes. The Company hereby irrevocably waives, to the fullest extent permitted by<br \/>\napplicable law, any objection which it may now or hereafter have to the laying<br \/>\nof venue of any such proceeding brought in such a court and any claim that such<br \/>\nproceeding brought in such a court has been brought in an inconvenient forum.<\/p>\n<p>         Section 10.11 No Adverse Interpretation of Other Agreements. This<br \/>\nIndenture may not be used to interpret another indenture, loan, security or debt<br \/>\nagreement of the Company or any Subsidiary thereof. No such indenture, loan,<br \/>\nsecurity or debt agreement may be used to interpret this Indenture.<\/p>\n<p>         Section 10.12 No Recourse Against Others. No incorporator, director,<br \/>\nofficer, employee, stockholder or controlling person, as such, of the Company<br \/>\nshall have any liability for any obligations of the Company under the Notes or<br \/>\nthis Indenture or for any claim based on, in respect of or by reason of such<br \/>\nobligations or their creation. By accepting a Note, each Holder shall waive and<br \/>\nrelease all such liability. The waiver and release shall be part of the<br \/>\nconsideration for the issue of the Notes.<\/p>\n<p>         Section 10.13 Successors. All agreements of the Company in this<br \/>\nIndenture and the Notes shall bind its successors. All agreements of the<br \/>\nTrustee, any additional trustee and any Paying Agents in this Indenture shall<br \/>\nbind its successor.<\/p>\n<p>         Section 10.14 Multiple Counterparts. The parties may sign multiple<br \/>\ncounterparts of this Indenture. Each signed counterpart shall be deemed an<br \/>\noriginal, but all of them together represent one and the same agreement.<\/p>\n<p>         Section 10.15 Table of Contents, Headings, etc. The table of contents,<br \/>\ncross-reference sheet and headings of the Articles and Sections of this<br \/>\nIndenture have been inserted for convenience of reference only, are not to be<br \/>\nconsidered a part hereof, and shall in no way modify or restrict any of the<br \/>\nterms or provisions hereof.<\/p>\n<p>         Section 10.16 Separability. Each provision of this Indenture shall be<br \/>\nconsidered separable and if for any reason any provision shall be invalid,<br \/>\nillegal or unenforceable, the validity, legality and enforceability of the<br \/>\nremaining provisions shall not in any way be affected or impaired thereby to the<br \/>\nextent allowed by law.<\/p>\n<p>         Section 10.17 Translation. The original and controlling version of this<br \/>\nIndenture and any related agreements shall be the English language version. All<br \/>\ntranslations of this Indenture<\/p>\n<p>                                       68<\/p>\n<p>or any agreements related hereto into other languages shall be for the<br \/>\nconvenience of the parties only, and shall not control the meaning or<br \/>\napplication of this Indenture. All notices and other communications required or<br \/>\npermitted by this Indenture or any other transactional agreement must be in<br \/>\nEnglish or accompanied by an English translation, and the interpretation and<br \/>\napplication of such notices and other communications shall be based solely upon<br \/>\nthe English language version thereof.<\/p>\n<p>                                       69<\/p>\n<p>         IN WITNESS WHEREOF, the parties have caused this Indenture to be duly<br \/>\nexecuted all as of the date and year first written above.<\/p>\n<p>                                             Company:<\/p>\n<p>                                             HEALTHSOUTH CORPORATION<\/p>\n<p>                                             By: \/s\/ Malcolm E. McVay<br \/>\n                                                &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\n                                                 Name:  Malcolm E. McVay<br \/>\n                                                 Title: Executive Vice President<br \/>\n                                                        and Treasurer<\/p>\n<p>                                             Trustee:<\/p>\n<p>                                             NATIONAL CITY BANK, as Trustee<\/p>\n<p>                                             By: \/s\/ Linda Wickliffe<br \/>\n                                                &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\n                                                 Name: Linda Wickliffe<br \/>\n                                                 Title: Vice President<\/p>\n<p>                                      S-1<\/p>\n<p>                                                                      EXHIBIT A<\/p>\n<p>                             [FORM OF SERIES A NOTE]<\/p>\n<p>                                                                CUSIP No.:<\/p>\n<p>                             HEALTHSOUTH CORPORATION<\/p>\n<p>                            __% SENIOR NOTE DUE 20__<\/p>\n<p>No.                                                                   $<\/p>\n<p>         HEALTHSOUTH CORPORATION, a corporation incorporated in Delaware (the<br \/>\n&#8220;Company,&#8221; which term includes any successor entity), for value received<br \/>\npromises to pay to or registered assigns, the principal sum of $ on October 1,<br \/>\n20__.<\/p>\n<p>         Interest Payment Dates: April 1 and October 1, commencing April 1,<br \/>\n2002.<\/p>\n<p>         Record Dates:  March 15 and September 15.<\/p>\n<p>         Reference is made to the further provisions of this Note contained<br \/>\nherein and the Indenture (as defined), which will for all purposes have the same<br \/>\neffect as if set forth at this place.<\/p>\n<p>                                      A-1<\/p>\n<p>         IN WITNESS WHEREOF, the Company has caused this Note to be signed<br \/>\nmanually or by facsimile by its duly authorized directors, officers or other<br \/>\nauthorized signatories.<\/p>\n<p>                                            HEALTHSOUTH CORPORATION<\/p>\n<p>                                            By:<br \/>\n                                               &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\n                                                Name:<br \/>\n                                                Title:<\/p>\n<p>                                            By:<br \/>\n                                               &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\n                                                Name:<br \/>\n                                                Title:<\/p>\n<p>CERTIFICATE OF AUTHENTICATION<\/p>\n<p>Date:  September 28, 2001<\/p>\n<p>         This is one of the __% Senior Notes due 20__ referred to in the<br \/>\nwithin-mentioned Indenture.<\/p>\n<p>                                            NATIONAL CITY BANK, as Trustee<\/p>\n<p>                                             By:<br \/>\n                                                &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;-<br \/>\n                                                 Name:<br \/>\n                                                 Title:<\/p>\n<p>                                      A-2<\/p>\n<p>                              (REVERSE OF SECURITY)<\/p>\n<p>                            __% SENIOR NOTE DUE 20__<\/p>\n<p>         1. Interest. HEALTHSOUTH CORPORATION, a corporation incorporated in<br \/>\nDelaware (the &#8220;Company&#8221;), promises to pay interest on the principal amount of<br \/>\nthis Note at the rate per annum shown above. Interest on the Notes will accrue<br \/>\nfrom the most recent date on which interest has been paid or duly provided for,<br \/>\nor if no interest has been paid, from the date of the original issuance of the<br \/>\nNotes. The Company will pay interest semi-annually in arrears on each Interest<br \/>\nPayment Date, commencing April 1, 2002. Interest will be computed on the basis<br \/>\nof a 360-day year comprised of twelve 30-day months.<\/p>\n<p>         The Company shall pay interest on overdue principal and on overdue<br \/>\ninstallments of interest (without regard to any applicable grace periods) to the<br \/>\nextent lawful from time to time on demand at the rate borne by the Notes.<\/p>\n<p>         2. Method of Payment. The Company shall pay interest on the Notes<br \/>\n(except defaulted interest) to the Persons who are the registered Holders at the<br \/>\nclose of business on March 15 or September 15 immediately preceding the Interest<br \/>\nPayment Date (whether or not such day is a Business Day) even if the Notes are<br \/>\ncanceled on registration of transfer or registration of exchange after such<br \/>\nRecord Date. Holders must surrender Notes to a Paying Agent to collect principal<br \/>\npayments. Payments of principal and premium, if any, will be made (on<br \/>\npresentation of such Notes if in certificated form) in U.S. legal tender;<br \/>\nprovided, however, that the Company may pay principal, premium, if any, and<br \/>\ninterest by check payable in U.S. legal tender. The Company may deliver any such<br \/>\ninterest payment by check mailed to the address of the Person entitled thereto<br \/>\nas such address will appear on the security register.<\/p>\n<p>         3. Paying Agents and Registrar. Initially, National City Bank, a<br \/>\nnational banking association (the &#8220;Trustee&#8221;), will act as Paying Agent and the<br \/>\nTrustee will act as Registrar. The Company may change any Paying Agents,<br \/>\nRegistrar or co-Registrar without notice to the Holders. Neither the Company nor<br \/>\nany of its Subsidiaries or Affiliates may act as Paying Agent but may act as<br \/>\nRegistrar or co-Registrar.<\/p>\n<p>         4. Indenture. The Company issued this Note under an Indenture, dated as<br \/>\nof September 28, 2001 (the &#8220;Indenture&#8221;), by and between the Company and the<br \/>\nTrustee. This Note is one of a duly authorized issue of Initial Notes of the<br \/>\nCompany designated as its __% Senior Notes due 20__ (the &#8220;Notes&#8221;). The Notes<br \/>\ninclude the Initial Notes and the Exchange Notes issued pursuant to the<br \/>\nIndenture. The Initial Notes and the Exchange Notes of this maturity are treated<br \/>\nas a single class of securities under the Indenture. Capitalized terms herein<br \/>\nare used as defined in the Indenture unless otherwise defined herein. The terms<br \/>\nof the Notes include those stated in the Indenture and those made part of the<br \/>\nIndenture by reference to the Trust Indenture Act of 1939 (15 U.S. Code ss.ss.<br \/>\n77aaa-77bbbb) (the &#8220;TIA&#8221;), as in effect on the date of the Indenture.<br \/>\nNotwithstanding anything to the contrary herein, the Notes are subject to all<br \/>\nsuch terms, and Holders of Notes are referred to the Indenture and the TIA for a<br \/>\nstatement of them. The Notes are general unsecured obligations of the Company.<\/p>\n<p>                                      A-3<\/p>\n<p>         5. Redemption. The Notes will be redeemable, in whole or in part, at<br \/>\nthe option of the Company at any time at a redemption price equal to 100% of the<br \/>\nprincipal amount of the Notes to be redeemed plus any applicable Make-Whole<br \/>\nPremium (together, the &#8220;Redemption Price&#8221;) plus accrued interest thereon to the<br \/>\ndate of redemption.<\/p>\n<p>         &#8220;Adjusted Treasury Rate&#8221; means, with respect to any redemption date,<br \/>\nthe rate per annum equal to the semi-annual equivalent yield to maturity of the<br \/>\nComparable Treasury Issue, assuming a price for the Comparable Treasury Issue<br \/>\n(expressed as a percentage of the principal amount) equal to the Comparable<br \/>\nTreasury Price for such redemption date, plus 0.50%.<\/p>\n<p>         &#8220;Comparable Treasury Issue&#8221; means the United States Treasury security<br \/>\nselected by a Quotation Agent as having a maturity comparable to the remaining<br \/>\nterm of the Notes to be redeemed that would be utilized, at the time of<br \/>\nselection and in accordance with customary financial practice, in pricing new<br \/>\nissues of corporate debt securities of comparable maturity to the remaining term<br \/>\nof such Notes.<\/p>\n<p>         &#8220;Comparable Treasury Price&#8221; means, with respect to any redemption date,<br \/>\n(i) the average of the Reference Treasury Dealer Quotations for such redemption<br \/>\ndate, after excluding the highest and lowest of such Reference Treasury Dealer<br \/>\nQuotations, or (ii) if the Trustee obtains three or fewer such Reference<br \/>\nTreasury Dealer Quotations, the average of all such quotations.<\/p>\n<p>         &#8220;Make-Whole Premium&#8221; means, for any Note to be redeemed, a premium<br \/>\nequal to the excess (if any) of (i) as determined by a Quotation Agent, the sum<br \/>\nof the present values of the remaining scheduled payments of principal and<br \/>\ninterest on such Note discounted to the redemption date on a semi-annual basis<br \/>\n(assuming a 360-day year consisting of twelve 30-day months) at the Adjusted<br \/>\nTreasury Rate over (ii) 100% of the unpaid principal amount of such Note. If a<br \/>\nredemption date does not fall on an interest payment date, then, with respect to<br \/>\nthe interest payment immediately succeeding the redemption date, only the<br \/>\nunaccrued portion of such interest payment as of the redemption date shall be<br \/>\nincluded in the calculation pursuant to clause (i) above.<\/p>\n<p>         &#8220;Quotation Agent&#8221; means one of the Reference Treasury Dealers appointed<br \/>\nby the Trustee after consultation with the Company.<\/p>\n<p>         &#8220;Reference Treasury Dealer&#8221; means (i) each of UBS Warburg LLC and<br \/>\nDeutsche Banc Alex. Brown Inc. and their respective successors; provided,<br \/>\nhowever, that if any of the foregoing shall cease to be a primary U.S.<br \/>\nGovernment securities dealer in New York, New York (a &#8220;Primary Treasury<br \/>\nDealer&#8221;), the Company shall substitute therefor another Primary Treasury Dealer;<br \/>\nand (ii) any other Primary Treasury Dealer selected by the Trustee after<br \/>\nconsultation with the Company.<\/p>\n<p>         &#8220;Reference Treasury Dealer Quotation&#8221; means, with respect to each<br \/>\nReference Treasury Dealer and any redemption date, the average, as determined by<br \/>\nthe Trustee, of the bid and asked prices for the Comparable Treasury Issue<br \/>\n(expressed in each case as a percentage of its principal amount) quoted in<br \/>\nwriting to the Trustee by such Reference Treasury Dealer at 5:00 p.m. on the<br \/>\nthird business day preceding such redemption date.<\/p>\n<p>                                      A-4<\/p>\n<p>         If less than all of the Notes are to be redeemed at any time, selection<br \/>\nof the Notes to be redeemed will be made by the Trustee from among the<br \/>\noutstanding Notes on a pro rata basis, by lot or by any other method permitted<br \/>\nin the Indenture. On and after the redemption date, interest will cease to<br \/>\naccrue on the Notes or portions thereof called for redemption.<\/p>\n<p>         The Notes will not be entitled to any sinking fund.<\/p>\n<p>         6. Notice of Redemption. Notice of redemption under paragraph 5 of this<br \/>\nNote will be mailed at least 30 days but not more than 60 days before the<br \/>\nRedemption Date to each Holder of Notes to be redeemed at such Holder&#8217;s<br \/>\nregistered address.<\/p>\n<p>         Except as set forth in the Indenture, if monies for the redemption of<br \/>\nthe Notes called for redemption shall have been deposited with the Paying Agent<br \/>\nfor redemption on such Redemption Date, then the Notes called for redemption<br \/>\nwill cease to bear interest from and after such Redemption Date and the only<br \/>\nright of the Holders of such Notes will be to receive payment of the Redemption<br \/>\nPrice plus interest accrued through the Redemption Date, if any.<\/p>\n<p>         7. Offers to Purchase. Prior to the occurrence of the Fall-Away Event<br \/>\n(as defined in the Indenture), the Indenture provides that, after certain Asset<br \/>\nSales (as defined in the Indenture) or upon the occurrence of a Change of<br \/>\nControl (as defined in the Indenture), and subject to further limitations<br \/>\ncontained therein, the Company will make an offer to purchase certain amounts of<br \/>\nthe Notes in accordance with the procedures set forth in the Indenture.<\/p>\n<p>         8. Registration Rights. Pursuant to the Registration Rights Agreement<br \/>\nby and between the Company and the Initial Purchasers, the Company will be<br \/>\nobligated to consummate an exchange offer pursuant to which the Holder of this<br \/>\nNote shall have the right to exchange this Note for the Company&#8217;s Series B __%<br \/>\nSenior Notes due 20__ (the &#8220;Exchange Notes&#8221;), at such time as the Exchange Notes<br \/>\nshall have been registered under the Securities Act, in like principal amount<br \/>\nand having terms identical in all material respects to the Initial Notes (except<br \/>\nthat such Exchange Notes will not contain terms with respect to transfer<br \/>\nrestrictions or additional interest). The Holders of the Initial Notes shall be<br \/>\nentitled to receive certain Additional Interest payments in the event such<br \/>\nexchange offer is not consummated and upon certain other conditions, all<br \/>\npursuant to and in accordance with the terms of the Registration Rights<br \/>\nAgreement.<\/p>\n<p>         9. Denominations; Transfer; Exchange. The Notes are in definitive,<br \/>\nfully registered form, without coupons, in minimum denominations of $1,000 and<br \/>\nin integral multiples of $1,000 in excess thereof. A Holder shall register the<br \/>\ntransfer or exchange of Notes in accordance with the Indenture. The Registrar<br \/>\nmay require a Holder, among other things, to furnish appropriate endorsements<br \/>\nand transfer documents and to pay certain transfer taxes or similar governmental<br \/>\ncharges payable in connection therewith as permitted by the Indenture. The<br \/>\nRegistrar need not register the transfer of or exchange of any Notes or portions<br \/>\nthereof selected for redemption.<\/p>\n<p>         10. Persons Deemed Owners. The registered Holder of a Note shall be<br \/>\ntreated as the owner of such Note for all purposes.<\/p>\n<p>         11. Unclaimed Money. If money for the payment of principal or interest<br \/>\nremains unclaimed for two years, the Trustee and the Paying Agent will pay the<br \/>\nmoney back to the<\/p>\n<p>                                      A-5<\/p>\n<p>Company. After that, Holders entitled to money must look to the Company for<br \/>\npayment as general creditors unless an &#8220;abandoned property&#8221; law designates<br \/>\nanother person.<\/p>\n<p>         12. Legal Defeasance and Covenant Defeasance. If the Company at any<br \/>\ntime deposits with the Trustee U.S. legal tender or other obligations of the<br \/>\ntypes set forth in the Indenture sufficient to pay the principal of and interest<br \/>\non the Notes to Stated Maturity or redemption, if applicable, and complies with<br \/>\nthe other provisions of the Indenture relating to Legal Defeasance or Covenant<br \/>\nDefeasance, the Company will be discharged from certain provisions of the<br \/>\nIndenture and the Notes (including certain covenants, but excluding its<br \/>\nobligation to pay the principal of and interest on the Notes).<\/p>\n<p>         13. Amendments, Supplements, and Waivers. Subject to certain<br \/>\nexceptions, the Indenture or the Notes may be amended or supplemented with the<br \/>\nwritten consent of the Holders of at least a majority in aggregate outstanding<br \/>\nprincipal amounts of the Notes, and any existing Default or Event of Default or<br \/>\nnoncompliance with any provision may be waived with the written consent of the<br \/>\nHolders of a majority in aggregate principal amount of the Notes then<br \/>\noutstanding. Without notice to or consent of any Holder, the parties thereto may<br \/>\namend or supplement the Indenture or the Notes to, among other things, cure any<br \/>\nambiguity, defect or inconsistency or make any other change that does not<br \/>\nadversely affect in any material respect the rights of any Holder of a Note.<\/p>\n<p>         14. Restrictive Covenants. The Indenture imposes certain limitations on<br \/>\nthe ability of the Company and its Subsidiaries to, among other things, make<br \/>\npayments in respect of its Capital Stock, incur additional Indebtedness, make<br \/>\ncertain investments, sell assets, enter into transactions with Affiliates,<br \/>\ncreate Liens, merge or consolidate with or into any other Person or sell, lease,<br \/>\nconvey or otherwise dispose of all or substantially all of its assets or create<br \/>\ndividend or other payment restrictions affecting Subsidiaries of the Company.<br \/>\nSuch limitations are subject to a number of important qualifications and<br \/>\nexceptions and, in certain instances upon the occurrence of certain events,<br \/>\ncease to be binding upon the Company and its Subsidiaries. The Company must<br \/>\nreport on an annual basis to the Trustee on compliance with such limitations.<\/p>\n<p>         15. Successor. When a Successor assumes, in accordance with the<br \/>\nIndenture, all the obligations of its predecessor under the Notes and the<br \/>\nIndenture, and immediately before and thereafter no Default exists and certain<br \/>\nother conditions are satisfied, the predecessor entity will be released from<br \/>\nthose obligations.<\/p>\n<p>         16. Defaults and Remedies. Events of Default are set forth in the<br \/>\nIndenture. If an Event of Default (other than an Event of Default with respect<br \/>\nto the Company pursuant to SECTION 6.01(F) OR 6.01(G) of the Indenture) shall<br \/>\nhave occurred and be continuing, then the Trustee by written notice to the<br \/>\nCompany, or the Holders of not less than 25% in aggregate principal amount of<br \/>\nthe Notes then outstanding by written notice to the Company and the Trustee, may<br \/>\ndeclare to be immediately due and payable the entire principal amount of all the<br \/>\nNotes then outstanding plus accrued interest to the date of acceleration;<br \/>\nprovided, however, that after such acceleration but before a judgment or decree<br \/>\nbased on such acceleration is obtained by the Trustee, the Holders of a majority<br \/>\nin aggregate principal amount of the outstanding Notes by written notice to the<br \/>\nCompany and the Trustee may rescind and annul such acceleration and its<br \/>\nconsequences if all existing Events of Default, other than the nonpayment of<br \/>\nprincipal, premium,<\/p>\n<p>                                      A-6<\/p>\n<p>if any, or interest that has become due solely because of the acceleration, have<br \/>\nbeen cured or waived. No such rescission shall affect any subsequent Default or<br \/>\nimpair any right consequent thereto. In case an Event of Default with respect to<br \/>\nthe Company specified in Section 6.01(f) or 6.01(g) of the Indenture occurs, the<br \/>\nprincipal amount, together with premium, if any, and interest with respect to<br \/>\nall of the Notes, shall be due and payable immediately without any declaration<br \/>\nor other act on the part of the Trustee or the Holders of the Notes.<\/p>\n<p>         17. Trustee Dealings with Company. The Trustee under the Indenture, in<br \/>\nits individual or any other capacity, may make loans to, accept deposits from,<br \/>\nand perform services for the Company, and may otherwise deal with the Company,<br \/>\nits Subsidiaries or their respective Affiliates as if it were not the Trustee.<\/p>\n<p>         18. No Recourse Against Others. No incorporator, director, officer,<br \/>\nemployee, stockholder or controlling person, as such, of the Company shall have<br \/>\nany liability for any obligations of the Company under the Notes or the<br \/>\nIndenture or for any claim based on, in respect of or by reason of such<br \/>\nobligations or their creation. By accepting a Note, each Holder shall waive and<br \/>\nrelease all such liability. The waiver and release shall be part of the<br \/>\nconsideration for the issue of the Notes.<\/p>\n<p>         19. Authentication. This Note shall not be valid until the Trustee or<br \/>\nAuthenticating Agent manually signs the certificate of authentication on this<br \/>\nNote.<\/p>\n<p>         20. Multiple Counterparts. The parties may sign multiple counterparts<br \/>\nof this Note. Each signed counterpart shall be deemed an original but all of<br \/>\nthem together represent one and the same Note.<\/p>\n<p>         21. Governing Law. THIS NOTE SHALL BE GOVERNED BY AND CONSTRUED IN<br \/>\nACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK, AS APPLIED TO CONTRACTS MADE<br \/>\nAND PERFORMED WITHIN THE STATE OF NEW YORK, WITHOUT REGARD TO PRINCIPLES OF<br \/>\nCONFLICTS OF LAW. EACH OF THE PARTIES TO THE INDENTURE HAS AGREED TO SUBMIT TO<br \/>\nTHE JURISDICTION OF THE COURTS OF THE STATE OF NEW YORK IN ANY ACTION OR<br \/>\nPROCEEDING ARISING OUT OF OR RELATING TO THIS NOTE.<\/p>\n<p>         22. Abbreviations and Defined Terms. Customary abbreviations may be<br \/>\nused in the name of a Holder of a Note or an assignee, such as: TEN COM (=<br \/>\ntenants in common), TEN ENT (= tenants by the entireties), JT TEN (= joint<br \/>\ntenants with right of survivorship and not as tenants in common), CUST (=<br \/>\nCustodian), and U\/G\/M\/A (= Uniform Gifts to Minors Act).<\/p>\n<p>         23. CUSIP Numbers. The Company has caused CUSIP numbers to be printed<br \/>\non the Notes as a convenience to the Holders. No representation is made as to<br \/>\nthe accuracy of such numbers as printed on the Notes and reliance may be placed<br \/>\nonly on the other identification numbers printed hereon.<\/p>\n<p>         24. Indenture. Each Holder, by accepting a Note, agrees to be bound by<br \/>\nall of the terms and provisions of the Indenture, as the same may be amended<br \/>\nfrom time to time.<\/p>\n<p>                                      A-7<\/p>\n<p>         The Company will furnish to any Holder of a Note upon written request<br \/>\nand without charge a copy of the Indenture. Requests may be made to: HEALTHSOUTH<br \/>\nCorporation, One HealthSouth Parkway, Birmingham, Alabama 35243, Telephone No.<br \/>\n(205) 969-4977, Facsimile No. (205) 969-4730, Attention: William W. Horton.<\/p>\n<p>                                      A-8<\/p>\n<p>                                 ASSIGNMENT FORM<\/p>\n<p>         If you the Holder want to assign this Note, fill in the form below and<br \/>\nhave your signature guaranteed:<\/p>\n<p>I or we assign and transfer this Note to:<\/p>\n<p>&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<\/p>\n<p>&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<\/p>\n<p>&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\n                  (Print or type name, address and zip code and<br \/>\n                  social security or tax ID number of assignee)<\/p>\n<p>and irrevocably appoint                                                        ,<br \/>\n                       &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;-<br \/>\nagent to transfer this Note on the books of the Company. The agent may<br \/>\nsubstitute another to act for him.<\/p>\n<p>Date:                                       Signed:<br \/>\n       &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;               &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<\/p>\n<p>                                                     NOTICE: The signature on<br \/>\n                                                     this assignment must<br \/>\n                                                     correspond with the name as<br \/>\n                                                     it appears upon the face of<br \/>\n                                                     the within Note in every<br \/>\n                                                     particular without<br \/>\n                                                     alteration or enlargement<br \/>\n                                                     or any change whatsoever<br \/>\n                                                     and be guaranteed by the<br \/>\n                                                     endorser&#8217;s bank or broker.<\/p>\n<p>Medallion Guarantee:<br \/>\n                    &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<\/p>\n<p>                                      A-9<\/p>\n<p>                      [OPTION OF HOLDER TO ELECT PURCHASE]<\/p>\n<p>         If you want to elect to have this Note purchased by the Company<br \/>\npursuant to SECTION 4.12 or SECTION 4.15 of the Indenture, check the appropriate<br \/>\nbox:<\/p>\n<p>                                Section 4.12 |_|<br \/>\n                                Section 4.15 |_|<\/p>\n<p>         If you want to elect to have only part of this Note purchased by the<br \/>\nCompany pursuant to SECTION 4.12 or SECTION 4.15 of the Indenture, state the<br \/>\namount you elect to have purchased:<\/p>\n<p>$  ________________________<\/p>\n<p>Date:______________________ <\/p>\n<p>_____________________________________________<br \/>\n(Sign exactly as your name appears on the other side of this Note)<\/p>\n<p>                                      A-10<\/p>\n<p>                                                                       EXHIBIT B<\/p>\n<p>                             [FORM OF SERIES B NOTE]<\/p>\n<p>                                                                  CUSIP No.:<\/p>\n<p>                             HEALTHSOUTH CORPORATION<\/p>\n<p>                            __% SENIOR NOTE DUE 20__<\/p>\n<p>No.                                                                    $<\/p>\n<p>         HEALTHSOUTH CORPORATION, a corporation incorporated in Delaware (the<br \/>\n&#8220;Company,&#8221; which term includes any successor entity), for value received<br \/>\npromises to pay to or registered assigns, the principal sum of $ on October 1,<br \/>\n20__.<\/p>\n<p>         Interest Payment Dates: April 1 and October 1, commencing April 1,<br \/>\n2002.<\/p>\n<p>         Record Dates:  March 15 and September 15.<\/p>\n<p>         Reference is made to the further provisions of this Note contained<br \/>\nherein and the Indenture (as defined), which will for all purposes have the same<br \/>\neffect as if set forth at this place.<\/p>\n<p>                                      B-1<\/p>\n<p>         IN WITNESS WHEREOF, the Company has caused this Note to be signed<br \/>\nmanually or by facsimile by its duly authorized directors, officers or other<br \/>\nauthorized signatories.<\/p>\n<p>                                              HEALTHSOUTH CORPORATION<\/p>\n<p>                                              By:<br \/>\n                                                 &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\n                                                  Name:<br \/>\n                                                  Title:<\/p>\n<p>                                              By:<br \/>\n                                                 &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\n                                                  Name:<br \/>\n                                                  Title:<\/p>\n<p>CERTIFICATE OF AUTHENTICATION<\/p>\n<p>Date:<\/p>\n<p>         This is one of the __% Senior Notes due 20__ referred to in the<br \/>\nwithin-mentioned Indenture.<\/p>\n<p>                                              NATIONAL CITY BANK, as Trustee<\/p>\n<p>                                              By:<br \/>\n                                                  &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\n                                                      Authorized Signatory<\/p>\n<p>                                      B-2<\/p>\n<p>                              (REVERSE OF SECURITY)<\/p>\n<p>                            __% SENIOR NOTE DUE 20__<\/p>\n<p>         1 Interest. HEALTHSOUTH CORPORATION, a corporation incorporated in<br \/>\nDelaware (the &#8220;Company&#8221;), promises to pay interest on the principal amount of<br \/>\nthis Note at the rate per annum shown above. Interest on the Notes will accrue<br \/>\nfrom the most recent date on which interest has been paid or duly provided for,<br \/>\nor if no interest has been paid, from the date of the original issuance of the<br \/>\nNotes. The Company will pay interest semi-annually in arrears on each Interest<br \/>\nPayment Date, commencing April 1, 2002. Interest will be computed on the basis<br \/>\nof a 360-day year comprised of twelve 30-day months.<\/p>\n<p>         The Company shall pay interest on overdue principal and on overdue<br \/>\ninstallments of interest (without regard to any applicable grace periods) to the<br \/>\nextent lawful from time to time on demand at the rate borne by the Notes.<\/p>\n<p>         2. Method of Payment. The Company shall pay interest on the Notes<br \/>\n(except defaulted interest) to the Persons who are the registered Holders at the<br \/>\nclose of business on March 15 or September 15 immediately preceding the Interest<br \/>\nPayment Date (whether or not such day is a Business Day) even if the Notes are<br \/>\ncanceled on registration of transfer or registration of exchange after such<br \/>\nRecord Date. Holders must surrender Notes to a Paying Agent to collect principal<br \/>\npayments. Payments of principal and premium, if any, will be made (on<br \/>\npresentation of such Notes if in certificated form) in U.S. legal tender;<br \/>\nprovided, however, that the Company may pay principal, premium, if any, and<br \/>\ninterest by check payable in U.S. legal tender. The Company may deliver any such<br \/>\ninterest payment by check mailed to the address of the Person entitled thereto<br \/>\nas such address will appear on the security register.<\/p>\n<p>         3. Paying Agents and Registrar. Initially, National City Bank, a<br \/>\nnational banking association (the &#8220;Trustee&#8221;), will act as Paying Agent and the<br \/>\nTrustee will act as Registrar. The Company may change any Paying Agents,<br \/>\nRegistrar or co-Registrar without notice to the Holders. Neither the Company nor<br \/>\nany of its Subsidiaries or Affiliates may act as Paying Agent but may act as<br \/>\nRegistrar or co-Registrar.<\/p>\n<p>         4. Indenture. The Company issued this Note under an Indenture, dated as<br \/>\nof September 28, 2001 (the &#8220;Indenture&#8221;), by and between the Company and the<br \/>\nTrustee. This Note is one of a duly authorized issue of Exchange Notes of the<br \/>\nCompany designated as its __% Senior Notes due 20__ (the &#8220;Notes&#8221;). The Notes<br \/>\ninclude the Initial Notes and the Exchange Notes issued pursuant to the<br \/>\nIndenture. The Initial Notes and the Exchange Notes of this maturity are treated<br \/>\nas a single class of securities under the Indenture. Capitalized terms herein<br \/>\nare used as defined in the Indenture unless otherwise defined herein. The terms<br \/>\nof the Notes include those stated in the Indenture and those made part of the<br \/>\nIndenture by reference to the Trust Indenture Act of 1939 (15 U.S. Code ss.ss.<br \/>\n77aaa-77bbbb) (the &#8220;TIA&#8221;), as in effect on the date of the Indenture.<br \/>\nNotwithstanding anything to the contrary herein, the Notes are subject to all<br \/>\nsuch terms, and Holders of Notes are referred to the Indenture and the TIA for a<br \/>\nstatement of them. The Notes are general unsecured obligations of the Company.<\/p>\n<p>                                      B-3<\/p>\n<p>         5. Redemption. The Notes will be redeemable, in whole or in part, at<br \/>\nthe option of the Company at any time at a redemption price equal to 100% of the<br \/>\nprincipal amount of the Notes to be redeemed plus any applicable Make-Whole<br \/>\nPremium (together, the &#8220;Redemption Price&#8221;) plus accrued interest thereon to the<br \/>\ndate of redemption.<\/p>\n<p>         &#8220;Adjusted Treasury Rate&#8221; means, with respect to any redemption date,<br \/>\nthe rate per annum equal to the semi-annual equivalent yield to maturity of the<br \/>\nComparable Treasury Issue, assuming a price for the Comparable Treasury Issue<br \/>\n(expressed as a percentage of the principal amount) equal to the Comparable<br \/>\nTreasury Price for such redemption date, plus 0.50%.<\/p>\n<p>         &#8220;Comparable Treasury Issue&#8221; means the United States Treasury security<br \/>\nselected by a Quotation Agent as having a maturity comparable to the remaining<br \/>\nterm of the Notes to be redeemed that would be utilized, at the time of<br \/>\nselection and in accordance with customary financial practice, in pricing new<br \/>\nissues of corporate debt securities of comparable maturity to the remaining term<br \/>\nof such Notes.<\/p>\n<p>         &#8220;Comparable Treasury Price&#8221; means, with respect to any redemption date,<br \/>\n(i) the average of the Reference Treasury Dealer Quotations for such redemption<br \/>\ndate, after excluding the highest and lowest of such Reference Treasury Dealer<br \/>\nQuotations, or (ii) if the Trustee obtains three or fewer such Reference<br \/>\nTreasury Dealer Quotations, the average of all such quotations.<\/p>\n<p>         &#8220;Make-Whole Premium&#8221; means, for any Note to be redeemed, a premium<br \/>\nequal to the excess (if any) of (i) as determined by a Quotation Agent, the sum<br \/>\nof the present values of the remaining scheduled payments of principal and<br \/>\ninterest on such Note discounted to the redemption date on a semi-annual basis<br \/>\n(assuming a 360-day year consisting of twelve 30-day months) at the Adjusted<br \/>\nTreasury Rate over (ii) 100% of the unpaid principal amount of such Note. If a<br \/>\nredemption date does not fall on an interest payment date, then, with respect to<br \/>\nthe interest payment immediately succeeding the redemption date, only the<br \/>\nunaccrued portion of such interest payment as of the redemption date shall be<br \/>\nincluded in the calculation pursuant to clause (i) above.<\/p>\n<p>         &#8220;Quotation Agent&#8221; means one of the Reference Treasury Dealers appointed<br \/>\nby the Trustee after consultation with the Company.<\/p>\n<p>         &#8220;Reference Treasury Dealer&#8221; means (i) each of UBS Warburg LLC and<br \/>\nDeutsche Banc Alex. Brown Inc. and their respective successors; provided,<br \/>\nhowever, that if any of the foregoing shall cease to be a primary U.S.<br \/>\nGovernment securities dealer in New York, New York (a &#8220;Primary Treasury<br \/>\nDealer&#8221;), the Company shall substitute therefor another Primary Treasury Dealer;<br \/>\nand (ii) any other Primary Treasury Dealer selected by the Trustee after<br \/>\nconsultation with the Company.<\/p>\n<p>         &#8220;Reference Treasury Dealer Quotation&#8221; means, with respect to each<br \/>\nReference Treasury Dealer and any redemption date, the average, as determined by<br \/>\nthe Trustee, of the bid and asked prices for the Comparable Treasury Issue<br \/>\n(expressed in each case as a percentage of its principal amount) quoted in<br \/>\nwriting to the Trustee by such Reference Treasury Dealer at 5:00 p.m. on the<br \/>\nthird business day preceding such redemption date.<\/p>\n<p>                                      B-4<\/p>\n<p>         If less than all of the Notes are to be redeemed at any time, selection<br \/>\nof the Notes to be redeemed will be made by the Trustee from among the<br \/>\noutstanding Notes on a pro rata basis, by lot or by any other method permitted<br \/>\nin the Indenture. On and after the redemption date, interest will cease to<br \/>\naccrue on the Notes or portions thereof called for redemption.<\/p>\n<p>         The Notes will not be entitled to any sinking fund.<\/p>\n<p>         6. Notice of Redemption. Notice of redemption under paragraph 5 of this<br \/>\nNote will be mailed at least 30 days but not more than 60 days before the<br \/>\nRedemption Date to each Holder of Notes to be redeemed at such Holder&#8217;s<br \/>\nregistered address.<\/p>\n<p>         Except as set forth in the Indenture, if monies for the redemption of<br \/>\nthe Notes called for redemption shall have been deposited with the Paying Agent<br \/>\nfor redemption on such Redemption Date, then the Notes called for redemption<br \/>\nwill cease to bear interest from and after such Redemption Date and the only<br \/>\nright of the Holders of such Notes will be to receive payment of the Redemption<br \/>\nPrice plus interest accrued through the Redemption Date, if any.<\/p>\n<p>         7. Offers to Purchase. Prior to the occurrence of the Fall-Away Event<br \/>\n(as defined in the Indenture), the Indenture provides that, after certain Asset<br \/>\nSales (as defined in the Indenture) or upon the occurrence of a Change of<br \/>\nControl (as defined in the Indenture), and subject to further limitations<br \/>\ncontained therein, the Company will make an offer to purchase certain amounts of<br \/>\nthe Notes in accordance with the procedures set forth in the Indenture.<\/p>\n<p>         8. Denominations; Transfer; Exchange. The Notes are in definitive,<br \/>\nfully registered form, without coupons, in minimum denominations of $1,000 and<br \/>\nin integral multiples of $1,000 in excess thereof. A Holder shall register the<br \/>\ntransfer or exchange of Notes in accordance with the Indenture. The Registrar<br \/>\nmay require a Holder, among other things, to furnish appropriate endorsements<br \/>\nand transfer documents and to pay certain transfer taxes or similar governmental<br \/>\ncharges payable in connection therewith as permitted by the Indenture. The<br \/>\nRegistrar need not register the transfer of or exchange of any Notes or portions<br \/>\nthereof selected for redemption.<\/p>\n<p>         9. Persons Deemed Owners. The registered Holder of a Note shall be<br \/>\ntreated as the owner of such Note for all purposes.<\/p>\n<p>         10. Unclaimed Money. If money for the payment of principal or interest<br \/>\nremains unclaimed for two years, the Trustee and the Paying Agent will pay the<br \/>\nmoney back to the Company. After that, Holders entitled to money must look to<br \/>\nthe Company for payment as general creditors unless an &#8220;abandoned property&#8221; law<br \/>\ndesignates another person.<\/p>\n<p>         11. Legal Defeasance and Covenant Defeasance. If the Company at any<br \/>\ntime deposits with the Trustee U.S. legal tender or other obligations of the<br \/>\ntypes set forth in the Indenture sufficient to pay the principal of and interest<br \/>\non the Notes to Stated Maturity or redemption, if applicable, and complies with<br \/>\nthe other provisions of the Indenture relating to Legal Defeasance or Covenant<br \/>\nDefeasance, the Company will be discharged from certain provisions of the<br \/>\nIndenture and the Notes (including certain covenants, but excluding its<br \/>\nobligation to pay the principal of and interest on the Notes).<\/p>\n<p>                                      B-5<\/p>\n<p>         12. Amendments, Supplements, and Waivers. Subject to certain<br \/>\nexceptions, the Indenture or the Notes may be amended or supplemented with the<br \/>\nwritten consent of the Holders of at least a majority in aggregate outstanding<br \/>\nprincipal amounts of the Notes, and any existing Default or Event of Default or<br \/>\nnoncompliance with any provision may be waived with the written consent of the<br \/>\nHolders of a majority in aggregate principal amount of the Notes then<br \/>\noutstanding. Without notice to or consent of any Holder, the parties thereto may<br \/>\namend or supplement the Indenture or the Notes to, among other things, cure any<br \/>\nambiguity, defect or inconsistency or make any other change that does not<br \/>\nadversely affect in any material respect the rights of any Holder of a Note.<\/p>\n<p>         13. Restrictive Covenants. The Indenture imposes certain limitations on<br \/>\nthe ability of the Company and its Subsidiaries to, among other things, make<br \/>\npayments in respect of its Capital Stock, incur additional Indebtedness, make<br \/>\ncertain investments, sell assets, enter into transactions with Affiliates,<br \/>\ncreate Liens, merge or consolidate with or into any other Person or sell, lease,<br \/>\nconvey or otherwise dispose of all or substantially all of its assets or create<br \/>\ndividend or other payment restrictions affecting Subsidiaries of the Company.<br \/>\nSuch limitations are subject to a number of important qualifications and<br \/>\nexceptions and, in certain instances upon the occurrence of certain events,<br \/>\ncease to be binding upon the Company and its Subsidiaries. The Company must<br \/>\nreport on an annual basis to the Trustee on compliance with such limitations.<\/p>\n<p>         14. Successor. When a Successor assumes, in accordance with the<br \/>\nIndenture, all the obligations of its predecessor under the Notes and the<br \/>\nIndenture, and immediately before and thereafter no Default exists and certain<br \/>\nother conditions are satisfied, the predecessor entity will be released from<br \/>\nthose obligations.<\/p>\n<p>         15. Defaults and Remedies. Events of Default are set forth in the<br \/>\nIndenture. If an Event of Default (other than an Event of Default with respect<br \/>\nto the Company pursuant to SECTION 6.01(F) or 6.01(G) of the Indenture) shall<br \/>\nhave occurred and be continuing, then the Trustee by written notice to the<br \/>\nCompany, or the Holders of not less than 25% in aggregate principal amount of<br \/>\nthe Notes then outstanding by written notice to the Company and the Trustee, may<br \/>\ndeclare to be immediately due and payable the entire principal amount of all the<br \/>\nNotes then outstanding plus accrued interest to the date of acceleration;<br \/>\nprovided, however, that after such acceleration but before a judgment or decree<br \/>\nbased on such acceleration is obtained by the Trustee, the Holders of a majority<br \/>\nin aggregate principal amount of the outstanding Notes by written notice to the<br \/>\nCompany and the Trustee may rescind and annul such acceleration and its<br \/>\nconsequences if all existing Events of Default, other than the nonpayment of<br \/>\nprincipal, premium, if any, or interest that has become due solely because of<br \/>\nthe acceleration, have been cured or waived. No such rescission shall affect any<br \/>\nsubsequent Default or impair any right consequent thereto. In case an Event of<br \/>\nDefault with respect to the Company specified in Section 6.01(f) or 6.01(g) of<br \/>\nthe Indenture occurs, the principal amount, together with premium, if any, and<br \/>\ninterest with respect to all of the Notes, shall be due and payable immediately<br \/>\nwithout any declaration or other act on the part of the Trustee or the Holders<br \/>\nof the Notes.<\/p>\n<p>         16. Trustee Dealings with Company. The Trustee under the Indenture, in<br \/>\nits individual or any other capacity, may make loans to, accept deposits from,<br \/>\nand perform services for the Company, and may otherwise deal with the Company,<br \/>\nits Subsidiaries or their respective Affiliates as if it were not the Trustee.<\/p>\n<p>                                      B-6<\/p>\n<p>         17. No Recourse Against Others. No incorporator, director, officer,<br \/>\nemployee, stockholder or controlling person, as such, of the Company shall have<br \/>\nany liability for any obligations of the Company under the Notes or the<br \/>\nIndenture or for any claim based on, in respect of or by reason of such<br \/>\nobligations or their creation. By accepting a Note, each Holder shall waive and<br \/>\nrelease all such liability. The waiver and release shall be part of the<br \/>\nconsideration for the issue of the Notes.<\/p>\n<p>         18. Authentication. This Note shall not be valid until the Trustee or<br \/>\nAuthenticating Agent manually signs the certificate of authentication on this<br \/>\nNote.<\/p>\n<p>         19. Multiple Counterparts. The parties may sign multiple counterparts<br \/>\nof this Note. Each signed counterpart shall be deemed an original but all of<br \/>\nthem together represent one and the same Note.<\/p>\n<p>         20. Governing Law. THIS NOTE SHALL BE GOVERNED BY AND CONSTRUED IN<br \/>\nACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK, AS APPLIED TO CONTRACTS MADE<br \/>\nAND PERFORMED WITHIN THE STATE OF NEW YORK, WITHOUT REGARD TO PRINCIPLES OF<br \/>\nCONFLICTS OF LAW. EACH OF THE PARTIES TO THE INDENTURE HAS AGREED TO SUBMIT TO<br \/>\nTHE JURISDICTION OF THE COURTS OF THE STATE OF NEW YORK IN ANY ACTION OR<br \/>\nPROCEEDING ARISING OUT OF OR RELATING TO THIS NOTE.<\/p>\n<p>         21. Abbreviations and Defined Terms. Customary abbreviations may be<br \/>\nused in the name of a Holder of a Note or an assignee, such as: TEN COM (=<br \/>\ntenants in common), TEN ENT (= tenants by the entireties), JT TEN (= joint<br \/>\ntenants with right of survivorship and not as tenants in common), CUST (=<br \/>\nCustodian), and U\/G\/M\/A (= Uniform Gifts to Minors Act).<\/p>\n<p>         22. CUSIP Numbers. The Company has caused CUSIP numbers to be printed<br \/>\non the Notes as a convenience to the Holders. No representation is made as to<br \/>\nthe accuracy of such numbers as printed on the Notes and reliance may be placed<br \/>\nonly on the other identification numbers printed hereon.<\/p>\n<p>         23. Indenture. Each Holder, by accepting a Note, agrees to be bound by<br \/>\nall of the terms and provisions of the Indenture, as the same may be amended<br \/>\nfrom time to time.<\/p>\n<p>         The Company will furnish to any Holder of a Note upon written request<br \/>\nand without charge a copy of the Indenture. Requests may be made to: HEALTHSOUTH<br \/>\nCorporation, One HealthSouth Parkway, Birmingham, Alabama 35243, Telephone No.<br \/>\n(205) 969-4977, Facsimile No. (205) 969-4730, Attention: William W. Horton.<\/p>\n<p>                                      B-7<\/p>\n<p>                                 ASSIGNMENT FORM<\/p>\n<p>                  If you the Holder want to assign this Note, fill in the form<br \/>\nbelow and have your signature guaranteed:<\/p>\n<p>I or we assign and transfer this Note to:<\/p>\n<p>&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<\/p>\n<p>&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<\/p>\n<p>&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\n                  (Print or type name, address and zip code and<br \/>\n                  social security or tax ID number of assignee)<\/p>\n<p>and irrevocably appoint                                                        ,<br \/>\n                       &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\nagent to transfer this Note on the books of the Company. The agent may<br \/>\nsubstitute another to act for him.<\/p>\n<p>Date:                                       Signed:<br \/>\n       &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;               &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;-<br \/>\n                                                   (Sign exactly as your name<br \/>\n                                                    appears on the other side<br \/>\n                                                    of this Note)<\/p>\n<p>                                                     NOTICE: The signature on<br \/>\n                                                     this assignment must<br \/>\n                                                     correspond with the name as<br \/>\n                                                     it appears upon the face of<br \/>\n                                                     the within Note in every<br \/>\n                                                     particular without<br \/>\n                                                     alteration or enlargement<br \/>\n                                                     or any change whatsoever<br \/>\n                                                     and be guaranteed by the<br \/>\n                                                     endorser&#8217;s bank or broker.<\/p>\n<p>Medallion Guarantee:<br \/>\n                    &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<\/p>\n<p>                                      B-8<\/p>\n<p>                      [OPTION OF HOLDER TO ELECT PURCHASE]<\/p>\n<p>         If you want to elect to have this Note purchased by the Company<br \/>\npursuant to SECTION 4.12 or SECTION 4.15 of the Indenture, check the appropriate<br \/>\nbox:<\/p>\n<p>                                Section 4.12 |_|<br \/>\n                                Section 4.15 |_|<\/p>\n<p>         If you want to elect to have only part of this Note purchased by the<br \/>\nCompany pursuant to Section 4.12 or Section 4.15 of the Indenture, state the<br \/>\namount you elect to have purchased:<\/p>\n<p>$  ______________________<\/p>\n<p>Date:____________________<\/p>\n<p>_______________________________________<br \/>\n(Sign exactly as your name appears on the other side of this Note)<\/p>\n<p>                                      B-9<\/p>\n<p>                                                                       EXHIBIT C<\/p>\n<p>                    [FORM OF RULE 144A TRANSFER CERTIFICATE]<br \/>\n                                     [date]<\/p>\n<p>[Name of Registrar]<br \/>\n[Address of Registrar]<\/p>\n<p>Ladies and Gentlemen:<\/p>\n<p>         Reference is hereby made to the Indenture, dated as of September 28,<br \/>\n2001, between HEALTHSOUTH Corporation, as Issuer (the &#8220;Company&#8221;), and National<br \/>\nCity Bank, as Trustee. Capitalized terms used but not defined herein shall have<br \/>\nthe respective meanings given to such terms in the Indenture or Rule 144A, as<br \/>\nthe case may be.<\/p>\n<p>         [Insert the following paragraph for any transfer made pursuant to<br \/>\nSECTION 2.15(B)(VI):<\/p>\n<p>         This certificate relates to US$___________ principal amount of Notes<br \/>\nwhich are held in the form of a beneficial interest in the Restricted Global<br \/>\nNote (CUSIP No. ______________ ) with the Depositary in the name of [insert name<br \/>\nof transferor] (the &#8220;Transferor&#8221;). The Transferor has requested a transfer of<br \/>\nsuch beneficial interest for one or more Certificated Notes to be registered in<br \/>\nthe name of [insert name of transferee] (the &#8220;Transferee&#8221;).]<\/p>\n<p>         [Insert the following paragraph for any transfer made pursuant to<br \/>\nSECTION 2.15(B)(V):<\/p>\n<p>         This certificate relates to US$___________ principal amount of Notes<br \/>\nwhich are held in the form of a beneficial interest in the Regulation S Global<br \/>\nNote (CUSIP No. ______________ ) with the Depositary in the name of [insert name<br \/>\nof transferor] (the &#8220;Transferor&#8221;). The Transferor has requested a transfer of<br \/>\nsuch beneficial interest for a beneficial interest in the Restricted Global Note<br \/>\nto be registered in the name of [insert name of transferee] (the &#8220;Transferee&#8221;).]<\/p>\n<p>         [Insert the following paragraph for any transfer made pursuant to<br \/>\nSECTION 2.15(C)(III):<\/p>\n<p>         This certificate relates to US$__________ principal amount of Notes<br \/>\nwhich are held in the form of one or more Certificated Notes registered in the<br \/>\nname of [insert name of transferor (the &#8220;Transferor&#8221;). The Transferor has<br \/>\nrequested a transfer of such Certificated Notes for a beneficial interest in the<br \/>\nRestricted Global Note (CUSIP No. _____________ ) to be held [with the<br \/>\nDepositary in the name of [insert name of Transferee] (the &#8220;Transferee&#8221;).]<\/p>\n<p>         In connection with such request for transfer and in respect of such<br \/>\nNotes, the Transferor does hereby certify that such transfer is being effected<br \/>\nin accordance with the transfer restrictions set forth in the Indenture and the<br \/>\nNotes and pursuant to and in accordance with Rule 144A, and accordingly the<br \/>\nTransferor does hereby certify:<\/p>\n<p>         (1) the Transferee is a person that the Transferor and any person<br \/>\nacting on behalf of the Transferor reasonably believe is purchasing such Notes<br \/>\nfor its own account, or for one or<\/p>\n<p>                                      C-1<\/p>\n<p>more accounts with respect to which the Transferee exercises sole investment<br \/>\ndiscretion, and the Transferee and each such account is a &#8220;qualified<br \/>\ninstitutional buyer&#8221; within the meaning of Rule 144A;<\/p>\n<p>         (2) the Transferor and any person acting on its behalf has taken<br \/>\nreasonable steps to ensure that the Transferee is aware that the Transferor may<br \/>\nbe relying on Rule 144A in connection with the transaction; and<\/p>\n<p>         (3) the transaction satisfies all other requirements of Rule 144A and<br \/>\nof any applicable securities laws of any state of the United States or any other<br \/>\njurisdiction.<\/p>\n<p>         You and the Company are entitled to rely upon this certificate and are<br \/>\nirrevocably authorized to produce this certificate or a copy hereof to any<br \/>\ninterested party in any administrative or legal proceedings or official inquiry<br \/>\nwith respect to the matters covered hereby.<\/p>\n<p>                                         [Name of Transferor]<\/p>\n<p>                                         By:<br \/>\n                                            &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\n                                             Name:<br \/>\n                                             Title:<\/p>\n<p>                                      C-2<\/p>\n<p>                                                                       EXHIBIT D<\/p>\n<p>                   [FORM OF REGULATION S TRANSFER CERTIFICATE]<br \/>\n                                     [date]<\/p>\n<p>[Name of Registrar]<br \/>\n[Address of Registrar]<\/p>\n<p>Ladies and Gentlemen:<\/p>\n<p>         Reference is hereby made to the Indenture, dated as of September 28,<br \/>\n2001, between HEALTHSOUTH Corporation, as Issuer (the &#8220;Company&#8221;), and National<br \/>\nCity Bank, as Trustee. Capitalized terms used but not defined herein shall have<br \/>\nthe respective meanings given to such terms in the Indenture or Regulation S, as<br \/>\nthe case may be.<\/p>\n<p>         [Insert the following paragraph for any transfer made pursuant to<br \/>\nSECTION 2.15(B)(III) or 2.15(B)(IV):<\/p>\n<p>         This certificate relates to US$__________ principal amount of Notes<br \/>\nwhich are held in the form of a beneficial interest in the Restricted Global<br \/>\nNote (CUSIP No.__________) with the Depositary in the name of [insert name of<br \/>\ntransferor] (the &#8220;Transferor&#8221;). The Transferor has requested a transfer of such<br \/>\nbeneficial interest for a beneficial interest in the Regulation S Global Note<br \/>\n(CUSIP No.__________) to be held [[include the following for any transfer made<br \/>\npursuant to SECTION 2.15(B)(III): with [Euroclear] [Clearstream] (Common Code<br \/>\nNo.__________)] through the Depositary in the name of [insert name of<br \/>\ntransferee] (the &#8220;Transferee&#8221;).]<\/p>\n<p>         [Insert the following paragraph for any transfer made pursuant to<br \/>\nSECTION 2.15(C)(III):<\/p>\n<p>         This certificate relates to US$__________ principal amount of Notes<br \/>\nwhich are held in the form of one or more Certificated Notes registered in the<br \/>\nname of [insert name of transferor) (the &#8220;Transferor&#8221;). The Transferor has<br \/>\nrequested a transfer of such Certificated Notes for a beneficial interest in the<br \/>\nRegulation S Global Note (CUSIP No.__________) to be held [with [Euroclear]<br \/>\n[Clearstream]] through the Depositary in the name of [insert name of transferee]<br \/>\n(the &#8220;Transferee&#8221;).]<\/p>\n<p>         In connection with such request for transfer and in respect of such<br \/>\nNotes, the Transferor does hereby certify that such transfer is being effected<br \/>\nin accordance with the transfer restrictions set forth in the Indenture and the<br \/>\nNotes and pursuant to and in accordance with Regulation S, and accordingly the<br \/>\nTransferor does hereby certify:<\/p>\n<p>         (1) the offer of such Notes was not made to a person in the United<br \/>\nStates;<\/p>\n<p>         (2) either (A) at the time the buy order for such Notes was originated,<br \/>\nthe Transferee was outside the United States or the Transferor and any person<br \/>\nacting on its behalf reasonably believed that the Transferee was outside the<br \/>\nUnited States or (B) the transaction was executed in, or through the facilities<br \/>\nof, a designated offshore securities market and neither the Transferor nor<\/p>\n<p>                                      D-1<\/p>\n<p>any person acting on its behalf knew that the transaction was pre-arranged with<br \/>\na buyer in the United States,<\/p>\n<p>         (3) no directed selling efforts have been made in the United States in<br \/>\ncontravention of the requirements of Rule 903(b) or 904(b) of the Securities<br \/>\nAct, as applicable, and<\/p>\n<p>         (4) the transaction is not part of a plan or scheme to evade the<br \/>\nregistration requirements of the Securities Act.<\/p>\n<p>         [Add the following for transfers made during the Regulation S<br \/>\nDistribution Compliance Period:<\/p>\n<p>         In addition, (A) if the provisions of Rule 903(c)(3) or Rule 904(c)(1)<br \/>\nof the Securities Act are applicable to the transaction, the Transferor hereby<br \/>\ncertifies that the transfer is being made in accordance with the requirements of<br \/>\nRule 903(c)(3) or Rule 904(c)(1), as the case may be, and (B) upon completion of<br \/>\nthe transaction, the Transferee will hold the transferred beneficial interest<br \/>\nthrough Euroclear or Clearstream.]<\/p>\n<p>         You and the Company are entitled to rely upon this certificate and are<br \/>\nirrevocably authorized to produce this certificate or a copy hereof to any<br \/>\ninterested party in any administrative or legal proceedings or official inquiry<br \/>\nwith respect to the matters covered hereby.<\/p>\n<p>                                         [Name of Transferor]<\/p>\n<p>                                         By:<br \/>\n                                            &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\n                                             Name:<br \/>\n                                             Title:<\/p>\n<p>                                      D-2<\/p>\n<p>                                                                       EXHIBIT E<\/p>\n<p>                     [FORM OF RULE 144 TRANSFER CERTIFICATE]<br \/>\n                                     [date]<\/p>\n<p>[Name of Registrar]<br \/>\n[Address of Registrar]<\/p>\n<p>Ladies and Gentlemen:<\/p>\n<p>         Reference is hereby made to the Indenture, dated as of September 28,<br \/>\n2001, between HEALTHSOUTH Corporation, as Issuer (the &#8220;Company&#8221;), and National<br \/>\nCity Bank, as Trustee. Capitalized terms used but not defined herein shall have<br \/>\nthe respective meanings given to such terms in the Indenture or Rule 144, as the<br \/>\ncase may be.<\/p>\n<p>         [Insert the following paragraph for any transfer made pursuant to<br \/>\nSECTION 2.15(B)(III):<\/p>\n<p>         This certificate relates to US$__________ principal amount of Notes<br \/>\nwhich are held in the form of a beneficial interest in the Restricted Global<br \/>\nNote (CUSIP No.__________) with the Depositary in the name of [insert name of<br \/>\ntransferor] (the &#8220;Transferor&#8221;). The Transferor has requested a transfer of such<br \/>\nbeneficial interest for a beneficial interest in the Regulation S Global Note<br \/>\n(CUSIP No.__________) to be held with the Depositary in the name of [insert name<br \/>\nof transferee] (the &#8220;Transferee&#8221;).]<\/p>\n<p>         [Insert the following paragraph for any transfer made pursuant to<br \/>\nSECTION 2.15(B)(VI):<\/p>\n<p>         This certificate relates to US$__________ principal amount of Notes<br \/>\nwhich are held in the form of a beneficial interest in the Restricted Global<br \/>\nNote (CUSIP No.__________) with the Depositary in the name of [insert name of<br \/>\ntransferor] (the &#8220;Transferor&#8221;). The Transferor has requested a transfer of such<br \/>\nbeneficial interest for one or more Certificated Notes to be registered in the<br \/>\nname of [insert name of transferee] (the &#8220;Transferee&#8221;).]<\/p>\n<p>         [Insert the following paragraph for any transfer made pursuant to<br \/>\nSECTION 2.15(B)(VII):<\/p>\n<p>         This certificate relates to US$__________ principal amount of Notes<br \/>\nwhich are held in the form of a beneficial interest in the Regulation S Global<br \/>\nNote (CUSIP No.__________) with the Depositary in the name of [insert name of<br \/>\ntransferor] (the &#8220;Transferor&#8221;). The Transferor has requested a transfer of such<br \/>\nbeneficial interest for one or more Certificated Notes to be registered in the<br \/>\nname of [insert name of transferee] (the &#8220;Transferee&#8221;).]<\/p>\n<p>         In connection with such request for transfer and in respect of such<br \/>\nNotes, the Transferor does hereby certify that such transfer has been effected<br \/>\nin accordance with the transfer restrictions set forth in the Indenture and the<br \/>\nNotes, and that the Notes are being transferred in a transaction permitted by<br \/>\nRule 144 under the Securities Act.<\/p>\n<p>                                      E-1<\/p>\n<p>         You and the Company are entitled to rely upon this certificate and are<br \/>\nirrevocably authorized to produce this certificate or a copy hereof to any<br \/>\ninterested party in any administrative or legal proceedings or official inquiry<br \/>\nwith respect to the matters covered hereby,<\/p>\n<p>                                         [Name of Transferor]<\/p>\n<p>                                         By:<br \/>\n                                            &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\n                                             Name:<br \/>\n                                             Title:<\/p>\n<p>                                      E-2<\/p>\n<p>                                                                       EXHIBIT F<\/p>\n<p>               [FORM OF ACCREDITED INVESTOR TRANSFER CERTIFICATE]<br \/>\n                                     [date]<\/p>\n<p>[Name of Registrar]<br \/>\n[Address of Registrar]<\/p>\n<p>Ladies and Gentlemen:<\/p>\n<p>         Reference is hereby made to the Indenture, dated as of September 28,<br \/>\n2001, between HEALTHSOUTH Corporation, as Issuer (the &#8220;Company&#8221;), and National<br \/>\nCity Bank, as Trustee. Capitalized terms used but not defined herein shall have<br \/>\nthe respective meanings given to such terms in the Indenture or Regulation D, as<br \/>\nthe case may be.<\/p>\n<p>         [Insert the following paragraph for any transfer made pursuant to<br \/>\nSECTION 2.15(B)(VI):<\/p>\n<p>         This certificate relates to US$__________ principal amount of Notes<br \/>\nwhich are held in the form of a beneficial interest in the Restricted Global<br \/>\nNote (CUSIP No.__________) with the Depositary in the name of [insert name of<br \/>\ntransferor] (the &#8220;Transferor&#8221;). The Transferor has requested a transfer of such<br \/>\nbeneficial interest for a beneficial interest in one or more Certificated Notes<br \/>\n(CUSIP No.__________) to be held with the Depositary in the name of [insert name<br \/>\nof transferee] (the &#8220;Transferee&#8221;].<\/p>\n<p>         [Insert the following paragraph for any transfer made pursuant to<br \/>\nSECTION 2.15(B)(VII) of the Indenture:<\/p>\n<p>         This certificate relates to US$__________ principal amount of Notes<br \/>\nwhich are held in the form of a beneficial interest in the Regulation S Global<br \/>\nNote (CUSIP No.__________) with the Depositary in the name of [insert name of<br \/>\ntransferor] (the &#8220;Transferor&#8221;). The Transferor has requested a transfer of such<br \/>\nbeneficial interest for one or more Certificated Notes to be registered in the<br \/>\nname of [insert name of transferee] (the &#8220;Transferee&#8221;).]<\/p>\n<p>         [Insert the following paragraph for any transfer made pursuant to<br \/>\nSection 2.15(c)(i) of the Indenture:<\/p>\n<p>         This certificate relates to US$__________ principal amount of Notes<br \/>\nwhich are held in the form of one or more Certificated Notes registered in the<br \/>\nname of [insert name of transferor] (the &#8220;Transferor&#8221;). The Transferor has<br \/>\nrequested a transfer of such Certificated Notes for one or more Certificated<br \/>\nNotes to be registered in the name of [insert name of transferee] (the<br \/>\n&#8220;Transferee&#8221;).]<\/p>\n<p>         The undersigned represents and warrants to you that:<\/p>\n<p>         (1) We are an institutional &#8220;accredited investor&#8221; (as defined in Rule<br \/>\n501(a)(1), (2), (3) or (7) of Regulation D under the Securities Act of 1933, as<br \/>\namended (the &#8220;Securities Act&#8221;))<\/p>\n<p>                                      F-1<\/p>\n<p>purchasing for our own account or for the account of such an institutional<br \/>\n&#8220;accredited investor&#8221;, and we are acquiring the Notes not with a view to, or for<br \/>\noffer or sale in connection with, any distribution in violation of the<br \/>\nSecurities Act or other applicable securities law and we have such knowledge and<br \/>\nexperience in financial and business matters as to be capable of evaluating the<br \/>\nmerits and risks of our investment in the Notes and invest in or purchase<br \/>\nsecurities similar to the Notes in the normal course of our business. We and any<br \/>\naccounts for which we are acting are each able to bear the economic risk of our<br \/>\ninvestment.<\/p>\n<p>         (2) We understand and acknowledge that the Notes have not been<br \/>\nregistered under the Securities Act or any other applicable securities law and,<br \/>\nunless so registered, may not be sold except as permitted in the following<br \/>\nsentence. We agree on our own behalf and on behalf of any investor account for<br \/>\nwhich we are purchasing Notes to offer, sell or otherwise transfer such Notes<br \/>\nprior to the date which is two (2) years after the later of the date of original<br \/>\nissue and the last date on which the Company or any Affiliate of the Company was<br \/>\nthe owner of such Notes (or any predecessor thereto) (such later date, the<br \/>\n&#8220;Resale Restriction Termination Date&#8221;) only (a) to a Person we reasonably<br \/>\nbelieve is a qualified institutional buyer (as defined in Rule 144A under the<br \/>\nSecurities Act) that purchases for its own account or for the account of a<br \/>\nqualified institutional buyer to whom notice is given that the resale, pledge or<br \/>\ntransfer is being made in a transaction meeting the requirements of Rule 144A<br \/>\nunder the Securities Act, (b) in a transaction meeting the requirements of Rule<br \/>\n144 under the Securities Act, (c) outside the United States to a foreign person<br \/>\nin a transaction meeting the requirements of Rule 904 of Regulation S under the<br \/>\nSecurities Act or (d) in accordance with another exemption from the registration<br \/>\nrequirements of the Securities Act, provided that in the case of a transfer,<br \/>\npledge or sale pursuant to this clause (d) such transfer is subject to the<br \/>\nreceipt by the Registrar (and the Company, if it so requests) of a certification<br \/>\nof the transferor and an Opinion of Counsel to the effect that such transfer is<br \/>\nin compliance with the Securities Act, (e) to the Company or its Affiliates or<br \/>\n(f) pursuant to an effective registration statement under the Securities Act<br \/>\nand, in each case, in accordance with any applicable securities laws of any<br \/>\nstate of the United States or any other applicable jurisdiction and the<br \/>\nIndenture governing the Notes. Any transfer of Notes pursuant to clause (d)<br \/>\nabove to an institutional &#8220;accredited investor&#8221; within the meaning of Rule<br \/>\n501(a)(1), (2) (3) or (7) of Regulation D under the Securities Act that is<br \/>\npurchasing the Notes for its own account or for the account of such an<br \/>\ninstitutional &#8220;accredited investor,&#8221; shall involve a minimum purchase price of<br \/>\nUS$250,000 for such Notes, subject in each of the foregoing cases to any<br \/>\nrequirement of law that the disposition of our property or the property of such<br \/>\ninvestor account or accounts be at all times within our or their control and in<br \/>\ncompliance with any applicable state securities laws. The foregoing restrictions<br \/>\non resale will not apply subsequent to the Resale Restriction Termination Date.<br \/>\nIf any resale or other transfer of the Notes is proposed to an institutional<br \/>\n&#8220;accredited investor&#8221; prior to the Resale Restriction Termination Date, the<br \/>\ntransferor shall deliver to the Company and the Trustee a letter from the<br \/>\ntransferee substantially in the form of this letter, which shall provide, among<br \/>\nother things, that the transferee is an institutional &#8220;accredited investor&#8221;<br \/>\nwithin the meaning of Rule 501 (a)(l), (2), (3) or (7) of Regulation D under the<br \/>\nSecurities Act and that it is acquiring such Notes for investment purposes and<br \/>\nnot for distribution in violation of the Securities Act. We acknowledge that the<br \/>\nCompany and the Trustee reserve the right prior to any offer, sale or other<br \/>\ntransfer of the Notes pursuant to clause (c) or (d) above prior to the Resale<br \/>\nRestriction Termination Date to require the delivery of an opinion of counsel,<br \/>\ncertifications and\/or other information satisfactory to the Company and the<br \/>\nTrustee.<\/p>\n<p>                                      F-2<\/p>\n<p>         (3) We are acquiring the Notes purchased by us for our own account or<br \/>\nfor one or more accounts as to each of which we exercise sole investment<br \/>\ndiscretion.<\/p>\n<p>         You and the Company are entitled to rely upon this certificate and are<br \/>\nirrevocably authorized to produce this certificate or a copy hereof to any<br \/>\ninterested party in any administrative or legal proceedings or official inquiry<br \/>\nwith respect to the matters covered hereby.<\/p>\n<p>                                          [Name of Transferee]<\/p>\n<p>                                          By:<br \/>\n                                             &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;-<br \/>\n                                              Name:<br \/>\n                                              Title:<\/p>\n<p>                                      F-3<\/p>\n","protected":false},"template":"","meta":{"_acf_changed":false,"_stopmodifiedupdate":true,"_modified_date":"","_cloudinary_featured_overwrite":false},"corporate_contracts_companies":[7751,8287],"corporate_contracts_industries":[9415,9438],"corporate_contracts_types":[9560,9566],"class_list":["post-41067","corporate_contracts","type-corporate_contracts","status-publish","hentry","corporate_contracts_companies-healthsouth-corp","corporate_contracts_companies-national-city-corp","corporate_contracts_industries-financial__banks","corporate_contracts_industries-health__misc","corporate_contracts_types-finance","corporate_contracts_types-finance__indenture"],"acf":[],"_links":{"self":[{"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts\/41067","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts"}],"about":[{"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/types\/corporate_contracts"}],"wp:attachment":[{"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/media?parent=41067"}],"wp:term":[{"taxonomy":"corporate_contracts_companies","embeddable":true,"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts_companies?post=41067"},{"taxonomy":"corporate_contracts_industries","embeddable":true,"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts_industries?post=41067"},{"taxonomy":"corporate_contracts_types","embeddable":true,"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts_types?post=41067"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}